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ABSTRACT 
 
FACTORS AFFECTING COMPLIANCE WITH ANTI-HYPERTENSIVE DRUG 
TREATMENT AND REQUIRED LIFESTYLE MODIFICATIONS AMONG 
HYPERTENSIVE PATIENTS ON PRASLIN ISLAND 
 
Student:   Edo, Thomas Akpan 
Degree:   Master of Public Health 
Department: Health Studies, University of South Africa 
Supervisor:   Prof. L De Villiers 
    
Various studies on compliance with anti-hypertensive medications and 
appropriate lifestyle modifications have been conducted worldwide but studies 
specific to the Island of Praslin are lacking. The purpose of this quantitative, 
descriptive-correlational study was to describe factors that affected compliance 
with hypertension medications and lifestyle modification strategies in a sample of 
102 hypertensive persons. The comprehensive version of the Health Belief 
Model served as the conceptual framework directing the study. The researcher 
investigated whether there were any significant relationships between 
compliance and the Health Belief Model variables. Data was collected by means 
of structured interviews and document analysis, involving an interview schedule 
and a checklist. All respondents were diagnosed hypertension patients registered 
at either of the two public health centres on the Island of Praslin. Individual 
perception of the benefits and risks of hypertension treatment as well as cues to 
action were found to be significant determinants of compliance behaviour. The 
study highlighted the need for improved health education and follow-up 
measures to strengthen patients’ perceptions about the benefits of treatment and 
compliance.  
KEY TERMS 
Adherence; Compliance; Hypertension; Health Belief Model; Lifestyle 
modification; Drug treatment; Quantitative descriptive-correlational research; 
Perception. 
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CHAPTER 1 
INTRODUCTION AND OVERVIEW 
 
 
 
1.1 INTRODUCTION 
 
Ensuring patients’ compliance with antihypertension medications and lifestyle 
modifications to prevent complications of hypertension remains a major 
challenge to public health in many developing countries. Non-compliance with 
treatment is the most important single reason for uncontrolled hypertension. 
Several factors, which may be patient or health system related, continue to 
militate against compliance behaviour. Thus it is essential to identify such 
factors and develop strategies to improve compliance.  
 
This quantitative, descriptive-correlational study was focused on identifying 
and explaining factors associated with compliance with antihypertension 
medications and lifestyle modifications among diagnosed hypertensive 
patients attending outpatient clinics on the Island of Praslin, Seychelles. This 
chapter outlines the research problem, the research context and the 
background to the study. The research purpose and specific research 
questions are spelt out and an indication of the significance of this study is 
given. 
 
1.2  RESEARCH PROBLEM AND BACKGROUND TO THE STUDY 
 
1.2.1 Research problem 
 
According to Burns and Grove (2005:10), a research problem is a situation in 
need of a solution, improvement or alteration, a discrepancy between the way 
things are and the way they ought to be, which represents a knowledge gap in 
clinical practice.   
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Hypertension is a common chronic disease amenable to control by 
appropriate medication or adopting relevant lifestyle modifications. However, 
a lack of knowledge about the severity of the disease and the importance of 
adhering to the prescribed treatment, and a lack of motivation to make some 
lifestyle changes in terms of diet and physical exercise may constitute barriers 
to compliance behaviour. In certain circumstances, lifestyle modifications 
alone may be sufficient to lower blood pressure and achieve normalcy, while 
in others medication use is also required (Kaplan 2005:13; Lewanczuk 2006: 
615). 
 
Non-compliance with prescribed medications or adopting lifestyle 
modifications is associated with uncontrolled hypertension and the risks of 
developing complications (Campbell, Petrella & Kaczorowski 2006:599; 
Lahdenpera & Kyngas 2000:826). Due to increased longevity, both the 
incidence and the complications of the disease are simultaneously increasing 
thus spelling the urgent need to orchestrate increased population sensitisation 
to compliance with prescribed medication and lifestyle modification regimens 
consistent with lowering blood pressure. According to Lewanczuk (2006: 615) 
and Kaplan (2005:4) such population-based measures would help prevent 
avoidable complications and improve the quality of life of hypertensive 
patients. 
 
Antihypertension medications are provided free of charge in all public health 
centres to all those diagnosed with hypertension in Seychelles. In addition, 
health care professionals routinely offer practical advice on lifestyle 
modifications essential for lowering blood pressure. However, compliance with 
antihypertension medications is generally poor in Seychelles ranging from 
26% to 46% (Bovet, Burnier, Madeleine, Waeber & Paccaud 2002:33). 
 
According to McDonald, Garg and Haynes (2002:2869), medication 
compliance is a complex multidimensional phenomenon involving various 
personal and social factors which are not clearly understood. It is therefore 
important that health care professionals understand what factors affect 
compliance in their own context in order to manage the disease effectively.   
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While studies have been conducted universally on the subject, specific 
studies to elucidate factors associated with medication and lifestyle 
compliance behaviour on the Island of Praslin are lacking. This current study 
utilised the comprehensive framework of the Health Belief Model to identify 
and correlate multiple factors that contribute to low compliance with 
antihypertension medication and lifestyle modification regimens on the island. 
To the researcher's knowledge no such study had been performed on the 
island previously. 
 
1.2.2 Hypertension as a public health problem 
 
Hypertension is a leading cause of death in developing countries. According 
to the World Health Organization, more than 80% of deaths from hypertension 
and associated cardiovascular diseases now occur in low and middle-income 
countries and this is particularly common among people of low socio-
economic status (Boutayeb & Boutayeb 2005:2; WHO 2003a: 12). Such 
deaths occurring among economically productive age groups undermine 
socio-economic development of families in particular, and the country involved 
in general (WHO 2003a:28 ). 
 
In sub-Saharan Africa, the prevalence of hypertension once thought to be low, 
has now assumed epidemic proportions. According to Opie and Seedat 
(2005:3562), about 10 to 20 million people are affected with hypertension in 
the region. Effects of Westernisation, urbanisation, changes in dietary 
patterns and sedentary lifestyles are among the factors fuelling the epidemic 
of hypertension in sub-Saharan Africa (Opie & Seedat 2005:3565). These 
factors account for the obvious disparity between the prevalence of 
hypertension in rural and urban areas in this region. A study by Cappucio, 
Micah, Emmett, Kerry, Antwi, Martin-Peprah, Phillips, Plange-Rhule and 
Eastwood (2004:1017) found that in rural West Africa the prevalence of 
hypertension among patients older than 65 years ranged from 30% to 40%, 
while in semi-urban areas the prevalence was estimated at 50%. In another 
study, Steyn, Gaziano, Bradshaw, Laubschar and Fourie (2001:1717) 
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reported a prevalence of 50-60% among similar age groups in South Africa. 
Undoubtedly, lifestyle related factors contribute significantly to a high 
prevalence of hypertension in many countries. 
 
Research on hypertension in Seychelles indicates a high prevalence which is 
rising consistently and merits serious attention. The first population-based 
study on the prevalence of hypertension in the country conducted in 1989 by 
Bovet, Shamlaye, Kitua, Riesen, Paccaud and Darioli (1991:1730), found that 
the prevalence of hypertension among respondents aged 25-64 years was 
28% among men (n=513) and 22% among women (n=568). In 1997, a 
population based knowledge, attitudes and practices survey conducted in the 
country by Aubert, Bovet, Gervasoni, Rwebogora, Waeber and Paccaud 
(1998:1136) reported an increase in the prevalence of hypertension among 
men and women aged 25-64 years to 35.8% and 25% respectively. 
Hypertension was defined as having blood pressure ≥160/95 mmHg. In 2006 
another study conducted by Bovet, Shamlaye, Gabriel, Riesen and Paccaud 
(2006:9) found a markedly increased prevalence of 43.6% among men, and 
35.5% among women for the same age group. Although hypertension was 
defined as blood pressure ≥140/90 mm Hg in the latter study, it can be 
concluded the prevalence shows an increase in the population. Unfortunately, 
no further population-based study has been conducted in the country since 
2006. 
 
The consequences of a high prevalence of hypertension and related 
cardiovascular diseases constitute the leading cause of morbidity, disability 
and mortality in Seychelles. The statistical reports of the Ministry of Health 
reveal that between 1995 and 2005, mortality due to hypertensive diseases 
alone oscillated between 14% and 19% against total mortality (Seychelles 
Health Statistics 2005:10). When combined with diabetes and other 
cardiovascular diseases, the total mortality approached 40% for the same 
period (Ministry of Health 2005:14).  
 
Various factors are considered to be responsible for the high prevalence of 
hypertension in the country. Among these is the fact that Seychelles, a 
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medium income country, began to witness epidemiological transition in the 
early 1970's (WHO 2005:6). Like many other developing countries, as a result 
of increased longevity and improvement in the standard of living as well as the 
influence of the western lifestyle such as cigarette smoking and alcohol 
consumption, hypertension has assumed a major public health predicament.  
Risk factors for hypertension such as a sedentary lifestyle, obesity, 
consumption of fatty foods and resultant dyslipidemia are highly prevalent in 
the population and these factors contribute to the epidemic (Bovet et al 2006: 
9; WHO 2003b: 38).  
 
The high prevalence of hypertension in the country calls for concern for two 
major reasons. Firstly, the relatively small population size requires a healthy 
workforce as the driving force of the economy. The workforce should be 
protected from chronic debilitating illnesses, which could affect productivity. 
Secondly, health care is offered free of charge to all citizens at enormous 
cost. The cost of treating complicated hypertension and associated 
cardiovascular diseases is high  and constitutes a significant financial burden 
on the state (UNDP 2003b:7). Bovet et al (2006:9) estimate that it would take 
US$45.6 per capita to treat a high-risk cardiovascular patient in Seychelles. A 
high-risk patient is defined by the said author as a hypertensive person with 
related co-morbidities such as dyslipidemia and diabetes. The cost was 
analysed as follows: hypertension US$11.2, diabetes US$3.8 and 
dyslipidemia US$ 30.6. The researchers noted that the cost of treatment 
needed to reduce these conditions in the population, exceeds the normal 
budget in most low- and middle-income countries. 
 
A serious problem in the management of hypertension in the country is the 
phenomenon of non-compliance with antihypertension medications. It is 
estimated that more than 70% of patients on antihypertension medications do 
not take them as prescribed. During 2001, Bovet et al (2002:33-39) monitored 
the compliance to antihypertension medications in Seychelles over a period of 
one year. The researchers found that only 46% (n=1067) were compliant in 
the first month and this percentage decreased to 26% by the twelfth month. 
This low level of medication compliance is worrisome because it contributes to 
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an increasing level of morbidity and mortality due to hypertensive diseases in 
the country. 
 
There is a lack of data estimating compliance of patients to lifestyle 
modification requirements, but judging by the low level of medication 
compliance it is conceivable that compliance with lifestyle modification 
regimens, which requires greater efforts to execute, would be equally low. 
 
1.3 CONTEXTUALISING THE RESEARCH PROBLEM 
 
1.3.1 Location  
 
Seychelles is a tropical archipelago consisting of 116 granitic and coral 
islands located in the south-western part of the Indian Ocean about 1600 km 
east of Kenya and northeast of the islands of Madagascar and Mauritius.  Its 
land area constitutes 445km2, while the country’s exclusive economic zone 
covers over 1.3 million km2
 
 of vast marine reserves. The entire population live 
on the three main islands of Mahe, Praslin and La Digue with Mahe hosting 
the country’s capital - Victoria (Seychelles in Figure 2007:2). 
Praslin Island, the second largest in Seychelles shares similar cultural and 
socio-economic characteristics with the other islands. Its population of over 
7000 inhabitants are mainly involved in fishing and tourism related activities 
(Seychelles in Figures 2007: 4). The island is only 11km long and 4km, wide 
and is situated 40km away from the main Island of Mahe. Its land area of 38 
km2
 
 is characterised by numerous gigantic boulders dotting the coastline while 
the interior is predominantly virgin forest. Praslin is home to Vallee de Mai 
National Park – a UNESCO World Heritage site and a popular tourist 
destination since 1984. The Park grows the unique palm trees that bear the 
world’s largest seed called Coco de Mer, which is shaped like the female 
pelvis (Seychelles in Figures 2007: 4).  
The two administrative districts of Baie Sainte Anne and Grand Anse lie 10km 
apart with Baie Sainte Anne serving as the island’s headquarters. The two 
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public health institutions on the island are Grand Anse Health Centre, and 
Baie Sainte Anne Hospital and Health Centre. The latter offers some 
secondary health care services in addition to primary health care because of 
the remoteness of the island (Seychelles in Figures 2007:4).  
 
1.3.2 Socio-economic development  
 
Seychelles is regarded as a middle-income country with a relatively high GNP 
per capita, which in 2006 was estimated at US$ 16560 - the highest in Sub-
Saharan Africa  (WHOSIS 2008). The high level of sanitation coupled with 
free health care and education has resulted in a relatively high standard of 
living among the population (Ministry of Health 2004:2). The economic and 
social development of the country is remarkably impressive such that in 2002, 
the Human Development Index of the United Nation Development Programme 
placed it 36th out of 193 in the world, making it the only African country to be 
in the High Human Development category (UNDP 2003a:199). However, the 
recent UNDP report (UNDP 2007:259) places the country in the 50th
 
 position.  
The degree of socio-economic development is impressive despite its small 
economic base and vulnerability to external shocks such as the spiralling 
price of crude oil, which resulted in a reduction in tourism earnings (UNDP 
2003b:7). According to Rosalie and Campling (2004:7), Seychelles’ 
vulnerabilities to external shocks are implicitly comprehended when 
conceptualised in the context of Small Island Developing States. The small 
population size and remoteness from major international markets coupled with 
a limited resource base (tourism & fisheries) hinder competitiveness and 
impede serious macroeconomic development. The economy depends heavily 
on imports of both consumer items and capital inputs rendering it not only 
highly vulnerable to these external shocks which it absorbs, but also to 
consistent trade deficits (National HIV and AIDS Strategic Plan 
2005:14;UNDP 2003b:7).  
 
Therefore, the country’s limited financial means underscore the importance of 
compliance to hypertension treatment to reduce the risk of developing co-
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morbidities. The added costs of non-compliance is high due to having to treat 
complications such as cardiovascular and neurovascular diseases (refer to 
section 2.5). This implies a financial burden which the country can ill afford. 
 
1.3.3 Demography 
 
The total population of Seychelles in 2006 was estimated at 84600. Persons 
younger than 15 years constituted 23.8%; Persons 15-44 years constituted 
50.9%; 45-64 years 17.5%; and  65 years and above 7.8% of the population. 
The sex ratio (male:female) for all ages  was 91:100. Currently the entire 
population live on the three main islands of Mahe (87.4%), Praslin (8.7%) and 
La Digue (3.9%) (MISD 2004:14; Seychelles in Figures 2007:9; WHO 2005:5).
 
 
Fertility and mortality have been declining resulting in the reduction in 
population growth. For instance, between 2000 and 2008 the annual 
population growth rate ranged from 0.428 to 0.49. The total fertility rate 
declined from 7 children per woman in 1966 to 2.1 children per woman in 
1997 and has remained constant since 1997. Due to declining fertility and 
mortality, the overall age of the population showed an increase. About 10% of 
the population reached the age of 60 years (MISD 2004:14; WHO 2005: 5). 
Between 1960 and 2002, the average life expectancy at birth for both sexes 
rose from 63.4 years to 70.9 years. In 2006 the average life expectancy for 
both sexes was 72.2 years (males 68.9 years and females 75.7 years). For 
men, the life expectancy increased from 58.4 years to 66.6 years from 1980 to 
2002. For the same period, that of women increased from 67.8 years to 75.8 
years (Seychelles in Figures 2007:9; Rosalie & Campling 2004:7; WHOSIS 
2009).  
The importance of an increasing ageing population is reflected in the 
preponderance of non-communicable diseases, particularly hypertension, 
diabetes and cancers as the leading causes of morbidity and disability. The 
virtual elimination of vaccine preventable diseases due to high national 
immunisation coverage has brought to the fore, non-communicable diseases 
as the major burden of health care (Ministry of Health 2004:2). In 2006, the 
mortality distribution was cardiovascular diseases 36%; neoplasms 16%; 
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respiratory diseases 12%; and endocrine diseases 8% (Seychelles in Figures 
2007:12).  
 
A resounding problem has been bridging the decade gap between the life 
expectancy of women and men in favour of the former. The Health Authority 
already recognised this discrepancy and in its 2005 report, the male gender 
was construed as a vulnerable group with urgent need for targeted 
intervention. This and subsequent reports highlight the observation that males 
in the country are more prone than the females to external injuries, less 
compliant with treatment for chronic diseases, have higher propensity to 
abuse alcohol, cigarettes and drugs and generally seek medical treatment at 
the eleventh hour when the health problem is in an advanced stage of 
progression. Targeted interventions, which should include improving 
compliance with drug treatment and adoption of lifestyle changes consistent 
with good health, remain a challenge to public health practice in Seychelles 
(Ministry of Health 2005: 18; Seychelles in Figures 2007:33). 
 
1.3.4 Socio-cultural characteristics of Seychelles  
 
Seychellois (Seychelles citizens) have a rich mixed cultural heritage drawn 
from Europe, Africa and Asia, synthesised into a unique harmonious hybrid - 
called the Creole culture. It is estimated that 65% of the population are from 
black African descent, 10% are Caucasian, 5% have Indian or Chinese origin 
and the remaining 20% are mixed (Bovet et al 1991:1730). Creole, English 
and French are the major languages which are widely spoken. Most 
Seychellois embrace the Christian faith, although adherents of other religions 
such as Bahai, Hindu and Islam are also present.  
 
1.3.5 Health care system 
 
The national health care system operates on the philosophy of Health for all 
and Health by all. Health for all implies the recognition of the fundamental 
human right of every citizen to achieving good health and the centrality of 
national health to wealth creation and social stability. Health by all implies the 
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recognition of peoples’ responsibility for their own health. The government 
remains the main provider of health care in Seychelles (Ministry of Health 
2005: 23). This philosophy translates to a strong political commitment to 
health care, a commitment stoutly supported by Seychelles Constitution. 
Article 29 of the 1994 Constitution states the following: 
“ The State recognizes the right of every citizen to protection of health 
and the enjoyment of the highest attainable standards of physical and 
mental health and with a view to ensuring the effective exercise of this 
right, the State undertakes: (a) to take steps to provide free primary 
health care in State health institutions for all its citizens…" (Seychelles 
Constitution 1994:33). 
 
1.3.5.1 The structure of the national health care system   
 
The national health care system is structured on the tier system for health 
care delivery and is organised on the three main levels of care - primary, 
secondary and tertiary.  
 
• Primary health care  
 
Primary health care is the first level of care and entry point to the national 
health care system. It forms the cornerstone of the country’s health care 
delivery. This approach has been adopted and implemented since 1979 
(Ministry of Health 2005: 3). Primary health care is focused on the 
comprehensive provision of basic preventive, curative and rehabilitative 
services in the community in line with the global primary health care strategy.  
 
There are 16 geopolitical districts each with a health centre offering these 
services. As stated in section 1.3.5 constitutionally, access to primary care is 
free at all points of use while the government regulates access to other levels 
of care (Ministry of Health 2005: 4). 
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• Secondary health care 
 
At present Victoria Hospital Mahe, serves as the main referral hospital offering 
secondary care and to a limited extent, tertiary care. Patients are referred 
from the primary health care centres to the hospital according to standard 
protocols. The hospital offers specialist services in various fields including 
obstetrics and gynaecology, emergency medicine, paediatrics, internal 
medicine and oncology. Other specialities include general and orthopaedic 
surgery, ophthalmology, otolaryngology, psychiatry and pathology. Each 
specialty is headed by a consultant-in-charge (WHO 2005:15). 
 
• Tertiary care 
 
Patients are usually sent abroad for tertiary care.  However, local capacity is 
being strengthened to provide such services locally. Such overseas 
treatments are usually undertaken on the recommendation of a Board of 
Consultants instituted for such purposes by the Ministry of Health (Ministry of 
Health 2005: 5). 
 
• Private health care 
 
In 1979, the government banned private health care practice but lifted the ban 
in 1992. At present, there are few private medical practitioners on the two 
major islands of Mahe and Praslin functioning as primary health care 
providers (WHO 2005:16
 
). 
1.3.5.2 Organis
 
ation of the Ministry of Health 
The Minister, appointed by the President of the Republic heads the Ministry.  
The Principal Secretary, also appointed by the President, is the Chief 
Executive Officer of the Ministry. His responsibilities include among others the 
management of health resources and programmes to achieve the overall aim 
of improving the health status of the population. A Central Management Board 
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is constituted to assist the Principal Secretary in performing these tasks. To 
enhance service delivery, the Ministry of Health is divided into 6 divisions:  
Primary Health Care, Health Planning, Research and Information, Disease 
Prevention and Control, Health Education and Promotion, Hospital Services, 
and Administration and Finance (WHO 2005:7). 
 
1.3.5.3  Health financing 
 
Health care is financed according to the following proportions: general 
taxation (80%), donors (15%) and user fees (5%). User fees are requested for 
services regarded as non-essential and which falls outside the purview of 
primary health care. The government attaches high priority to health 
development and demonstrates very strong political commitment towards the 
provision of health care services in the country. For instance, in 2003, the 
Ministry of Health received the highest allotment of 16% in the national budget 
(WHO 2005: 7). 
 
Over the years, Seychelles health sector had received enormous financial 
assistance from international donors and friendly countries. Unfortunately, the 
high ranking accorded to the country on the Human Development Index (refer 
to section 1.3.2) has rendered it ineligible for debt forgiveness and caused a 
precipitous decline in development assistance.  According to the WHO 
(2005:19), with the rise in per capita income, many countries and donor 
agencies removed Seychelles from their list of countries destined for 
assistance. Aid flow to the country’s health sector plummeted remarkably from 
US$ 30 million in 1997 to US$ 3 million in 2007 (OECD 2009). This is 
occurring against the backdrop of soaring public expectation, the emergence 
of new diseases, a demographic transitional shift and the double burden of 
communicable and non-communicable diseases. 
 
1.4 STATEMENT OF THE RESEARCH PROBLEM 
 
Hypertension and related complications are important health problems on 
Praslin Island. This is in line with the global realities. Hypertension sufferers’ 
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non-compliance to their pharmacological regimen and required lifestyle 
changes result in uncontrolled hypertension and the consequent 
complications such as cardiovascular, renal and cerebrovascular diseases 
(Psaty, Lumley, Furberg, Schellenbaum, Pahor, Alderman  & Weiss 
2003:2534). This added burden of disease, places additional pressure on the 
limited health care budget of Seychelles. 
 
In order to mitigate the effects of the disease in populations, it is essential to 
improve compliance amongst sufferers of the disease by identifying 
underlying contextual factors mitigating against compliance behaviour and 
developing effective interventions to overcome these factors (Thrall, Lip & 
Lane 2004:595). While various possible explanations for the occurrence of 
non-compliance have been identified through previous research, there was a 
lack of data on the reasons specific to the hypertension sufferers on Praslin 
Island when this current study was conceptualised. Factors affecting 
compliance behaviour are unique to individuals and are context specific, and 
therefore, studies done in other countries may not apply to the circumstances 
surrounding the Island of Praslin.  
 
This current study was borne out of the need to identify factors affecting drug 
treatment and lifestyle modification compliance and to recommend strategies 
that could improve compliance with both drug treatment and required lifestyle 
modifications involving hypertension sufferers on Praslin Island.  The central 
question, which guided the research, was:  
 
What are the reasons for non-compliance with the drug and lifestyle 
modification regimens among hypertensive patients on Praslin Island? 
 
1.5 AIM OF THE STUDY 
 
The aim of this study was to add to the existing body of knowledge about 
factors affecting compliance to hypertension medication and lifestyle 
modifications necessary to maintain hypertension control, and to propose 
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strategies that would assist policy makers and clinicians with hypertension 
management decisions.  
 
1.5.1 Research purpose 
 
The purpose of this study was to describe the compliance (to the drug and 
lifestyle modification regimens) of diagnosed hypertension patients and to 
identify the factors which influenced their compliance behaviour. The study 
further sought to investigate the relationships between compliance and the 
theoretical variables of the Health Belief Model.  
 
1.5.2 Research questions 
 
Burns and Grove (2001:171) define a research question as a "concise, 
interrogative statement that is worded in the present tense and includes one 
or more variables (or concepts)." Research questions when employed usually 
have three foci: To describe variables, examine relationships among variables 
and determine differences between two or more variables.  These aspects 
were thoroughly considered in this study and led to the development of the 
following specific research questions to direct it.  
 
● Research question 1 
How compliant are the respondents with their hypertension drug 
regimen? 
● Research question 2 
How compliant are the respondents with their lifestyle modifications 
regimen? 
● Research question 3 
What is the relationship between treatment compliance (lifestyle 
modification and antihypertensive drug treatment adherence) and the 
following variables among patients diagnosed with hypertension on the 
Island of Praslin: socio-demographic factors (age, gender, ethnic 
background; marital status, educational status, work status, household 
income); physiological factors (weight status); duration of illness; 
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number of medications prescribed; doses of medication skipped; and 
alcohol intake per week?  
● Research question 4 
What is the relationship between treatment compliance (lifestyle 
modification and antihypertensive drug treatment adherence) and the 
following variables among patients diagnosed with hypertension on the 
Island of Praslin: perception of severity; perception of risk; perception 
of benefits; perception of barriers; internal factors; health care provider 
factors; cues to action?  
● Research question 5 
Which of the following variables are predictor variables for treatment 
compliance: socio-demographic variables; perception of severity; 
perception of risk; perception of benefits; perception of barriers; internal 
factors; health care provider factors; and cues to action? 
  
1.6 SIGNIFICANCE OF THE STUDY 
 
This study sought to examine various factors responsible for compliance and 
non-compliance in the research context and elucidated relationships existing 
between them. Such information would assist health care professionals to 
manage hypertension appropriately. It would also assist policy makers in 
developing context specific and relevant policies capable of improving the 
management of hypertension in the clinics. Ultimately, it is envisioned that the 
implementation of effective strategies would lead to improved compliance, 
increased levels of controlled blood pressure and reduced occurrences of 
complications. 
 
1.7 DEFINITIONS OF KEY CONCEPTS  
 
1.7.1 Blood pressure 
 
Blood pressure is the force exerted by blood against the walls of arteries as a 
result of the pumping action of the heart. The peak pressure (about 120 mm 
Hg in a young adult) is recordable during systole (systolic pressure) and the 
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minimum pressure (70 mm Hg in a young adult) is recordable during diastole 
(diastolic pressure) (Ganong 2003:589). Blood pressure can be measured 
with a standard mercury sphygmomanometer (Pocket Medical Dictionary 
1987:38).  
 
During this study, blood pressure was measured twice on the right upper arm 
with the respondent in a sitting position after the respondent had rested for 5 
minutes in line with the WHO/MONICA Project recommendation (Kuulasmaa, 
Hense & Tolonen 1998). A standard mercury sphygmomanometer (ERKA 
3000®) attached to an appropriate inflatable cuff size 12-13cm wide was 
used. The bell of the stethoscope was placed over the brachial artery at the 
cubital fossa of either arm to listen to the Korotkoff sounds. Phase 1 of the 
Korotkoff sounds was recorded as systolic blood pressure while Phase V was 
taken as the diastolic blood pressure (Ganong 2003:590) (refer to section 
2.3.2.1).  
 
1.7.2 Drug treatment  
 
Drug is defined as “a substance used as medicine” (Oxford Dictionary of 
Current English 2001:273). Treatment is defined as “medical care for an 
illness or injury” (Oxford Dictionary of Current English 2001:976). In this study, 
drug treatment is defined as the use of an approved pharmacologically active 
medicinal substance for the purpose of controlling hypertension.  
 
1.7.3 Compliance and adherence 
 
Compliance is defined as “the extent to which a person’s behaviour (taking 
medicines, or executing lifestyle changes) coincides with medical or health 
advice” (Kaveh & Kimmel 2001:244). Bloom (2001:647) describes compliance 
as an act of adhering to the regimen of care recommended by the clinician 
and persisting with it over time.  
 
The World Health Organization defines adherence as "the extent to which a 
person's behaviour - taking medications, following a diet and/or executing 
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lifestyle changes, corresponds with agreed recommendations from a health 
care provider" (WHO 2003a: 3). For the purpose of this study compliance and 
adherence are used interchangeably. 
 
1.7.3.1 Compliance with prescribed antihypertensive drug 
treatment 
 
Compliance with prescribed antihypertensive drugs was measured with a 
Compliance to Medication Regimen Instrument developed specifically for this 
study. The instrument contained 14 closed-ended items on a four point Likert 
type scale. The mean score for the 14 items was calculated. A mean score of 
3 was designated as the cut-off point. Respondents with a score below 3 were 
categorised as non-compliant while respondents with a score of 3 and above 
were categorised as compliant with the medication regimen (refer to section 
4.3.2). 
 
1.7.3.2 Compliance with lifestyle modifications  
 
Compliance with lifestyle modifications aimed at lowering blood pressure 
includes regular exercise (at least 30 minutes thrice per week), eating salt and 
fat free diets, cessation of smoking, and a reduction in the daily alcohol 
consumption to less than 20g of ethanol for men and less than 10g of ethanol 
for women (Svetkey, Erlinger, Vollmer, Feldstein, Cooper, Appel, Ard, Elmer, 
Harsha, & Stevens 2005:21; Xin, He, Frontini, Ogden, Motsamai & Whelton 
2001:1114).  
 
Compliance with lifestyle modifications was measured with a Compliance to 
Lifestyle Modification Instrument developed specifically for this study. The 
instrument contained 11 closed-ended items on a four point Likert type scale. 
The mean score for the 11 items was calculated. A mean score of 3 was 
designated as the cut-off point. The respondents with a score below 3 were 
categorised as non-compliant while respondents with a score of 3 and above 
were categorised as compliant with the lifestyle modification regimen.  
 
 18 
1.7.4 Diagnose   
 
To diagnose implies to identify the nature of an illness (Oxford Dictionary of 
Current English 2001:244). In this study, an individual was identified as a 
hypertension sufferer based on a confirmed diagnosis on the clinical record of 
that individual. 
 
1.7.5 Hypertension  
 
Hypertension is defined as abnormally high arterial blood pressure involving 
high systolic and/or diastolic levels (Ganong 2003:644). For the purpose of 
this study, hypertension is defined as the persistent systolic blood pressure 
equal to and greater than 140 mmHg and/or persistent diastolic blood 
pressure equal to and greater than 90 mmHg (WHO 2003c: 1984).   
 
1.7.6 Lifestyle factors 
 
The Collins Concise Dictionary and Thesaurus (1995:549) defines lifestyle as 
“a set of attitudes, habits  and possessions regarded as typical of a particular 
group or an individual”. Applied to this study, lifestyle factors are those 
attitudes, habits and behaviours of hypertension patients that influence the 
development and course of the disease. 
 
1.7.7 Modification 
 
Modification is defined as “a small alteration, adjustment or limitation” (Free 
Online Dictionary 2006). In this study modification refers to a change 
(adjustment) in lifestyle, namely attitudes, habits and behaviours necessary 
for controlling hypertension. 
 
1.7.8 Patient 
 
A patient is defined as “a person receiving or registered to receive medical 
treatment” (Oxford Dictionary of Current English 2001:656). For the purpose 
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of this study, patient refers to a person diagnosed with hypertension as 
defined in section 1.7.5 and receiving medical treatment. 
 
1.7.9 Reason 
 
Reason is defined as “the basis or motive for an action, decision or conviction. 
It is a declaration made to explain or justify actions, decisions or convictions” 
(Free Online Dictionary 2006). Applied to this study,  reason refers to the 
motive for compliant or non-compliant behaviour with regard to drug treatment 
and recommended lifestyle modifications. 
 
1.8 THEORETICAL FRAMEWORK 
 
The Health Belief Model, which is widely used to study health behaviour, 
formed the theoretical framework for this study. According to Glanz, Rimer 
and Lewis (2002:46), the Model was first used in the Public Health Service of 
the United States of America (USA) to study why people refused to utilise a 
freely available mammogram-screening program. The core components of the 
Model are perceived susceptibility, perceived severity, perceived benefits and 
perceived barriers. The Model postulates that health behaviour towards a 
disease or treatment is succinctly influenced by the extent to which individuals 
believe they are susceptible to the disease and how severe they believe the 
disease is, the benefits they stand to gain by adopting the required health 
behaviour and the barriers standing in the way of adopting the required health 
behaviour. The expanded version of the Model also includes variables such 
as self-efficacy and cues to action. The expanded version of the Model 
postulates that individuals’ sense or lack of self-efficacy and external cues 
(such as health education campaigns) also influence their health behaviour. 
Socio-demographic variables such as age, gender and income are believed to 
influence health behaviour in addition to all the abovementioned variables. 
The Health Belief Model is regarded to be a suitable predictor of health 
behaviour. The Health Belief Model was selected as a theoretical framework 
for this current study because it assisted the researcher in selecting the 
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research variables and the development of the data collection instrument. The 
Model is described in detail in section 2.6. 
 
1.9 RESEARCH DESIGN AND METHOD 
 
A quantitative descriptive-correlational study was conducted to examine the 
level of compliance with the antihypertensive drug treatment and lifestyle 
modifications regimens of the respondents, the factors which influenced 
compliance or non-compliance behaviour and the relationships existing 
between these variables. All respondents were diagnosed hypertensive 
patients systematically sampled from the disease registers at Baie Sainte 
Hospital and Grand Anse Health Centre both situated on the Island of Praslin. 
Structured interviews, applying an interview schedule, were held at the homes 
of the respondents. In addition to this, document analysis was conducted. A 
checklist was used to extract data from the clinical records of the 
respondents. Both descriptive and inferential statistics were calculated to 
answer the specific research questions. 
 
1.10 SCOPE OF THE STUDY 
 
This research focused on diagnosed hypertensive persons on the Island of 
Praslin. The respondents were randomly selected from a population of 
patients who were treated for hypertension at the two public health institutions 
on the island. The findings and conclusions of this study are therefore, 
generalisable to the hypertension patients on the Island of Praslin and not 
Seychelles in general. 
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1.11 STRUCTURE OF THE DISSERTATION 
 
This dissertation is structured as follows: 
 
CHAPTER CHAPTER TITLE CONTENT DESCRIPTION 
1 Introduction and overview 
 
Overview of the research problem, context and the 
underpinning theory. 
Explication of the aim and significance of the study. 
Definition of key concepts 
2 Literature review In depth exploration of the core research concepts, 
namely hypertension, compliance and the Health Belief 
Model 
3 Research design and methods Overview of the research design and methods used in 
this study  
4 Data presentation Overview of the research findings 
5 Discussion conclusions and 
recommendations 
Synthesis of the research findings and 
recommendations stemming from the research results 
 
1.12 CONCLUSION  
 
This current research was designed to study the variables that affected 
compliance with drug treatment and lifestyle modifications and the 
relationships existing between these variables among diagnosed hypertensive 
persons on Praslin Island. The research variables were derived from the 
Health Belief Model. The outcome of this research could contribute to the 
existing body of knowledge regarding non-compliance as a behavioural 
phenomenon. Knowledge of factors compounding the problem would aid the 
development of effective policy and treatment guidelines to enhance 
compliance behaviour and reduce the occurrence of complications of 
hypertension, which has serious cost implications for a country with a limited 
health care budget. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
 
2.1 INTRODUCTION 
 
This chapter introduces the literature review. The literature review is an 
important component of research because it reveals similar studies done on a 
given topic and prevents unnecessary duplication of studies. It guides the 
choice of a sound conceptual framework suitable for the research in question 
while exposing the researcher to the fundamental issues concerning the topic 
(Burns & Grove 2005:133). This chapter is centred on hypertension and 
aspects related to its management and control, and the Health Belief Model. 
 
2.2 HYPERTENSION   
 
2.2.1 Definition 
   
Hypertension is a chronic systemic disease characterised by an abnormally 
high blood pressure. The peak and lowest pressures in the cardiovascular 
system correspond with the systolic and diastolic blood pressures respectively 
(Ganong 2003:644). The normal blood pressure value is less than 120/80 
mmHg.  
 
However, the Hypertension Working Group of American Society of 
Hypertension (in Giles, Berk, Black, Conn, Kostis, Izzo & Weber 2005:505), 
argue that the definition of hypertension should be broadened and extended 
beyond discrete values to include a description of the risk factors and disease 
sequelae. Consequently the Group defines hypertension as “a progressive 
cardiovascular syndrome arising from complex interrelated aetiologies. Early 
markers of the syndrome are often present before blood pressure elevation is 
observed. Therefore, hypertension cannot be classified solely by discrete 
blood pressure thresholds. Its progression is strongly associated with 
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functional and structural cardiac and vascular abnormalities that damage the 
heart, kidneys, brain, vasculature, and other organs, and lead to premature 
morbidity and death” (Giles et al 2005:505).  
 
This latter definition has been criticised for lacking a clear public health 
approach to the management of hypertension. According to Pickering 
(2005:702), the definition gives no direction on when hypertension should be 
diagnosed and relies heavily on words rather than numbers which had been 
the crux of the management of hypertension globally. Notwithstanding the 
controversy, the importance of this definition seems to lie in its emphasis that 
health care professionals must search for evidence of target organ damage 
and other components of the “syndrome” with each diagnosis of hypertension. 
 
2.2.2 Hypertension types 
 
Two types of hypertension exist, namely primary and secondary hypertension. 
 
2.2.2.1 Primary hypertension 
 
Primary hypertension also referred to as essential or idiopathic hypertension, 
is the most prevalent of the two types and constitutes 95% of cases. The 
cause of primary hypertension is unknown (Ganong 2003:645). Several 
lifestyle related risk factors are thought to contribute to hypertension. These 
include the following: 
 
• Weight gain and obesity 
 
There is a strong correlation between overweight, obesity and hypertension. A 
sedentary lifestyle and weight gain are associated with hypertension (Wolk, 
Shamsuzzaman & Somers 2003:1067). A longitudinal study in the USA 
sampled a cohort of 4549 American Indian respondents aged 45-74 years and 
followed them up from 1989 to 1999. The cohorts were examined twice during 
the period (1992-1994 and 1996-1999). During each examination, blood was 
taken for cholesterol, blood glucose and urinary protein; weight was measured 
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while the body mass index was estimated. The researchers reported that 
overweight individuals were 1.46 times more likely than those with normal 
weight to have elevated blood pressure while obese individuals were 1.9 
times more likely than those with normal weight to develop hypertension 
(Wang, Lee, Fabsitz, Devereux, Best, Welty & Howard 2006:403). 
 
• Effects of dietary salt  
 
Research has shown that consumption of large quantities of dietary salt is 
significantly associated with high blood pressure.  A study in the USA by 
Obarzanek, Proschan, Vollmer, Moore, Sacks, Appel, Svetkey, Most-
Winhauser, and Cutler (2003:459), assessed 188 respondents at three levels 
of dietary sodium intake: high (140mmol/d), medium (104mmol/d) and low 
(62mmol/d) corresponding to 3.3g, 2.5g and 1.5g of dietary sodium intake for 
30 days. The researchers reported that lowering of dietary sodium intake level 
was statistically associated with lowering of blood pressure in all subgroups 
tested - blacks, nonblacks, men and women. These findings were supported 
by a meta analysis by He and MacGregor (2003:1), who examined clinical 
trials relating salt reduction and a reduction in blood pressure. The latter 
researchers reported that a reduction of salt intake by 3g/day was associated 
with a reduction in systolic blood pressure ranging from 3.6-5.6mmHg and a 
reduction in diastolic blood pressure ranging from 1.9-3.2mmHg in 
hypertensive persons. The authors also assessed the effects in 
normotensives and observed a systolic blood pressure reduction from 1.8-3.5 
mmHg and a diastolic blood pressure reduction from 0.8-1.8mmHg. The 
authors opined that the effects would be doubled with a 6g/day reduction and 
tripled with a 9g/day reduction in salt intake. With regards to the public health 
impact dietary salt reduction would make in the population, the researchers 
argue that "a conservative estimate indicates that a reduction of 3g/day would 
reduce strokes by 13% and ischemic heart disease by 10%.” According to 
Chobanian and Hill (2000) in Kaplan (2005:67), "there is conclusive evidence 
that dietary salt intake is positively associated with high blood pressure and 
[that] blood pressure can be lowered with a reduction in sodium intake of 40 to 
50 mmol (per day) in both hypertensive and nonhypertensive persons."  
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• Cigarette smoking   
 
The relationship between cigarette smoking and hypertension is thought to be 
due to the presence of nicotine in cigarettes leading to the release of 
noradrenaline from adrenergic fibres. Thus persistent stimulation of the 
sympathetic nervous system through habitual smoking is thought to be 
responsible for sustained elevation of blood pressure and an increased risk of 
cardiovascular disease in smokers (Kaplan 2005:29). 
 
• Alcohol consumption 
 
Research has shown that excess consumption of alcohol is a risk factor in the 
development of hypertension. The study by Wang et al (2006:408) revealed 
that alcohol consumers at the time of the study were 1.22 times more likely 
than non-consumers to develop hypertension. Consuming more than 20g of 
ethanol (men) or 10g of ethanol (women) per day may be sufficient to cause 
sustained elevation of blood pressure (Kaplan 2005:29). 
 
• Stress 
 
This is believed to be a risk factor for hypertension through the mechanism of 
the sympathetic nervous system. Persistent stress leads to the release of 
certain hormones notably adrenaline and cortisol resulting in a sustained 
elevation of blood pressure (Gianaros, Jennings, Sheu, Derbyshire & 
Mathews 2007:134).  
 
• Age 
 
Hypertension is more prevalent in adults over the age of 25 than in younger 
persons. Advancing age is therefore thought to be a risk factor for 
hypertension. In their study, Wang et al (2006:404) demonstrated that the 
incidence of hypertension among respondents 65 years and older was about 
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38% higher than among adults between 45 and 54 years.  Also, respondents 
aged 55-64 years had a higher incidence of hypertension than respondents 
45-54 years. The finding supported the conclusion that the older a person is, 
the more likely the individual will develop hypertension. 
 
• Genetic factors associated with primary hypertension 
 
Primary hypertension is thought to be hereditary because it clusters around 
families (Kaplan 2005:58). There are inconsistent findings with maternal or 
paternal linkage but a strong family history of hypertension is observed with 
most patients with the disease. In 2002, researchers reported the discovery of 
three variants of a kidney gene thought to be responsible for primary 
hypertension. The gene variants, collectively named G protein coupled 
receptor kinase type 4 (GRK4), act individually or in association with other 
variant genes, and are believed to contribute to the body's inability to excrete 
sodium and consequently to hypertension (UVAHS 2002). The discovery has 
significant public health implications towards the control of hypertension. The 
subsequent development of a sensitive measure to detect those at risk of 
developing hypertension could guide clinicians to provide timely lifestyle 
modification advice to individuals at risk (UVAHS 2002). 
 
2.2.2.2 Secondary hypertension  
 
When the cause of hypertension is distinctly known, it is referred to as 
secondary hypertension. In contrast to primary hypertension, secondary 
hypertension are sometimes treatable, and they constitute about 5% of cases 
of hypertension. The following are known causes of secondary hypertension:  
• sleep apnoea  
• drugs such as contraceptive pills and anti-inflammatory pills  
• chronic renal disease 
• primary aldosteronism  
• renovascular disease 
• steroid therapy  
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• Cushing syndrome  
• phaeochromocytoma 
• coarctation of the aorta  
• thyroid and parathyroid disease (Kannel 2004:396). 
 
2.2.3 Epidemiology of hypertension  
 
Under a threshold of 140/90 mmHg, the World Health Organization estimates 
that nearly 1 billion people in developed and developing countries are affected 
with hypertension. About 1 in 8 deaths worldwide is due to hypertension and 4 
million people die annually thus making it the third largest killer in the world 
(Khatib 2004:778).  The seriousness of hypertension as a global public health 
problem is evident by its high prevalence and associated increase in 
cardiovascular complications in virtually all countries of the world. According 
to Khatib (2004:778), for all hypertensive persons the risk of developing 
cerebrovascular disease is "continuous, consistent and independent of other 
risk factors". Thus, the higher the blood pressure, the higher the risk of 
developing complications. Furthermore, for hypertensive persons aged 40-70 
years, an increase in systolic blood pressure by 20mmHg and diastolic blood 
pressure by 10mmHg, doubles the risk of developing cardiovascular 
complications (Khatib 2004:778). 
 
In developed countries, the emergence of advanced medical technologies 
have contributed to a significant drop in mortality due to hypertension 
complications although the prevalence in these countries remains significantly 
high (Khatib 2004:779). However, hypertension is especially prevalent in 
developing countries which currently account for 70% of hypertension and 
cardiovascular related deaths (Stranges & Cappuccio 2007:183). The upsurge 
in hypertension is largely due in part to the phenomenon of epidemiological 
transition, occurring vis-à-vis changes in dietary habits, urbanisation and 
westernisation. Large-scale migration of people from rural to urban areas in 
search of greener pastures and consequent stress and lifestyle changes 
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contribute significantly to the increased prevalence of hypertension in 
developing countries (Opie & Seedat 2005:3562). 
 
In Sub-Saharan Africa, hypertension has also emerged as a serious public 
health problem. A meta analysis of hypertension studies in the region 
conducted by Addo, Smeeth and Leon (2007:1012) reported that 
hypertension is more prevalent in urban than rural areas in all countries of the 
region. The researchers also reported that about 40% of research participants 
in various studies were ignorant of their disease state, 30% were on drug 
treatment and less than 20% had controlled blood pressure. The researchers 
concluded that contrary to widely held conception; hypertension is a major 
public health problem in Sub-Saharan Africa but unfortunately, most countries 
of the region lack the resources to detect, prevent and treat the disease (Addo 
et al 2007:1012).   
 
The first population-based survey on the prevalence of hypertension 
conducted in Seychelles in 1989 by Bovet et al (1991:1730), reported a high 
prevalence of hypertension in men (28%) and women (22%). Only 21% of 
people diagnosed with hypertension received treatment.  A second study in 
1998 by Aubert et al (1998:1136) reported a remarkably increased prevalence 
in men (35.8%) and women (25%). Following the report of this survey, the 
health department initiated strategies to control hypertension and 
cardiovascular risk factors in the population. These included health education 
campaigns through the mass media and in schools. Hypertension screening 
in workplaces were promoted as well as the formation of heart health clubs in 
schools and clinics.  
 
The above efforts have witnessed mixed results. A study in 2004 by Bovet et 
al (2006:6), reported a decrease in the overall prevalence of hypertension 
from 38.6% in 1989 to 31.6% in 2004. The number of patients on 
antihypertension treatment also improved from 21.6% in 1989 to 59.3% in 
2004.  Tobacco smoking among men witnessed a dramatic decrease from 
54% in 1989 to 17.5% in 2004.  However, there was an increase in the 
occurrence of other risk factors. Obesity increased from 21% to 25% 
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particularly among women and hypercholesterolemia increased from 9% to 
24.2%. Indeed hypertension remains a serious public health issue in 
Seychelles and efforts to control the disease and the risk factors associated 
with it deserve urgent attention (Bovet et al 2006:6). 
 
2.2.4 Pathophysiology of hypertension 
 
It is essential for blood pressure to remain normal as low blood pressure leads 
to decreased tissue perfusion, hypoxia and cellular necrosis. High blood 
pressure on the other hand leads to increased afterload, and damage of 
functional and structural vascular components of the heart, kidneys, brain, 
eyes and other organs (Giles et al 2005:205). To maintain equilibrium, several 
interrelated mechanisms are believed to play roles to regulate blood pressure 
within normal limits (Beevers, Lip & O'Brien 2001:912). Three of these 
mechanisms namely, vascular volume and peripheral resistance, autonomic 
nervous system, and renin-angiotensin systems are discussed below. 
 
2.2.4.1 Vascular volume and peripheral resistance 
 
Normal blood pressure is maintained by equilibrium between the vascular 
volume and peripheral resistance. Most patients with primary hypertension 
are observed to have normal vascular volume but raised peripheral 
resistance. However, at an early stage of hypertension disease, most patients 
have high vascular volume but normal peripheral resistance. The reverse is 
believed to occur due to the compensatory mechanism of arterioles to prevent 
tissue injury.  According to Beevers, et al (2001:913), peripheral resistance is 
determined by tiny arteriolar smooth muscles. The sustained contraction of 
the latter mediated by calcium influx results in increased resistance and 
consequently hypertension. The evidence in support of this hypothesis is 
found in the vasodilatory hypotensive effects of calcium channel blockers. 
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2.2.4.2 The autonomic nervous system  
 
Baroreceptors located in the carotid sinus, the wall of the ventricle and the 
aortic arch are responsible for monitoring arterial circulation. Afferent nerve 
fibres originating from the baroreceptors are conveyed via the 
glossopharyngeal and vagus nerves to terminate in the nucleus of the tractus 
solitarius and medulla. Low levels or high levels of arterial pressure result in 
impulses fired to the hypothalamic brainstem. The latter processes such 
impulses and responds through the cholinergic or adrenergic nerve fibres to 
the heart and blood vessels. A low pressure stimulates the adrenergic system 
resulting in tachycardia, raised arteriolar resistance and raised pressure. 
Furthermore, a high pressure stimulates the cholinergic system resulting in 
bradycardia, vasodilation and consequently lowered pressure (Ganong 
2003:606).  
 
The specific nature of derangement of this mechanism in the pathogenesis of 
hypertension is uncertain. However, according to Gilbert (2009:13), sustained 
elevation of blood pressure probably results from a resetting of baroreflexes 
such that persistent adrenergic tone produces hypertension. The evidence in 
support of this hypothesis is found in certain medications such as alpha-
methyldopa which acts in the brain to decrease alpha-adrenergic stimulation 
resulting in decreased sympathetic outflow to other organs and low blood 
pressure (Beevers, et al 2001:913). 
 
2.2.4.3 Renin-angiotensin system 
 
Renin is a glycoprotein enzyme produced by the juxtaglomerular apparatus of 
the kidneys. It catalyses the conversion of angiotensinogen to angiotensin I 
which is subsequently converted by angiotensin converting enzyme in the 
lungs to angiotensin II. The latter, a potent generalised vasoconstrictor, leads 
to increased peripheral resistance and hypertension. It also stimulates the 
release of aldosterone from the adrenal cortex. Aldosterone causes retention 
of sodium ions in the extracellular fluid compartment, leading to fluid overload 
and hypertension (Ganong 2003: 378). 
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According to Gilbert (2009:13) the kidneys are responsible for regulating 
blood pressure by controlling the sodium excretion rate. A distortion of this 
system produces impaired sodium excretion, sodium retention and 
hypertension. The evidence in support of this hypothesis is found in diuretic 
treatment such that an increase in fluid and sodium loss results in lowered 
blood pressure.  
 
2.3 MANAGEMENT AND CONTROL OF HYPERTENSION 
 
2.3.1 Diagnosis of hypertension 
 
Uncomplicated hypertension is asymptomatic and diagnosis is made by using 
a standard mercury, anaeroid or electronic sphymomanometer to measure 
blood pressure. Quite often patients complain of headache, giddiness, tinnitus 
and fainting but these are thought to be psychogenic (Khatib  & El-Guindy 
2005:3).  
 
2.3.2 Measurement of blood pressure 
 
2.3.2.1  Technique of measurement 
 
The WHO guidelines for measuring blood pressure stipulate that a sitting 
posture is adequate for routine measurement, preferably after the patient has 
rested for at least 5 minutes. Measurement can be done with a standard 
mercury, anaeroid or electronic sphymomanometer on both arms, while noting 
any difference in the readings between the two arms. Where there is a 
difference, the arm with a higher value should be used for future 
measurement. Kaplan (2005:38) cites Singer and Hollander’s (1996) study in 
which 39% of respondents had a systolic blood pressure difference greater 
than 10mmHg in one arm. The higher value is usually recorded involving the 
right arm.  
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An appropriate cuff size covering at least 80% of the upper arm should be 
used for measuring blood pressure. The clinician inflates the cuff at least 20-
30 mmHg above the point of disappearance of the Korotkoff sounds and then 
releases gradually by 2mmHg at a time until the cuff has been deflated. The 
onset of the first Korotkoff sounds (Phase1) represents the systolic blood 
pressure and the point of complete disappearance of the sounds (Phase V) is 
noted as the diastolic blood pressure (Chobanian, Bakris, Black, Cushman, 
Green, Izzo, Jones, Materson, Oparil, Wright & Rocella  2003:1213). 
Conventionally, after measurement, the clinician should document the blood 
pressure, the arm, the posture and the cuff used during the measurement 
process for future reference (Khatib  & El-Guindy 2005:3). In patients younger 
than 30 years with hypertension in the upper limb, blood pressure should be 
measured in one leg to rule out coarctation of the aorta. 
 
2.3.2.2 Variation in blood pressure  
 
Normal blood pressure has a circadian rhythm - higher values in the day when 
one is awake and lower values at night during sleep. Individuals are observed 
to have about a 10-20% drop in blood pressure nocturnally and those without 
such drops are particularly at risk for cardiovascular complications. A sharp 
increase in blood pressure has been observed during the early hours of the 
morning while waking up from sleep (Chobanian et al 2003:1213). Most 
clinical decisions have been based on office blood pressure measurements 
and the latter is prone to white coat hypertension - a phenomenon 
characterised by a transient rise in blood pressure primarily in the hospital or 
health centre environment (Chobabian et al 2003:1213). Therefore, home 
blood pressure measurement may eliminate this apparent bias.  
 
Ambulatory blood pressure monitoring which provides a 24 hour monitoring 
system is useful to identify blood pressure variations and rule out white coat 
hypertension. Patients with a 24 hour ambulatory blood pressure of more than 
135/85 mmHg are found to have double the risk of cardiovascular 
complications than those with a blood pressure of less than 135/85 mmHg 
(Verdecchia 2000:844). 
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2.3.3 Classification of hypertension 
  
According to the 7th
 
 Report of the Joint National Committee on the Prevention, 
Detection, Evaluation and Treatment of High Blood Pressure (JNC VII) in the 
USA (Chobanian et al 2003:1211), blood pressure in adults over 18 years is 
classified as indicated in table 2.1. 
Table 2.1: Classification of blood pressure 
Blood pressure classification Systolic blood pressure (mmHg) Diastolic blood pressure 
(mmHg) 
Normal <120 and <80 
Prehypertension 120-139 or 80-89 
Stage I hypertension 140-159 or 90-99 
Stage II hypertension >160 or >  100 
(Chobanian et al 2003: 1211) 
 
Table 2.1 indicates that blood pressure is classified into 4 categories. A 
normotensive patient is one with systolic and diastolic blood pressures less 
than 120 mmHg and 80 mmHg respectively. Those with a systolic blood 
pressure of 120-139 or a diastolic blood pressure of 80-89 are regarded as 
prehypertensive, and may develop the disease as a result of advancing age 
or lifestyle related factors. According to the Report, pre-hypertensive persons 
are “individuals in whom early intervention by adoption of healthy lifestyles 
can reduce blood pressure, decrease the rate of progression of blood 
pressure to hypertensive levels with age, or prevent hypertension entirely” 
(Chobanian et al 2003:1210). Therefore pre-hypertensive persons require 
basic lifestyle modifications to stay healthy. Stage I hypertensive persons are 
patients with a systolic blood pressure ranging from 140-159 and a diastolic 
blood pressure of 90-99 respectively. Stage II hypertensive persons are 
patients with a systolic blood pressure of 160mmHg and above and a diastolic 
blood pressure of 100mmHg and above. Patients who have stage I and II 
hypertension require pharmacological treatment and need to modify their 
lifestyle. 
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2.3.4 Treatment of hypertension 
 
The treatment of hypertension involves lifestyle modification and 
pharmacological drug intake. 
 
2.3.4.1 Lifestyle modifications 
 
The definition of hypertension given by the American Society of Hypertension 
(refer to section 2.2.1) implies that lowering blood pressure solely with 
medications per se may be inadequate to prevent and control complications 
since blood pressure elevation usually coexist with other factors such as 
obesity, high serum cholesterol and type 2 diabetes mellitus. Lifestyle 
modifications are non-pharmacological approaches necessary to lower high 
blood pressure.  Chobanian et al (2003:1216) state that lifestyle modifications 
are fundamentally essential for patients with hypertension and should form an 
integral part of the management of those with the disease. In addition, the 
WHO strongly recommends lifestyle modifications since such treatment 
usually has no known adverse effects, do not affect the quality of life, and are 
usually less expensive than pharmacological treatment (WHO 2003c: 5). 
 
A randomised controlled clinical trial conducted to test the effects of 
comprehensive lifestyle modifications by hypertensive patients was conducted 
in Turkey by Cakir and Pinar (2006:190). The researchers randomly assigned 
70 patients into intervention and control groups and collected baseline data 
from both groups. The intervention group had health education sessions and 
individual counselling on lifestyle modifications while the control group had 
none. After six months, the authors reported that blood pressure, body weight, 
body mass index, waist circumference and fasting lipids reduced significantly 
among the intervention group compared to the control group (Cakir & Pinar 
2006:190). 
 
Similar findings were obtained in a related study in the USA. The results of the 
diet, exercise and weight loss intervention trial conducted in 2002 by a group 
of researchers showed that blood pressure could be controlled by 
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comprehensive lifestyle modifications (Miller, Erlinger, Young, Jehn, 
Charleston, Rhodes, Wasan & Appel 2002: 612-618). The study involved 44 
overweight hypertensive persons who were randomly assigned to two groups. 
Individuals in the experimental group were placed on a hypocaloric diet low in 
sodium and supervised moderate exercise 3 times per week. The control 
group received no intervention. After 9 weeks, the researchers reported a 
4.9kg mean reduction in weight, 9.5mmHg reduction in systolic blood 
pressure and 5.3mmHg reduction in diastolic blood pressure in the 
experimental group. No such observation was noticed in the control group. In 
addition, the researchers also reported a reduction in total low-density 
cholesterol levels in the experimental group. 
 
According to Chobanian et al (2003:1217) health related actions which lower 
blood pressure are weight reduction, adopting the Dietary Approach to Stop 
Hypertension (DASH) eating plan, reducing in dietary salt intake, reducing 
alcohol consumption and doing regular physical exercise. These actions are 
summarised in table 2.2 and each would be discussed in detail in the 
discussions that follow. 
 
Table 2.2: Lifestyle Modifications to Prevent and Manage Hypertension. 
Modification Recommendation Approximate systolic blood 
pressure reduction (range) 
1. Weight reduction Maintain normal body weight (body mass 
index 18.5-24.9kg/m2 
5-20mmHg/10kg weight 
reduction ) 
2. Adopt the DASH 
eating plan 
Consume a diet rich in fruits, vegetables, 
and low-fat dairy products with a reduced 
content of saturated and total fat. 
  
8-14 mmHg 
3. Dietary sodium 
reduction 
Reduce dietary 2-8 mmHg  salt intake to < 2400mg 
sodium per day or < 6000mg sodium 
chloride per day. 
4. Moderation of 
alcohol consumption 
 Limit alcohol consumption to no more 
than 2 drinks (e.g. 24 oz beer, 10 oz wine 
or 3 oz 80-proof whiskey) per day in men 
and to no more than 1 drink per day in 
women and lighter weight persons. 
2-4 mmHg 
5. Physical activity Engage in regular aerobic exercises such 
as brisk walking at least 30 minutes per 
day most days of the week. 
4-9 mmHg 
(Chobanian et al 2003:1217) 
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• Weight reduction   
 
The Body Mass Index is a measure of overweight and obesity. It is obtained 
by dividing body weight by the height squared. Individuals with a Body Mass 
Index of 18.5 – 24.9kg/m2 are considered to have optimal weight for height, 
those with a  Body Mass Index of 25-29.9kg/m2 are overweight and those with 
a Body Mass Index greater than 30kg/m2
 
 are considered obese.  Current 
estimates suggest that about 500 million people worldwide are overweight 
and another 250 million are obese (Harsha & Bray 2008:1420). Overweight 
and obesity are positively associated with hypertension, type 2 diabetes, 
cancers, and cardiovascular diseases.  
The Nurses Health Study of 1995 by Manson, Willet, Stampfer, Colditz, 
Hunter and Hankinson (1995:678) supported the positive correlation of 
overweight, obesity and hypertension.  The authors followed up 115119 
women who were aged 30 to 50 years and free from any known disease for 
16 years. During the period a total of 4726 died, out of which 881 died as a 
result of cardiovascular diseases, 2586 of cancer and 1259 of other causes. 
With regards to cardiovascular mortality, the authors observed a 2 to 6-fold 
increase in mortality among women with a Body Mass Index greater than 
30kg/m2 compared to women with a Body Mass Index less than 19kg/m2
 
. The 
public health goal of lifestyle modifications is to help individuals who are 
overweight or obese to achieve a normal Body Mass Index. According to He, 
Whelton, Appel, Charleston and Klag (2000:544) a 10kg weight reduction can 
lower systolic blood pressure by a range of 5-20 mmHg. 
• Dietary changes necessary to lower hypertension 
 
According to Miller et al (2002: 612) dietary changes alone can effectively 
reduce the systolic blood pressure of a person with hypertension by a range 
of 8-14 mmHg. Reduced saturated fat and dietary salt consumption are 
important dietary factors in the prevention and control of hypertension. 
Various dietary measures serve to lower blood pressure as indicated below: 
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• Increased potassium and decreased saturated fats consumption 
 
Dietary changes necessary in hypertension management include a reduction 
in fatty foods intake and an increase in potassium rich foods such as fruits 
and vegetables (Appel, Brands, Daniels, Karanja, Elmer & Sacks 2006: 296-
308). Red meat reputably rich in saturated fats should be replaced with fish.  
 
• Reduced dietary salt intake 
  
Dietary salt reduction is an essential component of the non-pharmacological 
treatment of hypertension.  Various studies have confirmed strong 
associations between salt intake and hypertension (Appel et al 2006:298; He 
& MacGregor 2003:1; Obarzanek et al 2003:459). Most family diets are 
generally high in sodium chloride. Hypertensive and non-hypertensive 
persons are advised to limit their dietary salt intake to 100mmol per day (2.4g 
of sodium) or 6g of sodium chloride per day (Appel et al 2006:298; Chobanian 
et al 2003:1217).  
 
• Reduced alcohol intake 
 
A meta-analysis of 15 randomised controlled trials examining the relationship 
between alcohol consumption and hypertension conducted in the USA by Xin 
et al (2001:1112-1117), suggests that limiting the quantity of alcohol-
consumed daily can lead to a significant reduction in both systolic and 
diastolic blood pressure by between 2-4 mmHg. The researchers reported a 
dose-response relationship between the mean alcohol reduction and mean 
blood pressure reduction.  According to the researchers, men should limit 
daily alcohol consumption to about 20g of ethanol and women 10g of ethanol. 
Apart from blood pressure reduction, minimising alcohol intake also reduces 
the risk for heart attacks, heart failure and cerebrovascular accidents (Greeff 
2006: 20). 
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• Physical activity 
 
Research has shown that regular moderate exercise such as walking briskly 
or performing aerobics (lasting at least 30 minutes three times per week) can 
lower systolic and diastolic blood pressure considerably (Miller et al 2002: 
612; Whelton, Chin, Xin & He 2002:493). The reductive effect is synergistic 
with other modifiable factors such as dietary modification and a reduction in 
alcohol consumption. Whelton et al (2002:493) found that regular physical 
exercise alone can lead to a reduction in systolic blood pressure by 4-
9mmHg.  
 
2.3.4.2 Drug treatment of hypertension 
 
Drug treatment of hypertension is effective in controlling the disease and 
preventing the development of complications. The goal of drug treatment is to 
maintain the systolic blood pressure below 140 mmHg and the diastolic blood 
pressure below 90 mmHg. The efficacy of drug treatment in hypertension was 
demonstrated in the Antihypertensive and Lipid Lowering Treatment to 
Prevent Heart Attack Trial reported in Geraci and Geraci (2003:389). The 
researchers conducted a randomised double blind controlled trial involving 
42448 patients with mild to moderate hypertension and having one or more 
coronary risk factor, who were drawn from multicultural backgrounds. All 
patients were randomised to each of three different classes of 
antihypertension medications - diuretics (chlorthalidone), calcium channel 
blockers (amlodipine) and angiotensin converting enzyme inhibitors 
(lisinopril). After 5 years of follow up, the researchers found that nearly two-
third of all the patients had achieved a normal blood pressure of less than 
140/90 mmHg (Geraci & Geraci 2003:381). The average systolic and diastolic 
blood pressure readings of patients on the three drugs were chlorthalidone 
133.9/75.4, amlodipine 134.7/74.6 and lisinopril 135.9/75.4 respectively. The 
importance of the findings is that compliance with drug treatment is effective 
in controlling hypertension.  
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Various commonly used classes of drugs, their mechanisms of action and 
common adverse effects are listed in table 2.3.  These are diuretics, calcium 
channel blockers, angiotensin converting enzyme inhibitors, Beta/Alpha 
adrenergic blockers, angiotensin II receptor blockers and centrally acting 
drugs. 
 
Table 2.3: Classes of antihypertensive drugs 
Antihypertensive Mechanism of action Side-effects 
Angiotensin Converting 
Enzyme inhibitors e.g. 
Lisinopril 
Blocking the conversion of 
angiotensin-1 to angiotensin-11, a 
potent vasoconstrictor and thereby 
leading to reduced vascular 
resistance 
Hypotension 
Persistent dry cough 
Angioedema 
Impotence 
Alopecia  
Diuretics
 
:  
Thiazides  
     e.g. Bendrofluazide 
 
 
 
Loop Diuretics 
     e.g Frusemide 
 
 
 
Potassium Sparers 
     e.g. Spironolactone 
Increasing fluid loss from the body. 
 
Inhibiting sodium reabsorption at the 
distal convoluted tubules. 
 
 
 
Inhibiting potassium reabsorption at 
the ascending limb of the loop of 
Henle in the renal tubule. 
 
 
Antagonising aldosterone and 
sparing potassium diuresis. 
 
 
Hyperuricemia (gout) 
Hyponatraemia 
Postural hypotension 
Impotence  
 
Hypokalemia 
Hyponatraemia 
Hypomagnesaemia 
Hypochloraemic alkalosis 
 
Hyponatremia 
Hyperkalemia 
Gastro-intestinal tract distur-
bances 
Impotence 
Menstrual irregularities 
Beta adrenoceptor blockers 
      e.g. Atenolol 
Blocking beta-adrenoceptors in the 
heart, peripheral vasculature, 
pancreas, liver, bronchi. 
Gastro-intestinal tract distur-
bances 
Bradycardia 
Hypotension 
Bronchospasm 
Calcium channel blockers  
     e.g. Amlodipine 
Blocking the inward flow of Ca+ ions 
through active cell membranes 
Bradycardia 
A-V block 
Hypotension 
Sleep disturbances 
Pedal oedema 
Angiotensin II receptor 
antagonists 
       e,g. Valsartan 
Blocking angiotensin-II receptors Anemia 
Neutropenia 
Cough 
Headache 
Alpha adrenergic blockers   
       e.g.   Prazosin 
 
 
 
Blocking post-synaptic adrenoceptors 
producing vasodilation. 
Postural hypotension 
Drowsiness 
Palpitations 
Priapism 
Urinary incontinence 
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Antihypertensive Mechanism of action Side-effects 
Centrally acting drugs  
         e.g. Methyldopa 
Stimulating alpha-adrenergic 
receptors in the brain thus inhibiting 
the sympathetic nervous system. 
Gastro-intestinal tract distur-
bances  
Stomatitis 
Hypersensitivity reactions 
Impotence 
Failure of ejaculation 
Decreased libido 
(BNF 2006:90 -114). 
 
2.4 COMPLIANCE  
 
2.4.1 Definition of compliance  
 
Compliance has been defined in section 1.7.3. The term adherence is often 
used synonymously with compliance. However, some researchers prefer to 
use the term “adherence." These researchers express their concerns that 
compliance signifies a judgemental point of view. According to Higgins 
(2006:28), compliance signifies a stance according to which "a patient is 
merely told what to do with regard to treatment and expected to follow the 
recommendations unquestionably," whereas "adherence assumes a 
collaboration between the patient and the treatment provider." However, Ren, 
Kazis, Lee, Zhang and Miller (2002:48) believe the two terms are synonymous 
and defines compliance as "adherence to provider directions by the patient 
about prescribed medication regimens."  
 
According to Garfield and Caro (2000:13) compliance consists of three 
components namely, acceptance of medication prescribed, adhering to it and 
continuing with it. Thus compliance is a complex and dynamic health 
enhancing behaviour that involves acts of appointment keeping, obtaining and 
ingesting medications and persisting with health provider recommendations 
such as lifestyle changes. Non-compliance on the other hand represents the 
opposite of compliance behaviour and is defined as a constant neglect of 
treatment or advice rather than mere temporary forgetfulness (Lahdenpera & 
Kyngas 2000: 826).  
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2.4.2 Compliance to hypertension treatment 
 
Hypertension has no cure therefore; patients are expected to take 
medications for life. Drug treatment of hypertension demands that patients 
comply with their medications as prescribed and they should return for a refill 
when medications are exhausted. They should honour their appointments for 
follow up visits with their clinician and adopt health actions that are 
recommended to lower their blood pressure (Appel et al 2006:298; Greeff 
2006:20; Xin et al 2001:1117). Compliance with pharmacological and non-
pharmacological treatment of hypertension has various benefits for the 
individual, the health care system and the society at large.  
 
Compliance with treatment at the individual level improves the quality of life by 
preventing complications and thereby premature death. To the immediate 
family, it prevents the negative psychological impact associated with sudden 
death or living with a family member suffering from a chronic debilitating 
disease such as a stroke. It also conserves family resources that would have 
been utilised to obtain health care.  
 
To the larger society, compliance with drug treatment is a cost saving 
measure since it decreases the incidence of complications and the need for 
additional medications (WHO 2003a:20). This is particularly crucial in a public 
financed health care system such as Seychelles. The dwindling economic 
fortunes of the country, which in 2003 necessitated the introduction of the 
Macro Economic Reform Programme signals the compelling need to 
maximise treatment outcomes by utilising resources effectively and efficiently 
(WHO 2005:11). To the health care system, compliance reduces the need for 
hospitalisations and decreased workload on staff. Moreover, satisfactory 
outcomes of treatment could help boost the morale of the attending clinician 
whereas treatment failure could be a source of frustration. 
 
Various factors affect patients' compliance with antihypertension medications. 
The study by Bovet et al (2002:33-34) found that compliance was relatively 
high in patients with skilled occupations, those who were health conscious 
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and those who regularly honoured their clinic appointments. Patients with 
skilled occupations are most likely to understand the need to comply with 
medication whereas patients who are health conscious would be likely to 
honour clinic appointments and comply with treatment.  
 
Patients' attitudes also influence their disposition to compliance behaviour. 
Jokisalo, Kampusalo, Enlund, Halonen and Takala (2002:577-583) found that 
attitudes such as carelessness, hopelessness and denial contributed 
significantly to medication non-compliance.  Careless patients are likely to 
skip medications for several days while patients who have a sense of 
hopelessness would certainly not perceive any benefit of taking their 
medications. A patient who denies being hypertensive would certainly not 
bother to take medications. Wang, Bohn, Knight, Glynn, Mogun and Avorn 
(2002: 504) report that psychosocial factors such as depression and level of 
social support influence compliance behaviour.  Depressed patients may lose 
interest in life itself and the appetite for food or medicine would consequently 
be suppressed.  Social support such as financial or logistical support would be 
expected to enhance compliance particularly in elderly and invalid patients.  
Other factors such as socio-demographic factors, health care related factors, 
self-efficacy and cues to action also influence compliance behaviour. These 
factors are discussed in detail in section 2.6.2.2. 
 
2.4.3 Consequences of non-compliance 
 
Complying with daily medication taking, smoking cessation, and dietary and 
alcohol restrictions require a change in behaviour which may be extremely 
difficult. Patients often do not comply with their treatment in spite of 
professional advice even when negating such advice is at their own risk. 
According to Ashford, Eccles, Bond, Hall and Bond (1999:15), introducing 
individual behavioural change is often met with some difficulty and scepticism 
which are attributable to personal characteristics such as beliefs, attitudes, 
knowledge and motivation regarding the behaviour.  
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Kim, Hill, Bone and Levine (2000:90) report that non-compliance with 
antihypertension treatment has grave implications for the individual and the 
society. The consequences of non-compliance with antihypertension 
medications are threefold; first, it leads to resistant or uncontrolled 
hypertension; secondly it leads to unnecessary hospitalisations and increased 
workload for health workers and lastly, it results in wastage of resources 
(Garfield & Caro 2000:15; Ren et al 2002:47).  
 
2.4.3.1 Consequences for the individual 
 
At the individual level, non-compliance leads to resistant or uncontrolled 
hypertension, which when not detected results in the development of 
complications such as congestive heart failure, coronary heart disease, renal 
failure and cerebrovascular accidents (Munger, Tassell & Lafleur 2007:58). 
Apart from jeopardising the health and well being of the patient, these 
complications also lead to premature deaths (Kim et al 2000:94), or the victim 
may survive with lifelong disabilities resulting in a life of dependence on 
others. The absolute effects of the complications of hypertension on 
individuals are enormous and may be difficult to quantify, particularly the 
physical and psychological suffering inflicted on the victim and the immediate 
family.  
 
2.4.3.2 Consequences for society 
 
At the societal level, high rates of non-compliance increases the cost of 
treatment, induces inefficient use of health resources and compromises 
treatment outcomes (Kim et al 2000:93). Money expended on drugs given to 
patients and time spent on consultations are wasteful when patients fail to 
take medications as prescribed. This produces treatment failure and disease 
deterioration, resulting in “preventable hospital admissions and loss of 
productivity" (Thrall, et al 2004:595). In addition, unnecessary regimen 
changes may occur in an attempt to effect adequate control. Therefore the 
phenomenon of non-compliance represents a waste of scarce resources for 
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the society because money expended does not produce the desired effects 
and complications are treated at higher cost to the society.  
 
This is of particular concern in Seychelles since the cost of hypertension 
treatment is completely borne by the state. The economic cost of non-
compliance to the society in fiscal terms is enormous. For instance, in the 
USA alone, Flack, Casciano, Casciano, Doyle, Arikian, Tang and Arocho 
(2002:28), estimate that non-compliance and  "failure to control blood 
pressure among the total USA hypertensive population was estimated to cost 
US$964 million, and among the treated hypertensive population, US$467 
million" (Flack et al 2002:28). This excludes the loss of productivity from work 
absence. Similar estimates are reported from the United Kingdom (UK) (Thrall 
et al 2004:594). 
 
2.4.4 Measurement of compliance 
 
Various methods could be employed to measure compliance but there is no 
gold standard. Eight different methods mentioned in the literature are 
discussed in this study and each approach has its advantages and 
disadvantages.  
 
2.4.4.1 Subjective assessment 
 
Various methods are utilised to conduct subjective assessments of 
compliance. 
 
• Monitoring clinic attendance 
 
Adherence to outpatient clinic appointments is a subjective approach to 
assessing compliance. Noncompliant persons may not honour their 
appointments. A study in Seychelles by Bovet et al (2002:33) showed that 
hypertensive persons who regularly honoured their appointments during a 
one-year period were more compliant than those who did not do so. The 
major attraction of this method is that it is easy and inexpensive to perform. 
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However, the major drawback with this method is that clinic attendance does 
not necessarily correlate with taking medication or maintaining the 
recommended lifestyle. 
 
• Self-report 
 
Self-report involves measurement of compliance through questionnaires or by 
interviewing patients directly about drug taking and lifestyle habits. A major 
advantage of self-report is the ease of application. It is cheap and easy to 
perform. Furthermore, most non-compliant persons usually would admit not 
taking medication on certain days. The major drawback with the self-report 
method is that patients may overestimate their medication taking habit. 
However, combining self-report with assessment of clinical records can 
increase the reliability of this method. (Garfield & Caro 2000:13; Hadi & 
Gooran 2004: 292).  For these reasons, the researcher considered this 
method appropriate for use in this study. 
 
2.4.4.2 Objective assessment 
 
Various methods are utilised to conduct subjective assessments of 
compliance. 
 
• Pill counts 
 
Pill counts is an objective approach of assessing compliance which may 
involve paying patients surprise visits to count the number of unused pills 
remaining in the container. The major drawback of this method is the 
resources that would be required to visit every home. Also paying 
unannounced visits may be regarded as intrusive on an individual's privacy. 
According to Garfield and Caro (2000:14), unless researchers have the 
resources to visit every home the outcome measures would not be credible. 
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• Pharmacy refill records 
 
The number of refills obtained by a patient may be used to assess 
compliance. According to Wetzels, Nelemans, Schouten, van Wijk and Prins 
(2006:8), this method is objective, relatively inexpensive and does not involve 
invading a patient's privacy. The initial dates the individual collected the 
medications from the pharmacy and when he/she returned for refill are noted. 
However, the major drawback with the method is that it does not necessarily 
correlate with actual medication ingestion as other factors such as 
forgetfulness or carelessness may contribute significantly to non-compliance 
(Wetzels et al 2006:8).  
 
• Biological markers  
 
This method involves using a urinary marker such as riboflavin to measure 
compliance. The drawback with this method is that noncompliant patients may 
be wrongly identified as compliant patients (Garfield & Caro 2000:14). In 
addition it is relatively expensive and time consuming and not suitable in 
outpatient clinical settings. 
 
• Measurement of drug metabolites 
 
An ideal objective method of assessing patients’ compliance would be to 
measure the drug metabolites in the blood or urine, as this would provide 
convincing evidence of drug ingestion. However, such measurements are 
problematic in hypertension treatment because many patients are on several 
drug combinations (Garfield & Caro 2000:14). 
 
• Medication Events Monitoring System (MEMS®)  
 
The medication events monitoring system (MEMS®) is an electronic pill bottle 
that contains a microprocessor embedded in the bottle cap. The processor 
records the time and date the bottle is opened and thereby provides an 
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objective method of assessing compliance (Mengden, Vetter, Tousset & Uen 
2006:36). Some MEMS caps have a screen display that reminds the patient of 
the number of tablets taken out in a day, while the information collected by the 
equipment can be transferred to a personal computer for analysis (Mengden 
et al 2006:36). This measure is sometimes referred to as the gold standard for 
the measurement of compliance. The MEMS device operates on 4 basic 
assumptions which are outlined by Denhaerynck, Schafer-Keller, Young, 
Steiger, Bock, and De Geest (2008:5) as follows: the electronic monitoring 
equipment must function correctly; all bottle openings should correspond to 
the actual intake of medication; the use of the equipment should not influence 
a change in behaviour; and, finally the equipment should not lead to sample 
bias.  
 
However, a study of adherence of 250 renal transplant patients with the 
MEMS by Denhaerynck et al (2008:5), revealed that in 0.4% of patients the 
equipment malfunctioned, in 62% of patients there was a mismatch between 
bottle openings and actual intake of medication and furthermore, adherence 
effects waned after the first five weeks of using the equipment. This indicates 
that the equipment has a waning intervention effect (Denhaerynck et al 
2008:5). 
 
2.5 COMPLICATIONS OF HYPERTENSION 
 
Hypertension sufferers can develop complications involving the 
cardiovascular, cerebrovascular, renal, and the ocular systems. 
 
2.5.1 Cardiovascular complications 
 
Sustained elevation of high blood pressure results in an overburdened heart. 
First to face the burden is the myocardial fibres of the left ventricle, which 
become hypertrophied. Over 30% of patients with sustained elevation of blood 
pressure have left ventricular hypertrophy (Weinberger 1999:5). This 
complication can lead to heart failure. Furthermore, hypertension promotes 
the development of atherosclerosis in the coronary artery supplying the heart. 
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A narrowing or complete occlusion leads to myocardial ischemia or infarction 
and sometimes death (Kaplan 2005: 145; Riaz 2007). 
 
2.5.2 Renal complications 
 
Hypertension leads to renal damage by promoting obstructive atherosclerotic 
plagues in the arteries supplying the kidneys. The vascular damage results in 
progressive deterioration of renal function and eventually renal failure (Kaplan 
2005:146; Sharma & Kortas 2007).  
 
2.5.3 Cerebrovascular complications 
 
Hypertension promotes the development of atherosclerotic plaques in the 
cerebral vasculature. Narrowing or complete vascular occlusion of such 
vessels produces ischemic stroke. Furthermore, hypertension aids the 
development of aneurysms, the rupture of which results in haemorrhagic 
stroke (Kaplan 2005:152).  
 
2.5.4 Ocular complications 
 
Uncontrolled hypertension damages the tiny ocular vascular supply resulting 
in retinopathy, which may lead to blindness (Kaplan 2005:164). 
 
2.6 THEORETICAL FRAMEWORK: THE HEALTH BELIEF MODEL 
 
The Health Belief Model served as the theoretical framework for this current 
study.  The Model formed the basis for the development of the research 
questions. In addition to this, the Model also served as a conceptual 
framework for the development of the interview schedule, and the 
interpretation and discussions of the research results. 
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2.6.1 Origins and purpose of the Model 
 
Historically, the Health Belief Model was developed by a group of social 
psychologists working in the United States Public Health Service led by 
Godfrey Hochbaum in the 1950s. Becker later modified it in 1974. The 
researchers were driven by the need to explain the surprising failure of public 
participation in free health screening programmes at that time. The 
development of the Model spawned out of the major concern of the United 
States Public Health Service programme implementers to identify factors 
which inhibited or motivated individuals to utilise free health screening 
services (Rosenstock, Strecher & Becker 1988: 175-176) 
 
Glanz, et al (2002:47) studied the relationship between perceived 
susceptibility to tuberculosis and perceived benefits from obtaining a mobile 
X-ray screening. They discovered that among those who reported a belief in 
their own susceptibility to develop tuberculosis and the benefits of X-ray 
screening, 82% had X-rays taken whereas, among those who did not hold this 
belief only 20% had undergone the X-ray screening test. The Model was 
subsequently applied by other researchers to study patients’ reactions to 
symptoms and compliance with prescribed medications (Finfgeld, 
Wongvatunyu, Conn, Grando & Russell 2003: 288; Naidoo & Wills 2003: 222; 
Rosenstock et al 1988: 177). 
 
2.6.2 Basic components of the Health Belief Model 
 
Historically, that the basic components of the Health Belief Model (perceived 
susceptibility, perceived severity, perceived benefits and perceived barriers) 
were derived from various models of psychological and behavioural theories 
of cognition. Cognitive theorists propose that health behaviour is volitional and 
largely dependent on the subjective value placed by an individual on an 
expected outcome of the action and the likelihood that such an action would 
achieve that outcome. This is referred to as value expectancy theory (Finfgeld 
et al 2003: 288; Glanz et al 2002:47).  
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As a value expectancy theory, the model conceptualises that preventive 
health actions is dependent upon values placed on proposed actions and the 
innate belief that the ultimate outcome would be what was anticipated. On the 
strength of the Model, a patient diagnosed with hypertension would have to 
consider his or her vulnerability to hypertension and its consequences before 
making "the judgement as to whether the benefit to be gained from a 
particular [compliance] behaviour is worth the cost" (Stewart & Eales 
2002:13).  
 
The behaviour examined in this research is compliance with lifestyle 
modifications (refer to section 2.3.4.1) and prescribed antihypertension 
medications (refer to section 2.3.4.2). This is based on the understanding that 
blood pressure control involves both drug treatment and lifestyle changes. 
Compliance behaviour is a complex and multidimensional phenomenon and 
various possible factors that could influence the behaviour have been studied 
and reported in the literature (WHO 2003b:29). These factors include socio-
demographic factors (such as age, gender, occupation and educational 
status); psychosocial factors (such as social class and personality); structural 
factors (such as knowledge about the disease); and prior contact with the 
disease. Other factors that influence compliance behaviour are cues to action 
(such as mass media campaigns, advice from friends, reminder messages 
from physicians or nurses, newspaper and magazine articles, or being in 
contact with family members or friends with a similar illness) and a sense of 
self-efficacy (Winfield & Whaley 2002:330). The variables of the Health Belief 
Model are described in detail and applied to this current study in the next 
sections. 
 
2.6.2.1 Individual perceptions 
 
The Health Belief Model incorporates perception as a core concept in its 
framework. The Oxford Dictionary of Current English (2001:663) defines 
perception as "a way of understanding or regarding something." The Model 
(figure 2.1) posits that individuals’ overall perception of the degree of severity 
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of the disease and their susceptibility to the consequences of the disease in 
one hand, and the benefits of or barriers to taking a recommended health 
action on the other hand, determine their behaviour towards the disease. 
People perceive phenomena in different ways depending on a myriad of 
factors including cultural, religious, social or psychological experiences. 
Perception of disease and treatment are largely influenced by these factors. It 
stands to reason that the perception of persons suffering from hypertension 
would invariably influence their acceptance or rejection of treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   (Naidoo & Wills 2003: 222). 
 
Figure 2.1  
Structure of the Health Belief Model adapted from Becker (1974) 
 
 
INDIVIDUAL PERCEPTIONS MODIFYING  FACTORS    LIKELIHOOD OF ACTION 
 
 
DEMOGRAPHIC VARIABLES:  
E.g. Age, gender, marital 
status, ethnicity, income 
PSYCHOSOCIAL VARIABLES: 
 E.g. locus of control, self-
efficacy, depression 
STRUCTURAL VARIABLES:  
E.g. knowledge of disease 
HEALTH CARE RELATED FACTORS: 
E.g. doctor characteristics 
Perceived benefits of 
behaviour change 
MINUS 
Perceived barriers to 
behaviour change 
Perceived 
susceptibility to 
hypertension 
 
Perceived severity of 
hypertension 
Perceived threat of 
hypertension 
Likelihood of 
complying with 
medication and 
lifestyle changes 
CUES TO ACTION: 
Mass media campaign 
Advice from others 
Reminder from nurse/physician 
Reminder from family member 
 
COMPLIANCE 
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• Perceived susceptibility to uncontrolled hypertension 
 
Perceived susceptibility refers to patients’ views of the risk of having a 
disease such as hypertension or the complications of uncontrolled 
hypertension such as heart attack, kidney failure, or stroke (Glanz et al 
2002:48). Since hypertension usually presents as an asymptomatic disease, 
patients must believe they are susceptible to develop complications with or 
without experiencing specific symptoms. Such a perception is based on sound 
knowledge of the disease. Patients with knowledge about the nature and 
course of hypertension as well as possible risks associated with non-
compliance with treatment would likely perceive themselves susceptible to the 
disease and its complications. According to the Health Belief Model a patient 
who feels susceptible to hypertension and its sequelae would more likely   
comply with treatment than those who do not hold this belief.   
 
• Perceived severity of hypertension 
 
Perceived severity refers to the extent to which persons judge a condition 
such as hypertension to be a serious disease. Perceived severity is the 
judgement of the ability of a disease to cause morbidity, disability or mortality. 
According to the Health Belief Model, persons who perceive hypertension to 
be a serious disease would be more compliant with medication and lifestyle 
modifications than those who do not hold this perception (Glanz et al 2002: 
48). 
 
• Perception of hypertension as a threat 
 
Carpenter (2005:194) defines perceived threat as "the anticipation of harm 
that is based on the cognitive appraisal of an event or cue that is capable of 
eliciting the individual's stress response". The definition highlights three 
themes - first, the anticipation of harm, which implies that individuals have 
needs, and goals they aspire to achieve in life and whatever could jeopardise 
those needs and goals constitutes a threat. Secondly, the anticipated threat 
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results in cognitive appraisal of the relevance or irrelevance of the threat and 
thirdly, an action is taken which involves evaluation of the resources available 
to deal with the threat and the method(s) of doing so (Carpenter 2005:193).  
Thus perception of threat is a cognitive phenomenon that can be influenced 
by the social and cultural environment in which the individual lives.  
 
Perceived threat represents the hallmark of the Health Belief Model, which 
postulates that perception of threat determines an individual’s response to the 
threat. Various socio-demographic, socio-psychological or structural variables 
could jointly influence patients’ decision outcomes. Perceived susceptibility 
and perceived severity combined influence their perception of hypertension as 
a threat. For patients suffering from uncomplicated asymptomatic 
hypertension, a combination of these factors would invariably determine their 
response to the prescribed treatment and advice given by health care 
professionals on lifestyle modifications.   
 
Persons who believe that they are not susceptible to hypertension or deny the 
existence of hypertension may not see the need for ingesting their 
medications as prescribed or change their lifestyle. A study in Finland by 
Jokisalo, Kumpusalo, Enlund and Takala (2001:756) reported that 66% of 
respondents denied being hypertensive and did not follow through with their 
treatment.   
 
2.6.2.2 Modifying factors influencing individuals’ perceptions and 
compliance behaviour 
 
Various modifying factors including socio-demographic, socio-psychological 
and structural factors are known to have significant influences on health 
behaviour. Some of these factors are discussed below. 
 
• Demographic factors 
 
The health belief Model stipulates that demographic factors influence health 
behaviour as indicated in this section. 
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Age 
A patient's age could influence the decision to comply with antihypertension 
medications. Elderly patients tend to have poor compliance owing to the 
presence of cognitive impairment (memory loss) and a reduction in functional 
capabilities such as failing eyesight, and decreased dexterity with hands that 
could affect activities such as bottle opening (WHO 2003a: 29). Furthermore, 
elderly patients require family support that might not be available particularly if 
they live alone. In addition, elderly patients tend to have multiple morbidities 
that necessitate various drug regimens thus further compounding the 
problem. It follows therefore, that compliance may be poor in the elderly owing 
to the above stated reasons.  Similarly, compliance may be poor in younger 
patients due to ignorance of the true nature of hypertension or denial of the 
existence of the disease.  However, there has been no consistency in findings 
relating age with medication compliance. Age-compliance behaviour 
relationship is a complex phenomenon that may involve various other 
variables not fully understood (Hadi & Rostami-Gooran  2004: 293). 
 
 
Gender 
There is inconclusive evidence about the implications of a person’s gender on 
compliance behaviour. As far back as 1992, Shea, Misra, Ehrlich, Field and 
Francis (1992:1607) found in their study in New York that women were more 
compliant with antihypertension medications than men. A cross-sectional 
study involving Chinese immigrants was conducted between 2002 and 2003 
in the USA. The study revealed that women were slightly more compliant than 
men with their medication regimens (75% versus 69% P= 0.42). Being male 
and a prolonged length of stay in the USA were statistically associated with 
non-adherence among the Chinese immigrants surveyed (Li, Wallhagen and 
Froelicher 2008:326).  
 
However, the study in Netherlands by Van Wijk, Klungel, Heerdink, and De 
Boer (2004:1832) found that men were more compliant than women. The 
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researchers had examined the association between compliance and change 
in antihypertension medication regimen in a nested case-control study of new 
antihypertensive drug users. They reported that non-compliance was more 
statistically associated with the female gender (OR=1.64 95% CI 1.37-1.94) 
compared to the male gender (OR= 1.14 95% CI 0.94-1.40). Knight, Bohn, 
Wang, Glynn, Mogun and Avorn (2001:810), have reported similar findings 
from a study conducted in Boston, USA. The researchers found that the 
female gender and widowhood were associated with non-compliance 
behaviour.   
 
On the other hand, some studies have found no significant relationship 
between gender and compliance behaviour (Bovet et al 2002:35; Hadi & 
Rostami-Gooran 2004:293). The inconsistency of findings reflects the 
complexity of compliance behaviour and the need to contextualise study 
findings for the effective implementation of interventions to improve 
compliance amongst patients.  
 
 
Educational status  
A study in Finland (Kyngas & Lahdenpera 1999: 832) reported that the female 
gender in combination with a high level of education was significantly 
associated with medication compliance. In contrast to this, the study by Bovet 
et al (2002:35) found that the respondents' level of education was not 
associated with their medication compliance.  
 
The inconsistencies in findings may be attributable to the complex nature of 
compliance behaviour and because it involves several underpinning personal 
and social factors. Education may lead to better understanding of the risks 
involved in non-compliance behaviour. Literate persons and those who are 
motivated to know more about their illness are more susceptible to health 
education than illiterate persons. However, according to Carlberg (1993) in 
Kyngas and Lahdenpera (1999:833) one’s level of education does not 
automatically produce and sustain a healthy behaviour. Other factors such as 
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cultural beliefs may assume eminence over education and affect individual 
capacity to adhere to medical advice. 
 
 
Occupation 
Bovet et al (2002:36) found in Seychelles that patients with highly skilled 
occupations were more compliant than those with lesser skills. The link 
between skilled occupation and compliance in the Seychelles context is not 
clear, but it is possible to argue that patients with skilled occupations would be 
of higher socio-economic status which, in turn, has been reported to be 
associated with compliance (WHO 2003a: 35). 
 
 
Alcohol abuse  
The World Health Organization report asserts that alcohol abuse and tobacco 
smoking are important modifiers of compliance behaviour (WHO 2003a:30).  
Studies by Bovet et al (2002:37) in Seychelles and Kyngas and Lahdenpera 
(1999:834) in Finland found that heavy alcohol drinkers were less compliant 
with their antihypertension medications than moderate drinkers. This is not 
surprising since the fear of drug interaction with alcohol could dissuade a 
patient from taking the medications. Non-adherence may also be largely due 
to forgetfulness in heavy drinkers. Heavy drinking and non-adherence affect 
patients suffering from other types of chronic diseases. For example, 
researchers examining the relationship between heavy alcohol consumption 
and adherence to antiretroviral drugs also report high levels of non-adherence 
(Parsons, Rosof & Mustanski 2007:357).  
 
• Psychosocial factors 
 
The health belief Model stipulates that psychological factors influence health 
behaviour as indicated in this section. 
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Socio-economic status 
The World Health Organization considers socio-economic status of patients 
as an important factor influencing compliance behaviour (WHO 2003b:28). 
Patients of low socio-economic status are often poor and cannot afford the 
cost of medications and transport costs to health centres. They often have to 
barter the pressing need to provide food for the family rather than procure 
medications. In a largely asymptomatic disease such as hypertension, it is not 
surprising that many would not consider medication compliance as a primary 
priority. However, low socio-economic status has not been consistently found 
to be an important and independent modifier of compliance behaviour (WHO 
2003b:28). 
 
 
Health locus of control 
Health locus of control is a socio-psychological variable in the social learning 
theory of personality that categorises patients' health seeking behaviour into 
two broad groups as either internalists or externalists. Internalists are persons 
who believe they are responsible for their health or illness and take actions to 
prevent or protect their health. They believe that "certain events and 
happenings are due to their own actions and behaviours, that is, their own 
actions are directly responsible for the events in their lives" (Moshki, 
Ghofranipour, Hajizadeh & Azadfallah 2007:295). Internalists are likely to 
comply with their medications or take advice about their health.  
 
In contrast, externalists believe other people such as doctors, an evil power or 
God are responsible for their health. Consequently, such persons are less 
likely to be compliant with treatment than internalists (Higgins 2006:28).  
Hong, Oddone, Dudley and Bosworth (2006:20) investigated the relationship 
between locus of control and medication adherence among 588 hypertensive 
veterans in the USA. The researchers found that the respondents with a high 
internal locus of control and low external locus of control were more compliant 
with medications than patients with low internal locus of control and high 
external locus of control. A study by Rose, Walker and Macleod (2004:607), in 
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the UK revealed that a strong emotional response to sickness and an internal 
locus of control were significantly associated with compliance behaviour.  
 
In the Seychelles context, Bovet et al (2002:37) found that respondents who 
regularly kept their appointments in the health centres were more compliant 
with medications than those who do not regularly honour their appointments. 
The researchers inferred that those respondents who honour their 
appointments comparatively have a higher internal locus of control with 
regards to health seeking behaviour than patients who do not honour their 
appointments.  Failure to honour clinic appointments in itself is a 
noncompliant behaviour. 
 
Self-Efficacy 
 
Lifestyle modifications have been shown to lower blood pressure and for 
patients with mild hypertension such measures alone could be adequate to 
maintain a normal blood pressure. However, lifestyle modifications require 
considerable levels of ability or self-confidence to adhere. It was Rosenstock 
et al (1988:175-183) who suggested that Bandura’s (1986) concept of self-
efficacy be included in the Health Belief Model to improve its ability to predict 
compliance behaviour. Initial application of the Model concerned simple 
preventive behaviour such as immunisation or screening tests. The authors 
proposed that behaviour change requiring greater efforts to execute would 
require a significant degree of confidence in one’s ability to effectively perform 
the behaviour. Kroll, Kehn, Ho and Groah (2007:34) cite Bandura’s (1997) 
definition of perceived self-efficacy as "beliefs in one's capabilities to organise 
and execute the courses of action required for producing given attainments".  
 
The Health Belief Model proposes that hypertensive patients with higher 
levels of perceived self-efficacy would be more compliant with medications 
and particular lifestyle modifications than those with lower levels of self-
efficacy. A recent clinical review by Cochrane (2008:543) identifies self-
efficacy as a unique universal concept that positively influences behaviour 
and is associated with successful actions. Most hypertension patients already 
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know what actions they should take, such as weight loss, smoking cessation 
or participating in exercise activities, but knowledge is insufficient to stimulate 
actions. Patients need to believe in their capability and have confidence to 
perform the expected behaviour. Health professionals could use verbal 
persuasion and expressive encouragement to stimulate self-efficacy in their 
patients to comply with medications or lifestyle modifications.  
 
• Structural factors 
 
Patients’ knowledge of hypertension is important in the management of the 
disease.  Research has shown that a high level of knowledge is important to 
achieve adequate control of blood pressure and lack of knowledge is a 
significant predictor of poor blood pressure control. This view was supported 
by a study in the USA by Knight et al (2001:809). The researchers also found 
that among diagnosed hypertensive persons’ awareness and knowledge of 
the disease was strongly related to good blood pressure control. Patients, 
who indicated lack of knowledge of what a normal systolic blood pressure 
value of ≤140mmHg signifies, had significantly higher blood pressures than 
those who knew. However, the relationship between knowledge of 
hypertension and medication compliance have been inconsistent. Wang et al  
(2002:509) found no significant effect between prior knowledge of 
hypertension and compliance with medication but reported depression was a 
significant predictor of non-compliance in their study.      
 
Knowledge of the disease is also an important factor that influences 
perceptions and ultimately compliance behaviour. In a population-based study 
of knowledge, attitudes and practices regarding hypertension in Seychelles in 
1998, Aubert et al (1998:1138) reported that a significant proportion of the 
Seychelles population had good knowledge about hypertension. More than 
96% of the respondents knew there is a relationship between obesity, salt 
intake and hypertension. About 79% knew the benefits of physical exercise 
and a significant number believed smoking can cause hypertension. However, 
only 28% believed hypertension has no symptoms, 10% knew their blood 
pressure values and 14% knew what a normal blood pressure value is (Aubert 
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et al 1998: 1139). By implication persons who believe that hypertension is 
symptomatic would most probably not seek treatment or comply with their 
prescribed drug regimen unless they develop the symptoms of hypertension. 
It is also important for patients to know what represents optimal blood 
pressure to enable them to strive to remain normotensive. Unfortunately no 
new population-based study has been conducted in the country to compare 
these findings. 
 
• Health care provider factors  
 
Health care professionals influence the compliance behaviour of persons 
suffering from hypertension. The study by Benson and Britten (2002:874) 
revealed that compliance with antihypertension medication treatment is 
promoted if patients experience their encounters with their doctors positively, 
receive adequate advice, trust the doctor and experience improvement in 
blood pressure control. Thus physicians play an important role in enhancing 
medication compliance by their patients. 
 
The qualitative study in 2000 by Benson and Britten (2002: 873) in the UK 
indicated that certain physicians’ characteristics might enhance medication 
compliance of their patients. The study listed such characteristics as empathy 
on the part of the physician, willingness to explain the disease and 
medications to the patient and patience during consultation. The study 
revealed that patients’ compliance is enhanced when they have confidence in 
the physician and communicate effectively (Ren et al 2002: 49). 
 
Patients who comply with treatment anticipate that it would lead to controlled 
blood pressure as a benefit and that implies clinicians must use appropriate 
and effective antihypertension medications. Patients may experience distress 
if their hypertension remains uncontrolled despite satisfactory compliance and 
this may result in their refusal to persist with the treatment. A study in the USA 
by Berlowitz, Ash, Hickey, Friedman, Glickman, Kader and Moskowitz 
(1998:1957) assessed doctors' decisions to alter medication during routine 
visits. The researchers reported that the doctors altered the medication 
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prescription only in 21.6% cases of elevated blood pressure (defined as 
systolic blood pressure greater than 160mmHg or diastolic blood pressure 
greater than 90mmHg).  This was a cross sectional study and there was a 
possibility that the doctors did alter the medication on subsequent visits. 
However, this finding could be a pointer to the fact that despite absolute 
compliance by patients, blood pressure may still remain uncontrolled due to 
clinical inertia on the part of the doctor (Wang & Vasan 2005:1652). Clinical 
inertia is described as the "wait and see and it will be okay" attitude. This 
attitude may be responsible for the reluctance to increase the current dose or 
introduce a new drug to the patient’s regimen even when hypertension is not 
controlled. 
 
A clinician's knowledge and background experience of hypertension could 
influence patients’ compliance.  A study conducted in the USA between 1996 
and 1998 by Ren et al (2002:47) reported that health care providers who were 
older and physicians who were non-specialists had patients who were less 
compliant with their treatment than patients seen by younger health care 
providers and specialist physicians. Therefore, patients’ perceptions of the 
professional competence of the clinicians could play a role in their compliance 
behaviour. 
 
• Cues to action 
 
Cues to action (motivators) refer to factors that could instigate or prompt an 
individual to take an action. Green and Kreuter (2000:162) refer to a cue as a 
“precipitating force that makes the person feel the need to take action.” Cues 
to action may be internal or external.  
 
Internal factors may be the manifestation of the symptoms of the disease 
(Glanz et al 2002:48). Peoples’ beliefs about disease and the manifestations 
of disease symptoms act as internal cues to compliance behaviour (Winfield & 
Whaley 2002: 332). According to Stewart and Eales (2002:13) many people 
perceive health as "being able to cope, feeling fit and being symptom free." 
Patients suffering from uncomplicated hypertension are usually fit and 
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symptom free and such a disposition would influence their perception of 
hypertension differently from, say, persons suffering from diabetes. The 
symptoms of hyperglycemia could stimulate a diabetic to take their 
medications and adhere to their diet while a hypertensive patient without any 
symptoms may not deem it necessary to comply with their treatment (Siegel 
2005:11). 
 
External factors could be media publicity or effective health education directed 
at a target audience (Glanz et al 2002:48). Cues such as reminder cards, 
telephone calls or e-mail messages can play an important role in compliance 
behaviour by reminding patients to take their medications. In this study, the 
influence of health education as an external cue would be assessed. 
 
2.6.2.3 Likelihood of compliance behaviour  
 
On the basis of the Health Belief Model, the likelihood of patients complying 
with their treatment depends on the degree to which they perceive themselves 
to be susceptible to the disease or its complications and their perceptions of 
the severity of the condition. This perceived threat of the disease is weighed 
against the benefits to be derived from compliance with the prescribed 
treatment and the barriers they need to overcome. The Health Belief Model 
postulates that a high perceived threat; low perceived barriers and a high-
perceived benefit would result in the likelihood of exhibiting compliance 
behaviour. However, the eventual outcome decision would be determined by 
an interplay of various demographic, psychosocial and structural factors 
surrounding the individual and the cues to action to which they are exposed 
(Munro, Lewin, Swart & Volmink 2007:5). 
 
• Perceived benefits of antihypertension treatment 
 
Perceived benefits relates to the belief which patients hold that a proposed 
course of action would be effective in eliminating the potential threat. The 
Health Belief Model hypothesises that patients who perceive benefits from 
adopting particular health behaviour are more likely to demonstrate the 
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required health behaviour than those who do not hold such a perception 
(Green & Kreuter 2000:162). Applied to this current study those persons who 
perceive that taking antihypertension medications and adopting lifestyle 
changes would benefit them, would be more likely to be compliant than those 
who do not hold such as a perception. Such perceptions are based on 
knowledge of the disease and its progression. 
 
The study by Benson and Britten (2002: 874) revealed that compliant 
respondents reported the perceived benefits they derived from taking 
medication as one of the reasons for their compliance. The anticipation of 
good outcomes such as feeling better and having peace of mind contributed 
towards their compliance (Benson & Britten 2002:874).  
 
• Perceived barriers to taking antihypertension medications 
 
Perceived barriers relate to the perception that there are obstacles standing in 
the way of executing the required health behaviour, such as compliance 
behaviour. Various perceived barriers to taking antihypertension medications 
identified in the literature include problems associated with medication side 
effects, complex dosing, frequent changes of medications and high costs 
involved. It is hypothesised that patients with greater perception of barriers 
are expected to be less likely to demonstrate compliance behaviour than 
those who believe that the benefits outweigh the barriers (Green & Kreuter 
2000:162). 
 
Medication side effects may be a reason for non-compliance. In Finland, a 
study by Jokisalo et al (2002:577) confirmed that serious side-effects of 
medications led to non-compliance. The study also confirmed that simplicity of 
dosing improved compliance particularly among the elderly respondents who 
had cognitive impairment. In the UK, Benson and Britten (2003:1314) noted 
increased compliance with a single daily dose compared with multiple daily 
doses. A meta analysis of eight studies on adherence by Isikedjian, Einarson, 
Mackeigan, Shear, Addis, Mittmann and Hersich (2002:303) reported that 
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patients on single daily doses (91.4%) were more compliant with treatment 
than patients with multiple daily doses (83.2%, P <0.001).   
 
In contrast, Hashmi, Afridi, Abbas, Sajwani and Salaheen (2007: 5) conducted 
a study in Pakistan and found that respondents on multiple drugs (3 or more) 
were more compliant than those who were on a single daily drug regimen. 
The authors argued that this finding could have been due to the possibility 
that patients on multiple drugs considered their disease to be more severe 
compared to those on a single drug treatment.  
 
The qualitative study in the UK by Benson and Britten (2002:874) identified 
various reservations patients hold regarding antihypertension medications. 
Some of the respondents expressed the desire to discontinue taking 
medication in order not to become addicted while others indicated they would 
prefer alternatives to drugs. Some of the patients expressed a fear of the 
hidden danger associated with lifelong medication consumption while others 
questioned the rationale behind taking antihypertension medications even 
when there are no symptoms. If patients deny the existence of the disease or 
believe there is a hidden danger associated with taking medications, chances 
are that they would not adhere to the treatment (Jokisalo et al 2001:756). On 
the basis of the Health Belief Model, patients need to understand clearly the 
nature of hypertension and their susceptibility to the risks involved in not 
taking medications (Stewart & Eales 2002:13). 
 
2.7 SUMMARY 
 
The literature review provided an overview of the nature of hypertension, its 
complications and management. The importance of compliance with 
treatment was stressed. The researcher then discussed the concept of 
compliance, factors affecting compliance and the ways in which compliance 
are measured. Finally the Health Belief Model, which served as the theoretical 
framework for the study was discussed and applied to the current study.  
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CHAPTER 3 
RESEARCH DESIGN AND METHODS 
 
 
 
3.1 INTRODUCTION 
 
Quantitative descriptive-correlational research was conducted to examine the 
relationships between compliance with the antihypertension drug treatment 
and lifestyle modification regimens and the variables of the Health Belief 
Model in a sample of diagnosed hypertension patients and to establish what 
factors influence compliance in this population. This chapter describes the 
research design and methods used, as well as measures to ensure scientific 
rigour and ethical research.  
 
3.2 PHILOSOPHICAL FOUNDATION 
 
Philosophy refers to the logical and rational manner of examining world 
phenomena. It offers the framework through which such reasoning occurs   
(Unisa 2006: 2). According to Burns and Grove (2005:12), perceptions of 
phenomena are influenced by an individual's philosophy and knowledge about 
the phenomena. A research study serves as a logical and systematic 
approach to unravelling phenomena and should be guided by philosophical 
principles.  
 
The philosophical foundation utilised in this study is logical positivist tradition. 
Logical positivists opine that natural phenomena can be understood through 
the principle of determinism. According to Babbie and Mouton (2001:20), 
determinism refers to the attribution of the occurrence of universal 
phenomena to consequences of cause and effect relationships. Thus each 
behaviour or disease is deemed to be a by-product of a cause and effect 
relationship, which could be investigated, identified, and manipulated. 
Furthermore, by applying the scientific method of inquiry into natural 
phenomena, authentic knowledge can be generated and utilised for human 
 66 
benefit. For example, if the causes of inappropriate behaviour are identified, 
strategies could be developed and measures adopted to prevent individuals 
from engaging in such behaviour (Unisa 2006:2). This current study was not 
focussed on establishing cause and effect relationships.  However, the 
researcher did establish correlations between compliance behaviour and the 
other variables of the Health Belief Model. 
 
Drawing comparison between the human body and a machine can elucidate 
the principles of mechanism and reductionism. Just as a machine could be 
decomposed into component parts and then re-synthesised, the human body 
and human functioning can be broken down into its various component parts 
and studied (Brown, Crawford & Hicks 2003:4). Although compliance 
behaviour is complex and is determined by various interacting factors, the 
researcher used the Health Belief Model to identify the distinct research 
variables. Each variable represent a specific aspect related to compliance 
behaviour. Each variable was studied individually after which statistical 
evidence was obtained about the interrelationships of the variables. The 
researcher argued that the understanding gained through this process would 
enable clinicians to implement strategies to improve hypertensive patients’ 
compliance with their treatment.  
 
According to Unisa (2006:3), there are five characteristics of the epistemology 
of logical positivism, which are quantification of data, deductive reasoning, 
objectivity, empiricism and verifiability.  
 
3.2.1 Quantification of data 
 
Research which is based on logical positivism involves adopting structured 
data collection methods and subjecting such data to statistical analysis. 
Inferences are thereafter made about the universe (Unisa 2006:3). In this 
study, the researcher developed an interview schedule and a checklist to 
collect structured data which was subsequently subjected to statistical 
analysis.  
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3.2.2 Deductive reasoning 
 
Positivism involves deductive reasoning, which implies generating a 
hypothesis from an existing theory and testing the hypothesis in order to make 
generalisations (Burns & Grove 2005:26, Unisa 2006: 3). In this study, the 
researcher utilised the Health Belief Model as the theoretical framework. The 
Model hypothesises that perception modifying factors and likelihood factors 
are determinant factors in health behaviour such as compliance (refer to 
figure 2.1). In this current study the Model was used to specify the research 
variables for investigation, develop the items which were incorporated into the 
data collection instruments and determine how the relationships between the 
variables would be investigated. This was not a hypothesis testing study. 
 
3.2.3 Objectivity 
 
According to Burns and Grove (2005:27), the researcher applying the 
positivist tradition must "adopt a distant and non-interactive posture with the 
research respondents to prevent bias." In this current study, the researcher 
maintained an independent stance with respondents while conducting 
structured data collection.  
 
3.2.4  Empiricism  
 
A research utilising the positivist tradition examines the real world. Information 
obtained in a systematic manner is used to expound natural phenomena for 
which causes may be determined (Burns & Grove 2005: 27). In this study, the 
researcher followed a structured systematic research process aimed at in-
depth analysis of various factors associated with the complex human 
behaviour of compliance with treatment in consonant with the positivist 
tradition. Non-causal relationships were investigated while drawing 
comparisons between compliant and non-compliant patients and identifying 
correlates of study variables that significantly influence compliance behaviour.  
Identified relationships were quantified and analysed statistically to generate 
useful information that would guide the development of intervention measures 
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to increase compliance and reduce the consequences of non-compliance in 
this population.  
 
3.2.5 Verifiability 
 
Logical positivism demands that studies conducted under the principle should 
generate verifiable results and not result in mere speculation (Unisa 2006:3). 
In this current study the researcher provided statistical evidence of the 
relationships between the various variables of the Health Belief Model.  
 
3.3 RESEARCH DESIGN 
 
Burns and Grove (2005:40) describe a research design as a blue print 
developed to tackle a research problem. According to the authors, the main 
purpose of a research design is to maximise control over factors that could 
interfere with the validity of the study findings. This current quantitative study 
employed a descriptive-correlational design. 
  
Quantitative research is defined as a "formal, objective, systematic process in 
which numerical data are used to obtain information about the world" (Burns & 
Grove 2005:23). A quantitative study utilises a representative sample 
obtained by applying a probability sampling method. This enhances the 
generalisability of the study findings to the target population. Reliable and 
valid data collection instruments are necessary to ensure the credibility of the 
study findings. A structured data collection method is preferable to 
unstructured methods because it eliminates researcher and respondent 
biases. Quantitative research techniques enable the collection of numerical 
data, which are analysed statistically to draw inferences about the universe 
(Burns & Grove 2005:37-42).   
 
Correlational designs involve an investigation of the degree of relationships 
between two or more identified variables (Brink, Van der Walt & Van 
Rensburg 2006:201; Burns & Grove 2005:30). Correlation occurs when two 
variables change simultaneously in a particular direction and is measured with 
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a coefficient r. If a decrease in one variable produces an increase in the other 
variable, the correlation is regarded as negative and is represented with 
minus sign. If an increase in one variable produces a corresponding increase 
in another variable, the correlation is regarded as positive and is represented 
with plus sign. If one variable changes without any corresponding change in 
the other variable, it is regarded as no relationship and “r” is represented with 
a zero. By implication if two variables are known to correlate strongly, then 
one can be used to predict the other. Correlational studies may be descriptive 
or predictive but their main weakness is that causality cannot be established 
since all study variables occurred before the study began. However, a strong 
correlation between variables may provide impetus for such relationships to 
be further subjected to experimental approaches that ascertain causality 
(Burns & Grove 2005:240). In this current study the researcher investigated 
the relationships between compliance and the other variables of the Health 
Belief Model. 
 
3.4 RESEARCH METHOD 
 
3.4.1 Sample selection 
 
Sample selection involves identifying the population with the characteristics of 
interest and selecting the specific elements to be included in the study (Polit & 
Beck 2008:290).  
 
3.4.1.1 Population 
  
Polit and Beck (2008:337), define a study population as the “entire 
aggregation of cases in which a researcher is interested.” A study population 
can further be subdivided into an accessible and target population.  An 
accessible population is the pool of subjects with designated criteria 
accessible to the researcher for the study, whereas, a target population refers 
to subjects with similar attributes to that of the research subjects to whom the 
researcher may generalise his findings (Polit & Beck 2008: 338). 
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In this current study, the target population consisted of all adult sufferers of 
hypertension residing in Seychelles. The accessible population consisted of 
all persons who suffered from hypertension and received treatment at the 
Grand Anse Health Centre and Baie Sainte Anne Hospital both situated on 
Praslin Island.  
 
3.4.1.2 Eligibility criteria  
 
These are criteria that specify the characteristics of the study population (Polit 
& Beck 2008: 338). They help determine whether a specific case should be 
included in the study and offer reasons for generalisability of the study 
findings (Webb, Bain & Pirozzo 2005:164).        
 
To be eligible for inclusion in this study, members of the population were: 
• diagnosed with hypertension  
• placed on treatment for at least one year prior to data collection 
• aged between 18 and 80 years 
• residents of Praslin island 
• mentally sound 
• registered outpatients at the relevant health care institutions. 
 
Patients were excluded from this study if they:  
• were too sick to be interviewed 
• could not give informed consent 
• were mentally unstable. 
 
3.4.1.3 Sampling technique 
 
Polit and Beck (2008:339) define sampling as the “process of selecting a 
portion of the population to represent the entire population so that inferences 
about the population can be made.” The portion selected forms the sample. 
According to Polit and Beck (2008:344), probability sampling involves random 
selection of study elements in such a way that each member of the study 
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population has an equal chance of being selected into the study. This 
approach confers a degree of confidence on the representative nature of the 
chosen sample by minimising researcher bias. For the purpose of this study, 
systematic probability sampling was chosen for sample selection.  
 
The systematic probability sampling technique involves establishing a 
sampling frame, which is a list of potential elements with desirable 
characteristics to participate in a study. From the list, the researcher then 
chooses a pth element at random in the total list and continues systematically 
till the required elements in the study are selected. Suppose the pth element is 
the number 5, the researcher selects every 5th
 
 element in the list (Polit & Beck 
2008:347-348).  
In this current study, the researcher utilised the two chronic case registers 
maintained at Baie Sainte Anne Hospital and Grand Anse Health Centre on 
Praslin Island as the sampling frame. The registers consisted of identified 
hypertensive patients in these centres and were a random heterogeneous 
aggregation of subjects of varying demographic and social backgrounds. 
Codes rather than real names were assigned to 660 identified sufferers of 
hypertension registered in these centres to form a single list.  From this list, 
the researcher (blindfolded) randomly selected the starting point and followed 
systematically upwards and downwards picking every 6th subject until 110 
subjects were selected. These steps were adopted to minimise the likelihood 
of selection bias.  
 
3.4.1.4 Sample size 
 
A sample is defined as a subset of the population selected for a study (Burns 
& Grove 2005: 750). Originally 110 persons were selected for this study as 
described in section 3.4.1.3. However, a total of 8 persons either refused to 
participate or did not meet the eligibility criteria for inclusion in the study.  
Following the advice of a statistician, and in view of the limited scope of this 
study, the final sample consisted of 102 persons with 58 females and 44 
males. 
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3.4.2 Data collection 
 
Burns and Grove (2005:470) describe data collection as the process of 
systematically gathering data from research subjects to answer research 
questions and achieve the research purpose and aim. The method and 
instrument employed depend on the research paradigm. Since this was a 
quantitative study, the researcher conducted structured interviews utilising a 
structured interview schedule to collect data. This section describes the data 
collection methods, research instruments and setting utilised in this study. 
These are outlined in Table 3.1. 
 
Table 3.1:  Overview of the data collection strategy 
Data collection methods Data collection instrument  Setting 
Structured interview  Structured interview schedule Respondents’ home 
Document analysis Checklist 
 
Health centre 
Physiological parameters: 
 Blood pressure 
 Height 
 Weight 
 
Sphygmomanometer 
Measuring scale 
Weighing scale 
Respondents’ home or health 
centre 
 
3.4.2.1 Data collection methods 
 
Data collection was conducted over a three months period extending between 
November 2008 and January 2009. 
 
• Structured interview  
 
Structured interview is a method through which a researcher gathers data 
from respondents by personal interaction with them. A structured interview 
often involves the use of a structured interview schedule through which the 
researcher asks similar questions containing pre-determined response 
options to all respondents. Burns and Grove (2005:396-397) state that a 
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structured interview offers researchers some degree of research control. An 
interview allows the researcher to clarify items which respondents do not 
understand. Since the researchers actually interact with the respondents face 
to face, the response rate is usually higher than in self-administered 
questionnaires. However, structured interview are self-report and are 
therefore subject to respondent bias (Polit & Beck 2008: 336).  
 
In this current study, interviews were conducted in the homes of the 
respondents on an agreed date and time. This approach facilitated the 
involvement of those who followed their treatment regimen as well as 
defaulters. Kyngas and Lahdenpera (1999:838) reported in their study of 
medication compliance that the least non-compliant patients did not attend the 
clinic; therefore such patients would be better interviewed at home. During the 
interviews, the researcher noted that most respondents felt at ease in their 
homes and willingly participated in the interviews. Each interview was 
conducted on one-on-one basis and lasted about 30 minutes. 
 
• Document analysis 
 
Document analysis is defined as "the collection, review, interrogation and 
analysis of various forms of texts as a primary source of research data" 
(O'Leary 2004:38). This implies that researchers utilise data in their research 
to corroborate their argument concerning a phenomenon of interest. 
According to O'Leary (2004:39), document analysis can take two approaches. 
One approach involves the use of a structured instrument. The items are 
formulated in a manner that elicits the required data from the documents. It 
also contains a scale on which the researcher records the data which is 
subsequently quantified. In the second approach, the researcher notes the 
frequency of occurrences numerically. Such occurrences could be words, 
phrases, readings and concepts related to the phenomenon of interest. These 
are noted down and then reduced to statistical analysis.   
  
The former approach was adopted in this current study.  The researcher 
developed a checklist with the assistance of the research supervisor to extract 
 74 
information from respondents’ clinical notes (refer to annexure F). The 
decision to use the clinical records of the respondents as data sources was 
based on the assumption that clinical records contain unbiased clinical data 
with a high degree of trustworthiness. The respondents’ clinical records were 
explored to crosscheck physiological measures, appointment keeping and 
prescribed treatment. 
 
3.4.2.2 Data collection instruments 
 
 The researcher utilised a structured interview schedule and a checklist as 
data collection instruments in this study.
 
  
• The interview schedule  
 
An interview schedule was used to collect structured data (refer to annexure 
G). This structured data collection instrument mandated the researcher to ask 
similar questions to all respondents and mark their responses using 
predetermined response options. According to Burns and Grove (2005:427), 
advantages of a structured data collection instrument include the ease of 
administering to respondents, the ease of statistical analysis and the 
possibility of assessing multiple variables simultaneously with minimal risks of 
researcher and respondent biases. However, major drawbacks with structured 
interview schedule include the fact they are time consuming and costly (Polit 
& Beck 2008: 336).  
 
The structured interview schedule with closed-ended questions and 
predetermined response options was developed specifically for the study. The 
items were derived from the expanded version of the Health Belief Model and 
incorporated the variables which are contained in the Model. The schedule 
had 10 sections and each measured different aspects of the compliance 
phenomenon. All sections with corresponding levels of measurement are 
indicated in table 3.2.  
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Table 3.2: The structure of the interview schedule 
Section Variable Level of measurement Cronbach (α) 
coefficient 
A Biographical Nominal, interval and ratio - 
B Compliance with medication 
regimen 
Ordinal 0.86 
C Compliance with lifestyle 
modification regimen 
Ordinal 0.73 
D Perception of severity Ordinal 0.38 
E Perception of risk Ordinal 0.98 
F Perception of benefits Ordinal 0.95 
G Perception of barriers Ordinal 0.85 
H Internal factors Ordinal 0.89 
I Health care provider factors Ordinal 0.91 
J Cues to action Ordinal 0.88 
 
 
Section A: Biographical data 
Section A comprised of 17 items which elicited demographic data such as 
age, gender, marital status, ethnic background, monthly income, duration of 
illness and the number of medication used per day. The respondents’ 
physiological measures such as blood pressure, height and weight were also 
measured. 
 
 
Section B: Compliance with the medication regimen 
A 14-item scale was developed to measure compliance with the medication 
regimen. A typical question asked was "how often do you take your medicine 
as prescribed?" The responses were noted on a 4-point Likert scale. The 
response options were: daily (4), frequently (3), rarely (2), never (1). Some 
questions were formulated in a negative format and the scoring was coded in 
the reversed order. For example the item, "how often are you careless about 
taking your medicine?" was coded as follows: daily (1), frequently (2), rarely 
(3), never (4). A higher total score reflected a higher level of compliance. The 
compliance score for each item was obtained by calculating the mean. A cut-
off point was set at 3 and respondents were categorised into compliant and 
noncompliant groups. Respondents with a score of 3 and above were 
considered as compliant and respondents with a score of below 3 were 
considered as non-compliant. In addition to this, the responses in this section 
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were summed and the mean was calculated to pave the way for the 
calculation of correlational and inferential statistics. The scale had a total 
score ranging from 14 to 56. The Cronbach’s alpha coefficient for this scale 
was 0.86.  
 
 
Section C: Compliance with the lifestyle modification regimen 
An 11-item scale was developed to measure compliance with the lifestyle 
modification regimen. The items were related to lifestyle factors which 
increase or decrease hypertension. A typical question asked was: "How often 
do you eat vegetables?" The responses were noted on a 4-point Likert scale. 
The response options were: daily (4), frequently (3), rarely (2), never (1). 
Some questions were formulated in a negative format and the scoring was 
coded in the reversed order. For instance, the question “how often do you 
smoke?" was coded as follows: daily (1), frequently (2), rarely (3) and never 
(4). The compliance score for each item was obtained by calculating the 
mean. A cut-off point was set at 3 and respondents were categorised into 
compliant and non-compliant groups. Respondents with a score of 3 and 
above were considered as compliant and respondents with a score of below 3 
were considered as non-compliant. In addition to this, the responses in this 
section were summed and the mean was calculated to pave the way for the 
calculation of correlational and inferential statistics. The scale had a total 
score ranging from 11 to 44. The Cronbach’s alpha coefficient for scale was 
0.73.  
 
 
Section D: Perception of severity 
A 4-item scale was developed to measure perception of severity of 
hypertension. Severity of hypertension in this sense connotes the capacity to 
cause complications, disability or death. Respondents were asked to rate their 
degree of agreement that hypertension is a severe disease. A typical 
statement to which they responded was: “My blood pressure condition is 
serious." The responses were noted on a 4-point Likert scale. The response 
options were: strongly agree (4), agree (3), disagree (2), strongly disagree (1). 
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Some questions were formulated in a negative format and the scoring was 
coded in the reversed order. The perception score for each item was obtained 
by calculating the mean. A cut off point was set at 3. Respondents with a 
score of 3 and above were regarded as having a high perception and those 
with scores of below 3 as having a low perception of severity. In addition to 
this, the responses in this section were summed and the mean was calculated 
to pave the way for the calculation of correlational and inferential statistics. 
The scale had a total score ranging from 4 to 16. The Cronbach’s alpha 
coefficient for the scale was 0.38. The low Cronbach’s alpha for this scale is 
attributable to the few number of items on the scale. 
 
 
Section E: Perception of risk 
Perception of risk was measured with a 9-item scale that assessed 
respondents’ perceived probability of developing complications from 
hypertension. The researcher inquired about the extent to which the 
respondents perceived their risk for developing complications of hypertension. 
The responses were noted on a 4-point Likert scale. The response options 
were: 75-100% chance (4), 50-74% chance (3), 25-49% chance (2), 0-24% 
chance (1). The perceptions score for each item was obtained by calculating 
the mean. A cut off point was set at 3. Respondents with a score of 3 and 
above were regarded as having a high perception of risk and those with 
scores of below 3 as having a low perception of risk. In addition to this, the 
responses in this section were summed and the mean was calculated to pave 
the way for the calculation of correlational and inferential statistics. The scale 
had a total score ranging from 9 to 36. The Cronbach’s alpha coefficient for 
this scale was 0.98. 
 
Section F: Perception of benefits
 
  
A 7-item scale was developed to measure respondents’ perception of benefits 
with antihypertension drug treatment. It was conceptualised that respondents 
with high perception of benefits of antihypertensive therapy would be more 
likely to comply with their treatment than those with a low perception of 
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benefits. The researcher inquired about the respondents’ perceptions by 
listing possible benefits of compliance such as: "keeping my blood pressure 
under control." The respondents indicated their degree of agreement or 
disagreement on a 4-point Likert scale. The response options were: extremely 
beneficial (4), beneficial (3), somewhat beneficial (2), not at all beneficial (1). 
The perception score for each item was obtained by calculating the mean. A 
cut off point was set at 3. Respondents with a score of 3 and above were 
regarded as having a positive perception of benefits and those with scores of 
below 3 a negative perception of benefits. In addition to this, the responses in 
this section were summed and the mean was calculated to pave the way for 
the calculation of correlational and inferential statistics. The scale had a total 
score ranging from 7-28. The Cronbach’s alpha coefficient for this scale was 
0.95.  
 
 
Section G: Perception of barriers 
Perception of barriers to antihypertension treatment was measured with a 7-
item scale developed for this study. The researcher inquired about the 
aspects that were problematic and hindered them from complying with their 
treatment such as: "not having enough time to exercise." The respondents 
indicated their level of agreement to the mentioned barriers on a 4-point Likert 
scale. The response options were: extremely problematic (4), problematic (3), 
somewhat problematic (2), not at all problematic (1). The barriers score for 
each item was obtained by calculating the mean. A cut off point was set at 3. 
Respondents with a score of 3 and above were regarded as having a high 
perception of barriers and those with scores of below 3 as having a low 
perception of barriers. In addition to this, the responses in this section were 
summed and the mean was calculated to pave the way for the calculation of 
correlational and inferential statistics. The scale had a total score ranging from 
7-28. The Cronbach’s alpha coefficient for this scale was 0.85.  
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Section H: Internal factors 
Three groups of internal factors believed to affect compliance with 
antihypertension treatment were measured with a 14-item scale. The factors 
were self-efficacy, knowledge of hypertension and locus of control. The 
researcher inquired about the extent to which the respondents agreed with 
statements such as: "I understand the nature of my condition." The 
respondents indicated their level of agreement to the mentioned factors on a 
4-point Likert scale. The response options were: strongly agree (4), agree (3), 
disagree (2) strongly disagree (1). Some questions were formulated in a 
negative format and the scoring was coded in the reversed order. A cut off 
point was set at 3. Respondents with a score of 3 and above were regarded 
as having a high internal factor score and those with a score of below 3 as 
having a low internal factor score. In addition to this, the responses in this 
section were summed and the mean was calculated to pave the way for the 
calculation of correlational and inferential statistics. The scale had a total 
score ranging from 14 to 56. The Cronbach’s alpha coefficient was 0.89. 
 
 
Section I: Health care provider factors   
A 13-item scale was developed to measure certain health care provider 
factors capable of having an influence on the respondents’ compliance with 
the medication and lifestyle modification regimens. The researcher inquired 
about aspects such as waiting time in the clinic, having confidence in the 
doctor and other health care professionals and availability of medications. The 
respondents indicated their level of agreement to the mentioned factors on a 
4-point Likert scale. The response options were: strongly agree (4), agree (3), 
disagree (2) strongly disagree (1). Some questions were formulated in a 
negative format and the scoring was coded in the reversed order. A cut off 
point was set at 3. Respondents with a score of 3 and above were regarded 
as having a positive perception on the health care provider factors and those 
with a score of below 3 as having a negative perception. In addition to this, 
the responses in this section were summed and the mean was calculated to 
pave the way for the calculation of correlational and inferential statistics. The 
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scale had a total score ranging from 13 to 52. The Cronbach’s alpha 
coefficient was 0.91.  
 
 
Section J: Cues to action  
A 12-item scale was developed to measure cues or factors that could 
motivate the respondents to demonstrate compliance behaviour. The 
researcher inquired about cues such as advice from the doctor or reading 
internet articles. The respondents indicated their level of agreement to the 
mentioned factors on a 4-point Likert scale. The response options were: 
strongly agree (4), agree (3), disagree (2) strongly disagree (1). Some 
questions were formulated in a negative format and the scoring was coded in 
the reversed order. A cut off point was set at 3. Respondents with a score of 3 
and above were regarded as having a high cues to action score and those 
with a score of below 3 as having a low cues to action score. Higher scores 
reflected stronger agreement with the scale cues as motivators of compliance 
behaviour while lower scores reflected the opposite. In addition to this, the 
responses in this section were summed and the mean was calculated to pave 
the way for the calculation of correlational and inferential statistics. The scale 
had a total score ranging from 12 to 48. The Cronbach’s alpha coefficient was 
0.88. 
 
Prior to conducting the main study, the researcher pre-tested the interview 
schedule on five patients diagnosed with hypertension at Grand Anse Health 
Centre. These patients were excluded from the main study and the results did 
not form part of the main study analysis. The main reason for pre-testing the 
instruments was to clarify the items and avoid ambiguity. It also enabled the 
researcher to estimate the duration of each interview which, at 25 to 30 
minutes, was considered appropriate. The items that were not clear were 
either modified or excluded from the interview schedule.  
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• The checklist 
 
A checklist was developed to extract quantitative information from the 
respondents’ medical and pharmacy records. Permission was received from 
the Ministry of Health to extract such information to supplement the data 
obtained during interviews. A systematic extraction of information bordered on 
evidence of medical diagnosis of hypertension, evidence of co-morbidity, 
types of medications and dosages prescribed, evidence of medication side-
effects, evidence of non-compliance with follow up appointments, medications 
intake or lifestyle modifications and evidence of uncontrolled hypertension. 
The variables were measured on the nominal level. 
 
3.4.2.3 Reliability and validity of the data collection instruments 
 
• Reliability of the interview schedule 
 
Reliability of a research instrument refers to the consistency with which it 
measures a particular attribute (Burns & Grove 2005:374). A reliable 
instrument should produce little variation with repeated measurements. 
Reliability testing is therefore a measurement of random error inherent in the 
instrument. Reliable instruments are necessary in a quantitative study to 
enhance the power of detecting significant differences or relationships that 
may exist in a study. According to Polit, Beck and Hungler (2001:242), there 
are six characteristics related with reliability. They are: internal consistency, 
quality, stability, clarity, adequacy and accuracy. There are also various 
methods of testing reliability but two commonly used methods involve 
evaluation of stability and internal consistency. In this current study the 
researcher calculated and reported on the Cronbach’s alpha coefficient (refer 
to table 3.2)  
 
Internal consistency of an instrument refers to the extent in which all items on 
the instrument consistently measure the variables they are supposed to 
measure. Internal consistency is assessed with the Cronbach's alpha 
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coefficient.  Cronbach's alpha coefficient of 0.00 indicates no reliability and a 
coefficient of 1.00 indicates perfect reliability (Burns & Grove 2005:365). 
However, for a newly developed instrument, a reliability coefficient of 0.70 is 
acceptable (Burns & Grove 2007:365). Reliability testing was performed on 
the interview schedule and Cronbach’s alpha coefficient for each section is 
discussed in section 3.4.2.2.  
 
• Reliability of the sphygmomanometer  
 
A standardised mercury sphygmomanometer was used in this study. The 
blood pressure of each respondent was taken with the same 
sphygmomanometer. The device consists of inflatable bladder and a 
compressible bulb connected through rubber tubing to a mercury column. 
Inflation and deflation of the bladder is operated manually by means of a 
control valve. Prior to measurement, the researcher checked the instrument to 
ensure that no leakage occurred either at the control valve or rubber tubing 
that could give inaccurate measurements.  
 
• Validity of the data collection instruments 
 
The validity of a quantitative instrument refers to the degree to which that 
instrument measures what it is intended to measure in the context of the 
phenomenon of interest (Polit & Beck 2008: 457-458). A research instrument 
must be capable of accurately measuring the variables underlying a research 
phenomenon. Three components of instrument validity, which should be 
assessed are face validity, content validity and construct validity.  
 
According to Burns and Grove (2005:377-378), face validity assessment is the 
subjective appraisal of the research instrument by experts in the field to 
ascertain its "appearance of measuring the content." To ensure face validity of 
the interview schedule and checklist, the research supervisor, a statistician 
and a practicing public health professional evaluated the instruments.  
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Content validity refers to the adequacy of representation of the variables 
under study being reflected by the instrument. Content validity demand an 
elaborate literature review on the part of the researcher as a crucial step to 
develop an instrument that incorporates all relevant aspects of the 
phenomenon under study (Burns & Grove 2005:377-378).  In this study, the 
researcher performed a thorough and comprehensive literature review on 
hypertension, compliance and the Health Belief Model. The interview 
schedule was developed under the supervision of the supervisor. The items 
were derived from the Health Belief Model and the literature review on the 
treatment of hypertension and compliance. The sections of the interview 
schedule agreed with the structure of the Health Belief Model. 
 
According to Burns and Grove (2005:230), construct validity "examines the fit 
between the conceptual definitions and operational definitions of variables." It 
ensures that constructs and concepts are well defined and measured within 
the framework of the theory guiding the study. To examine construct validity 
implies to assess whether the instrument indeed measures the concepts or 
constructs it claims to measure (Burns & Grove 2005:230). Operational 
definitions were developed for this current study and measurements were 
done in accordance with these definitions. 
 
3.5 DESIGN VALIDITY 
 
Burns and Grove (2005:214) define what they term as study validity as “a 
measure of the truth or accuracy of a claim.” Design validity of a study is 
concerned with the accuracy of the study findings reported by the researcher 
within the study context.  In a quantitative study such validity is determined by 
examining internal and external validity, and by addressing threats to each of 
these concepts (Burns & Grove 2005:814). External validity is of particular 
importance in descriptive-correlational studies. 
 
External validity refers to the extent to which the research results can be 
generalised beyond the sample used for the study (Burns & Grove 2005:218-
219). Generalisation of study findings can only be done if the sample was 
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representative of study population. In this study, a probability sampling 
method was employed to generate a representative sample and the 
researcher followed a statistician’s advice with regard to the sample size. 
Generalising the study findings to the study population would therefore be 
justifiable. By conducting interviews and visiting respondents’ homes, the 
researcher achieved a high response rate. Refusal to participate by 
substantial number of eligible respondents selected to participate in a study 
decreases its external validity. However, in this study out of 110 eligible 
respondents only 8 (7%) could not participate.   
 
3.6 DATA ANALYSIS    
 
Data analysis is “the systematic organization and synthesis of research data, 
and the testing of a research hypothesis using these data” (Polit & Beck 
2008:751). This current study employed descriptive and inferential statistics. A 
statistician analysed the data using the SAS JMP version 8.0. 
 
3.6.1 Descriptive analysis 
 
3.6.1.1 Frequencies, measures of central tendency and measures 
of dispersion 
 
Frequency distributions were used to organise the data and present the 
responses obtained. Measures of central tendency (mean, median, mode) 
and dispersion (standard deviation and distribution) were calculated and 
utilised to describe the data.  
 
3.6.1.2 Correlational analysis 
 
According to Burns and Grove (2005:484), correlational data analysis 
indicates the nature of a relationship between two variables and the 
magnitude of that relationship. The relationship could be positive or negative. 
In a positive relationship, a high score of one variable correlates with a high 
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score of the other. In a negative relationship, a high score of one variable 
correlates with a low score with the other.  
 
One method of performing correlational analysis is by using the Pearson's 
coefficient. This is a parametric test used to analyse relationships between 
two variables (Burns & Grove 2005:484). Pearson's r-coefficient is based on 
the assumption that variables relate in a linear fashion (Argyrous 2000:210). 
The coefficient is represented by r. An r = 1 indicates a perfect positive 
relationship, r = -1 indicates a perfect negative relationship, and r = 0 
indicates no relationship (Burns & Grove 2005:528).  
 
In this current study, the responses to several Likert items were summed and 
treated as interval data. Assumptions were made that the data was normally 
distributed and therefore Pearson's correlation analysis was considered to be 
an appropriate test. The significance level was pegged a priori at P<0.05. 
 
3.6.1.3 Regression analysis 
 
Stepwise multiple regression analysis was used to establish evidence for the 
relative contributions of individual predictor variables to compliance behaviour. 
It was used to determine the extent to which certain variables were related 
and the extent to which compliance (dependent variable) can be predicted if 
the predictor variable (independent variable) is present. Regression analysis 
is a parametric test that measures the degree of relationships between 
independent and dependent variables and subsequently using known values 
of the independent variable to predict values of the dependent variable 
(Argyrous 2000:201). Regression analysis only explains observed 
relationships and does not establish causality.  
 
3.6.2 Inferential statistics 
 
Associations between socio-demographic variables and compliance were 
explored using the Chi-square test and the differences between obtained 
means were examined through the Analysis of Variance test. 
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3.6.2.1 Chi-Square (X²) test 
 
The Chi-Square test is a nonparametric procedure used to test a hypothesis 
about the proportion of cases that fall into different categories as when a 
contingency table has been created (Polit & Beck 2008:493). It is an 
appropriate test when data are in the form of categories and frequencies 
(nominal data). The test is performed to calculate the significance of the 
differences between two or more groups. The most commonly preferred test 
is the Pearson's chi square test, used to test the null hypothesis that there is 
no relationship between observed frequency of events in two samples and 
whatever relationship is observed is due to chance (Burns & Grove 
2001:570).  
 
In this study the chi-square test was applied to establish whether significant 
relationships existed between the biographical variables and compliance. The 
significance level was pegged at p<0.05. 
 
3.6.2.2 Analysis of Variance (ANOVA) test 
 
The ANOVA test is a method for assessing the significance of differences 
between the means of two variables or two or more groups involving a single 
variable (Burns & Grove 2001: 583). This test is a parametric statistical test. It 
is regarded as a special form of t-test because it uses the same procedure 
and would produce the same result if only two means are analysed. However, 
the ANOVA test is preferable when examining the differences between the 
means of three or more levels of nominal variables. The test statistic is called 
an F-ratio (Argyrous 2000:230).  
 
In the current study, the responses on several Likert item scales were 
summed and treated as interval data. Assumptions were made that the data 
were normally distributed and therefore the ANOVA test was deemed 
appropriate. The one-way ANOVA test was consequently used to test the 
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relationships between the theoretical variables and treatment compliance. The 
significance level was pegged at P<0.05. 
 
3.7 ETHICAL CONSIDERATIONS 
 
In times past, individuals who were used as research subjects had their rights 
perverted by researchers. An important requirement in all research involving 
human subjects is the upholding of institutional and individual human rights. 
Research ethics is succinctly defined by De Vos (2002
 
:24) as "a set of moral 
principles which are suggested by an individual or group, subsequently widely 
accepted and which offers rules and behavioural expectations about the most 
correct conduct towards experimental subjects and respondents, employers, 
sponsors, other researchers, assistants and students."  
3.7.1 Protecting the rights of the institutions involved 
 
The institutions involved in this research were the University of South Africa 
and the Ministry of Health and Social Services of Seychelles. The researcher 
obtained written permission to conduct the study from the Research Ethics 
Committees of the University and the Ministry. Consent to gain access to the 
clinical records of the respondents was obtained in particular. The researcher 
ensured that the institutional protocol of confidentiality of information was not 
breached. All the respondents' clinical records were analysed by the 
researcher in a private room in the health centres.  The clinical records were 
not taken out of the health centres and analysed information was coded to 
ensure confidentiality.  
 
3.7.2 Protecting the rights of the respondents 
 
According to Brink et al (2006:31), there are three fundamental ethical 
principles that researchers must uphold and these are the principles of 
respect for persons, beneficence and justice.  How these principles were 
upheld in this research is explained below. 
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3.7.2.1 Principle of respect for human dignity 
 
The principle of human dignity encompasses the right to self-determination 
and the protection of vulnerable groups. 
 
• The right to self-determination 
 
The right to self-determination means that research participants have the 
freedom of choice whether to participate or withdraw from the study without 
coercion or risk of punishment. To ensure that this right is upheld, the 
researcher must fully explain not only the purpose and nature of the study but 
also his/her role and all aspects relating to the conduct and participation by 
the subjects. This ought to be done in a manner they would understand and 
allow them to make up their own minds (Burns & Grove 2005:181; Polit & 
Beck 2008:171-172). This constitutes informed consent, which is defined as 
"an ongoing agreement by a person to receive treatment, undergo procedures 
or participate in research, after risks, benefits and alternatives have been 
adequately explained to them" (RCN 2005:3). 
 
In this current study, all the respondents were fully informed of the research 
purpose, the nature of their involvement, their right to withdraw from the study, 
if they so wish, without any prejudicial punishment from the research team or 
the clinic staff.  The researcher fully explained the nature and purpose of the 
study to the respondents in the local language they could understand. All 
respondents were required to indicate their willingness to participate in the 
study by signing the consent form (refer to annexure B) while provision was 
also made for the respondents who could not write to thumbprint their 
approval. Consent was also obtained to use their clinical records. 
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• The  protection of vulnerable groups 
 
Individuals such as children, mentally retarded patients or those in an 
unconscious state are particularly vulnerable and require protection from 
exploitation for research purposes (Brink et al 2006:32). These are individuals 
who cannot make decisions on their own and depend completely on others for 
help. Therefore, in a given study, voluntary participation by individuals of 
sound mind and at least 18 years of age and above and the integrity of the 
researcher are important requirements. The respondents who participated in 
this current study were vulnerable because they relied on the clinics for their 
free treatment. They may have felt obliged to participate and the researcher 
took care to avoid any force of coercion. 
 
3.7.2.2 The  principle of justice 
 
This principle encompasses the respondents’ right to fair treatment and 
privacy. 
 
• The right to fair selection and treatment 
 
Every respondent in a study has an inalienable right to be treated fairly in line 
with the ethical principle of justice (Burns & Grove 2005:180). The principle 
stipulates fair selection of study participants; free from social, cultural, racial, 
political, gender or religious biases. It also advocates fair treatment of study 
participants, that is, respecting the prior agreement between the researcher 
and respondent such as providing benefits promised  (Burns & Grove 
2005:180)
 
. 
In this current study, the respondents were all registered patients attending 
two public health institutions on Praslin Island. They were selected by means 
of a probability sampling method, thus minimising researcher bias. No 
financial benefits were promised and none were handed out. The respondents 
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were informed that, although they would not experience immediate benefits, 
the outcomes of the research would eventually benefit the larger society. The 
researcher also explained that this study was for educational purposes and 
funding was entirely the responsibility of the researcher.  
 
• Right to privacy 
 
The right to privacy entails the right to withhold or share personal information 
with others (Burns & Grove 2005:186). Research subjects have the right to 
withhold information that may be deemed psychologically distressing and 
researchers must respect this. Disclosure of private information to a third 
party without the permission of the subjects constitutes a breach of this right. 
Obtaining data anonymously by secret taping or filming or recording is an 
infringement of the right of privacy (Brink et al 2006:33).  
 
In this current study, the researcher visited the respondents’ homes only after 
consent had been received to do so. Thereafter, respondents who accepted 
to participate voluntarily shared their personal information in the privacy of 
their homes. The interview questions were limited only to those in the 
interview schedule.  
 
Anonymity refers to keeping the identity of the respondent secret (Brink et al 
2006:35). Anonymity was ensured in this study by using code names rather 
than respondents’ real names during data collection and analysis. The same 
code name appeared on the interview schedule and checklist of each 
respondent. The list of real names was later destroyed.  
 
Confidentiality of information refers to keeping all the respondents’ divulged 
information safe. Such information including questionnaires, interview 
schedules, audio-tapes and video recordings must be locked in a safe place 
(Brink et al 2006:35).  In this current study, all interview schedules and 
checklists used for data collection were stored in a secure place. The 
researcher extracted data from each clinical record in a private room in the 
two health centres and immediately locked it in the record safe on completion.  
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3.7.2.3 Principle of beneficence and non-maleficence 
 
According to Davis (1990:29), beneficence means, "doing good," while non-
maleficence means "do no harm," These two concepts are derived from the 
Latin phrase Primum non nocere which means, "above all do no harm," Davis 
(1990:29) and Polit and Beck (2008:170-171) both emphasise the necessity 
for researchers to abide by these principles, which literally implies causing no 
harm and discomfort to respondents. 
 
• The right to protection from harm and discomfort 
 
Researchers must conduct their studies in a way that greatly minimises 
potential harm and discomfort. Polit and Beck (2008:170) and Burns and 
Grove (2005:190), mention four categories of harm and discomfort that could 
be caused during research, namely social, physiological, emotional and 
economic. Risks may be real or anticipated. On the other hand, a study could 
be directly beneficial to individual participants or may generate new 
knowledge and help advance the body of science (Burns & Grove 2005:192-
193). It is thus necessary to weigh the risks against the benefits. 
 
Regarding this current study, non-invasive physiological parameters of blood 
pressure, weight and height were measured without causing physical 
discomfort or physical harm. According to Burns and Grove (2005:190), 
interviews usually have minimal physical risks. This study involved structured 
interviews with respondents at their homes on an agreed date and time. Each 
interview did not take more than 30 minutes thus minimising physical risks 
such as fatigue and headache.  
 
Polit and Beck (2008:170-171), explain that a researcher should offer 
assurances to all respondents that information divulged would not be 
adversely used against them. In this current study the researcher offered such 
assurances and honoured this promise. The respondents may have feared 
victimisation if they revealed information about their non-compliance or their 
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health care provider perceptions. The researcher assured the respondents 
that the information obtained would not compromise their treatment at the 
clinics. The contact address and telephone number were left by the 
researcher should it become necessary to contact him after the interview.  
 
The study did not incur any financial cost to the respondents. The researcher 
bore the cost of transportation to the respondents’ homes and provided all 
instruments required for the study. This study intended to identify problems 
associated with compliance with medication use and lifestyle modifications. 
The research results could be used to improve compliance, which serves the 
interests of patients suffering from hypertension. Therefore, the researcher 
opined that the potential benefits of conducting this study far outweighed any 
anticipated risks. 
 
3.7.3 Scientific honesty and integrity  
 
According to Burns and Grove (2005:203), the main goal of any research is to 
generate sound scientific knowledge through honest methods. Scientific 
dishonesty involves fabrication or falsification of research steps and results, 
plagiarism and manipulating results to obtain financial benefits or honour.  
Research must be conducted and reported with honesty and integrity and in 
line with established national, institutional and professional codes of practice  
(Brink et al 2006:40). In this current study, the principle of scientific honesty 
and integrity in research was upheld. A due process of data collection was 
followed and made available to the research supervisor for scrutiny. An 
independent statistician performed the statistical analysis of data and no 
attempts were made to manipulate or fabricate raw data or falsify research 
findings. All quoted or paraphrased sources of information used in this study 
were acknowledged accordingly.  
 
3.8 CONCLUSION 
 
This descriptive-correlational research involved the data collection methods of 
interviewing and document analysis. Various issues related to the compliance 
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behaviour of 102 hypertensive respondents were investigated. Data collection 
was done involving an interview schedule and a checklist. Various measures 
were applied to enhance scientific rigour and to comply with the principles of 
research ethics. The data obtained is presented in the next chapter.  
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CHAPTER 4 
PRESENTATION OF RESEARCH FINDINGS 
 
 
4.1 INTRODUCTION 
 
This was a quantitative descriptive-correlational study conducted on the Island 
of Praslin, Seychelles during which structured interviews were held with 102 
respondents systematically sampled from registers of hypertension patients 
maintained at Baie Sainte Anne Hospital and Grand Anse Health Centre.  A 
108-item interview schedule consisting of 10 sections was developed 
specifically for the study. A 9-item checklist was also developed to extract 
information from the clinical records of the respondents.  
 
The study was purposed to describe compliance to the drug and required 
lifestyle modification regimens (treatment compliance) of diagnosed 
hypertension patients and to identify such factors that influenced compliance 
behaviour in this population. Furthermore, possible relationships between 
treatment compliance and the theoretical variables of the Health Belief Model 
were explored using statistical methods.  
 
 The results of the descriptive, correlational and inferential statistics are 
discussed in this chapter. Non-response items are presented as missing 
values below each table. Since percentages were rounded off to 2 decimal 
places, the cumulative percentages may not add up to 100.00 in all cases. 
However, in all such cases the error was never larger than 0.01% which was 
acceptable.  
 
Data analysis is presented in sections based on the interview schedule used 
for the study. Complementary information from the checklist is also included, 
where appropriate. In all cases, clarity of data is invigorated with the use of 
bar charts, histograms and tables. The analysis of data was conducted in two 
phases. In the first phase, descriptive analysis of all variables in the interview 
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schedule and checklist was performed. In the second phase, inferences and 
correlations of variables with treatment compliance were performed. 
 
4.2 BIOGRAPHICAL DATA 
 
This section presents data pertaining to the respondents’ physiological 
parameters of blood pressure, height, weight and body mass index. Also 
included are demographical data such as age, gender, ethnic background, 
duration of illness, employment status, marital status, educational status and 
family income. 
 
4.2.1 Blood pressure of respondents (N=102) 
 
Item A1 on the checklist inquired about evidence of a hypertension diagnosis 
on the clinical records of the respondents. All the respondents, namely 102 
(100%) were clinically diagnosed as having hypertension. 
 
Item A1 on the interview schedule inquired about the blood pressure of the 
respondents at the time of data collection. Hypertension was defined as a 
systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg 
(refer to section 1.7.5). The mean systolic blood pressure for males was 142 
(n=44), which was relatively higher than the mean systolic blood pressure for 
females, namely 137 (n=58). The mean diastolic blood pressures for the male 
and female respondents were 89 and 88 respectively. Figure 4.1 shows that 
altogether 67 (65.69%) respondents had high blood pressure and 35 
(34.31%) had a normal blood pressure at the time of data collection. Among 
those with high blood pressure, 39 (38.24%) were females and 28 (27.45%) 
were males and among those with normal blood pressure 19 (18.63%) were 
females and 16 (15.69%) were males.  
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Figure 4.1 
Respondents' blood pressure status taken during the interview (n=102) 
 
Item A9 on the checklist inquired about evidence of uncontrolled hypertension 
noted on the respondents’ clinical records during past three appointments 
(refer to figure 4.2). Altogether, 62 (60.78%) clinic records had evidence of 
uncontrolled hypertension. There was no evidence of uncontrolled 
hypertension in the clinical records of 40 (39.22%) respondents.  
 
21.57% 17.65%
39.22%
35.29%
25.49%
60.78%
Females Males Both
Normal BP High BP
 
Figure 4.2 
Uncontrolled hypertension noted on the respondents’ clinical records during past three 
appointments (n=102). 
The high number of respondents with high blood pressure values together 
with the evidence of uncontrolled hypertension, especially among the female 
respondents, is noteworthy.  
 
4.2.2 Body mass index of the respondents (N=102) 
Item A4 on the interview schedule inquired about the body mass index of the 
respondents. The researcher measured the weight and height of the 
respondents. The respondents’ body mass index was calculated by dividing 
the weight in kilograms (item A2) by the height (item A3) squared in meters. 
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The results are shown in figure 4.3. 51 (50.00%) of the respondents were 
obese, 38 (37.25%) overweight while only 13 (12.75%) had a normal body 
weight for height.  
 
50.00%
37.25%
12.75%
Obese Overw eight Normal w eight
 
Figure 4.3 
Body mass index of respondents 
 
The high percentage of obese and overweight respondents (87.25%) is of 
particular concern considering the fact that weight control is an important 
variable in blood pressure control. 
 
4.2.3 Age of respondents (N=102) 
 
Item A5 on the interview schedule inquired about the age of the respondents. 
The respondents' ages were grouped into 7 categories for analysis (refer to 
table 4.1). The majority of the respondents 26 (25.49%) fell in the category 
35-44 years, followed by 24 (23.53%) in the category 55-64 years, 21 
(20.59%) in the category 45-54 years and 16 (15.69%) in the category 65-74 
years.  
 
Altogether about 85.30% of respondents were aged between 35-74 years 
while only 14.70% were aged less than 35 years. This is not surprising as 
hypertension is largely seen in adult life. 
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Table 4.1: Age groups of respondents (n=102) 
Age Frequency Percent Cumulative frequency Cumulative percent 
<25 years 1 0.98 1 0.98 
25-34 years 9 8.82 10 9.80 
35-44 years 26 25.49 36 35.29 
45-54 years 21 20.59 57 55.88 
55-64 years 24 23.53 81 79.41 
65-74years 16 15.69 97 95.10 
≥75 years 5 4.90 102 100.00 
TOTAL 102 100.00 - - 
 
4.2.4 Gender of respondents (N=102) 
 
Item A6 on the interview schedule inquired about the gender of the 
respondents. The sample consisted of 58 (56.86%) females and 44 (43.14%) 
males. This is shown in figure 4.4 
 
56.86%
43.14%
Females Males
 
Figure 4.4 
Gender of respondents (N=102) 
 
 
4.2.5 Ethnic background (N=102) 
 
Item A7 on the interview schedule inquired about the ethnic background of the 
respondents (refer to figure 4.5). The majority of the respondents 51 (50.00%) 
identified themselves as Black Africans, 38 (37.25%) of mixed heritage, 11 
(10.78%) Caucasians and 2 (1.96%) Indian/Chinese. 
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Figure 4.5 
Ethnic background of respondents (N=102) 
 
4.2.6 Marital status (N=102) 
 
Item A8 on the interview schedule inquired about the marital status of the 
respondents (refer to figure 4.6). The majority of the respondents, namely 40 
(39.22%) were married, 30 (29.41%) were never married, 13 (12.75%) were 
cohabiting, 8 (7.84%) were widowed, 7 (6.86%) were divorced and 4 (3.92%) 
were separated.  
 
39.22%
29.41%
12.75%
7.84% 6.86%
3.92%
Married Never married Cohabiting Widow ed Divorced Seperated
 
Figure 4.6 
Respondents’ marital status (N =102) 
 
4.2.7 Educational status (N=102) 
 
Item A9 on the interview schedule inquired about the level of education 
attained by the respondents (refer to figure 4.7). The majority of the 
respondents, namely 47 (46.08%) had completed primary school, 31 
(30.39%) had completed secondary school, 12 (11.76%) had completed post 
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secondary school while 3 (2.94%) had completed university education. 9 
(8.82%) respondents had no schooling. 
 
The results suggest that the majority of the respondents (91.18%) had formal 
education and are literate. A highly literate population is associated with better 
understanding of health information and the importance of treatment 
compliance. This research population was mainly literate and capable of 
comprehending the significance of treatment compliance.  
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8.82%
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University No schooling
 
Figure 4.7 
Educational status of the respondents (N=102) 
 
4.2.8 Employment status (N=102) 
 
Item A10 on the interview schedule inquired about the respondents’ work 
status in the last three months (refer to figure 4.8). Majority of the 
respondents, namely 37 (36.27%) were government employees, 24 (23.53%) 
were retired, 17 (16.67%) were employed in the non-government sector, 14 
(13.73%) were self-employed and 10 (9.80%) were unemployed. There was 
no student in the sample. Thus 90.20% of the respondents in this study were 
either involved in one form of economic activity or retired. 
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Figure 4.8 
Respondents' employment status (N=102) 
 
4.2.9 Monthly income in Seychelles Rupees (SR) (N=102) 
 
Item A11 on the interview schedule inquired about the respondents’ average 
monthly earnings (in rupees) over the past year (refer to table 4.2). The 
majority of the respondents, namely 39 (38.24%) earned a monthly salary of 
between SR2000-2999, 24 (23.53%) earned SR3000-3999, 17 (16.67%) 
earned SR1000-1999, 11 (10.78%) earned SR4000-4999 and 7 (6.86%) 
earned SR5000 or more per month. Only 4 (3.92%) earned SR0-999.   
 
Table 4.2: Monthly income of the respondents 
Income Frequency Percent Cumulative 
frequency 
Cumulative percent 
SR 0 – 999 4 3.92 4 3.9 
SR 1000 – 1999 17 16.67 21 20.59 
SR 2000 – 2999 39 38.24 60 58.83 
SR 3000 – 3999 24 23.53 84 82.36 
SR 4000 – 4999 11 10.78 95 93.14 
SR ≥ 5000 7 6.86 102 100 
Total 102 100.00 -  
 
4.2.10  Duration of illness (N=102) 
 
Item A12 on the interview schedule inquired about the time when the 
respondents were informed that they had high blood pressure (refer to figure 
4.9). Most of the respondents, namely 62 (60.78%) were diagnosed more 
than five years ago. The duration of illness were further revealed as follows: 
diagnosed two years ago (10 (9.80%)), one year ago (9 (8.82%)), three years 
ago (9 (8.82%)), five years ago (9 (8.82%)), four years ago (6 (5.88%)), less 
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than one year ago (3 (2.94%)). Most of the respondents therefore had 
hypertension for more than five years.  
 
2.94%
8.82% 9.80% 8.82% 5.88% 2.94%
60.78%
Less than 1
year ago
1 year ago 2 years ago 3 years ago 4 years ago 5 years ago More than 5
years ago
 
Figure 4.9 
Duration of illness (N=102) 
 
4.2.11 Reported health complaints by respondents at time of the 
interview 
 
Item A13 on the interview schedule inquired about the respondents’ present 
health complaints (refer to table 4.3). Because many respondents had more 
than one complaint, they chose more than one response option. The majority 
of the respondents, namely 55 (32.80%) did not have any health complaints. 
25 (14.97%) respondents reported palpitations, 20 (11.98%) reported visual 
impairment, 14 (8.38%) reported swelling of the feet, 13 (7.78%) reported 
swelling of the leg, 11 (6.59%) reported heart problems, 11 (6.59%) reported 
dyspnoea on exertion and 7 (4.19%) reported angina. Furthermore, 4 (2.40%) 
reported dyspnoea at rest, 4 (2.40%) reported paralysis of a limb and 3 
(1.80%) reported kidney problems. 
 
Table 4.3: Health complaints by respondents at time of the interview 
Health complaint Frequency Percent (%) 
None 55 32.93 
Palpitations 25 14.97 
Visual impairment 20 11.98 
Swelling of the feet 14 8.38 
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Swelling of the leg 13 7.78 
Health complaint Frequency Percent (%) 
Heart problems 11 6.59 
Dyspnea on exertion 11 6.59 
Angina 7 4.19 
Paralysis of a limb 4 2.40 
Dyspnea at rest 4 2.40 
Kidney problems 3 1.80 
 
Item A2 on the checklist inquired about evidence of associated co-morbidity in 
the clinical records of the respondents (refer to figure 4.10). No co-morbidities 
were documented in the medical records of the majority of the respondents, 
namely 60 (58.82%). The clinical records of 17 (16.67%) included references 
to cardiac failure, 13 (12.75%) to visual impairment (specifically cataract 
attributable to aging), 8 (7.84%) to angina, 8 (7.84%) to chronic renal failure 
and 6 (5.88%) to coronary artery disease. 4 (3.92%) respondents had 
paralysis of a limb as a consequence of a stroke and none of the respondents 
was living with myocardial infarction.  
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Figure 4.10 
Complications of hypertension recorded in the clinical records (n=102). 
Key: CRF = Chronic renal failure; CAD = Coronary artery disease; MI = Myocardial infarction 
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4.3 COMPLIANCE WITH ANTIHYPERTENSION DRUG TREATMENT, 
CLINIC APPOINTMENTS AND BLOOD PRESSURE MONITORING 
 
In this section the researcher intends to answer the following research 
question: 
How compliant are the respondents with their hypertension drug 
regimen, clinic appointments and blood pressure monitoring? 
 
4.3.1  Number of medicines which the respondents were taking for 
hypertension (N=101) 
 
Item A14 on the interview schedule inquired about the number of different 
kinds of medicine the respondents were taking for hypertension (refer to figure 
4.11). The majority of the respondents, namely 33 (32.67%) took two different 
kinds of medicine, 30 (29.70%) took one kind, 22 (21.78%) took three kinds, 8 
(7.92%) took four kinds, while 4 (3.96%) took more than four kinds of 
medicine. Interestingly, 4 (3.96%) respondents reported they did not take any 
medicine for the blood pressure at all. One respondent declined to respond to 
this item. 
 
3.96%
29.70% 32.67%
21.78%
7.92%
3.96%
None One Tw o Three Four >Four
 
Figure 4.11 
Numbers of different kinds of medicine respondents were taking 
 
4.3.2 Types of medicines respondents were taking (N=102) 
Item A3 on the checklist inquired about the type of medications prescribed for 
each respondent (refer to figure 4.12). The majority of the respondents, 
namely 73 (71.57%) took Amlodipine singly or in addition to other 
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medications, 40 (39.22%) took Bendrofluazide and 38 (37.25%) took 
Lisinopril. 26 (25.49%) respondents were on Atenolol, 18 (17.65%) took 
Frusemide and 7 (6.86%) took Losartan. Only 4 (3.92%) respondents took 
Methyldopa and none of the respondents took Spironolactone. 
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Figure 4.12 
Types of medications taken by respondents 
 
4.3.3 Dosage of medications respondents were taking (N=102) 
Item A4 on the checklist inquired on the prescribed dosage of the medications 
in terms of a single or multiple dosage per day or a combination of single and 
multiple dosage (refer to figure 4.13). Generally, most antihypertension 
medications are taken only once a day (single dose). Almost all respondents, 
namely 98 (96.08%) were on a single dose regimen, whereas 4 (3.92%) were 
on combined single and multiple dose regimens. No respondent was on a 
multiple dose regimen only.  
 
96.08%
3.92% 0.00%
Single dose regimen Combined single & multiple
dose regimen
Multiple dose regimen only
 
Figure 4.13 
Dosage regimen of medications taken by respondents 
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4.3.4 Doses of medications respondents skipped in the last three 
days (N=102) 
 
Item A15 on the interview schedule inquired about the number of doses of 
medication the respondents had skipped during the past three days (refer to 
figure 4.14). The responses were collapsed into two groups: those who did 
not skip a dose of medication in the last three days were regarded as 
compliant and those who skipped one or more were regarded as non-
compliant. The majority of respondents, namely 72 (70.59%) did not skip a 
dose and 30 (29.41%) skipped one or more doses. 
 
70.59%
29.41%
Did not skip Skipped one or more
 
Figure 4.14 
Medications skipped by respondents in the last three days (N=102) 
 
4.3.5 Evidence of medication compliance in the last three appointments 
(N=102) 
 
Item A7 on the checklist inquired about evidence of medication compliance 
noted in the clinic records during the past three appointments (refer to figure 
4.15). In 73 (71.57%) records, there was no reference to non-compliance 
whereas 29 (28.43%) of the records included documented incidences of non-
compliance with medications. 
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Compliant with medications Non-compliant with medications
 
Figure 4.15 
Respondents' compliance with medications as reported in the clinical records 
 
Item B1 on the interview schedule inquired about how often the respondents 
took their medications (refer to table 4.4). The respondents were categorised 
into two groups; those who reported taking medication daily were regarded to 
be the compliant group and all others as the non-compliant group. This is 
because hypertension medications should be taken on a daily basis and not 
intermittently. Out of 102 respondents, 65 (63.73%) were compliant while 37 
(36.27%) were non-compliant. According to Zen et al (2002:12) non-compliant 
patients would usually admit not taking medications on certain days. 
 
Table 4.4: Compliance with medications 
Compliant Non-compliant 
65 (63.73%) 37 (36.27%) 
 
4.3.6 Medication side effects recorded in the clinical notes (N=102) 
 
Medication side effect is a significant reason why most patients would stop 
taking medications (Benson & Britten 2003:1314; Jokisalo 2002:577). Item A4 
on the checklist inquired about evidence of complaints of medication side 
effects during the past three appointments (refer to figure 4.16). Surprisingly, 
in 93 (91.18%) of the records, no entry was found for medication side effects. 
Only 9 (8.82%) of the records contained evidence of medication side effects. 
This finding may indicate the relative tolerability of antihypertension 
medications, inaccurate recordkeeping by the doctor, or failure on the part of 
the patient to report side-effects. 
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8.82%
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Figure 4.16 
Respondents' complaints of side effects of medications as reported in the clinical records 
 
Medication side effects did not appear to be problematic and was therefore 
unlikely to contribute to medication non-compliance. 
 
4.3.7 Compliance with clinic appointments and blood pressure 
monitoring (N=102) 
 
Item B13 on the interview schedule inquired about how often the respondents 
turned up for clinic appointments as scheduled (refer to table 4.5). Honouring 
clinic appointment was considered to be a variable indicative of medication 
compliance. The respondents were categorised into compliant and non-
compliant groups based on their responses. The majority of respondents, 
namely 80 (79.21%) were compliant with clinic appointments while 22 
(21.57%) were non-compliant.   
 
Table 4.5: Compliance with clinic appointments 
Compliant Non-compliant 
80 (79.21%) 22 (21.57%) 
 
Item A6 on the checklist inquired about evidence of follow-up visit compliance 
noted for past three appointments (refer to figure 4.17). The clinic records of 
74 (72.55%) respondents (N=102) contained no evidence of non-compliance 
and in 28 (27.45%) records there was documented evidence of follow up non-
compliance. 
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72.55%
27.45%
Compliant with follow up Non-compliant with follow up
 
Figure 4.17 
Respondents' compliance with follow up visits as reported in the clinical records. 
 
Item B14 on the interview schedule inquired about how regularly the 
respondents had their blood pressure checked. Interestingly, the majority of 
the respondents, namely 80 (78.43%) indicated rarely, 13 (12.75%) frequently 
and 5 (4.90%) never. Only 4 (3.92%) checked their blood pressure daily. 
 
4.3.8 Compliance as measured on the Compliance with the Medication 
Regimen Scale (n=101) 
 
Section B of the interview schedule measured compliance with the 
antihypertension medications regimen. This section discusses the descriptive 
statistics of responses to this scale, while inferences and correlations are 
presented in section 4.12. 
 
Responses to the items on the Compliance with the Medication Regimen 
Scale were collapsed for discussion purposes to indicate the respondents' 
reasons for failure to comply with their treatment. Table 4.6 shows that failure 
to obtain a refill of their prescription was the strongest reason for non-
compliance. Other significant reasons were forgetfulness, carelessness and   
the use of alternative remedies. Less significant reasons were medication side 
effects, medication ineffectiveness and fear of addiction. Frequent change of 
medications and frequent change of dosage were the least indicated reasons 
for not complying with the medication regimen. 
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Table 4.6: Reasons for non-compliance with antihypertension drug treatment 
Stated reasons for not complying with 
medications 
Agreement with stated 
reasons for not 
complying 
Disagreement with stated 
reasons 
Failure to refill a prescription * 22 (21.78%) 79 (78.22%) 
Forgetfulness * 19 (18.81%) 82 (81.18%) 
Carelessness * 17 (16.83%) 84 (83.17%) 
Use of alternative remedies * 13 (12.87%) 88 (87.13%) 
Because they are feeling better * 12 (11.88%) 89 (88.12%) 
Medication side-effects * 10 (9.90%) 91 (90.10%) 
It makes them feel worse * 9 (8.91%) 92 (91.09%) 
Belief that the medications are ineffective * 6 (5.94%) 95 (94.06%) 
Fear of addiction * 6 (5.94%) 95 (94.06%) 
Frequent change of medications * 4 (3.96%) 97 (96.04%) 
Frequent change of dosage ** 3 (2.97%) 98 (97.03%) 
* 1 Missing value; ** 2 Missing values 
 
Table 4.7 summarises the values of central tendency and dispersion on the 
Compliance with the Medication Regimen Scale. As can be seen in figure 
4.18, the distribution was negatively skewed (distribution = -1.01). This 
indicates that most respondents scored high thus clustering of scores 
occurred towards the right. By implication, most of the respondents tended to 
be compliant with antihypertension medications. For a skewed distribution, the 
median and the interquartile range best approximate the central location and 
the dispersion of distribution compared to the mean and standard deviation. 
The median represents the 50th percentile of the distribution and is not 
affected by outliers. The interquartile range, which represents the difference 
between the 75th percentile and 25th percentile of a distribution, is also not 
affected by outliers (Crawshaw & Chambers 2001:68). For this scale, the 
median was 3.14 and the interquartile range was 0.64 (refer to table 4.7).  
 
Table 4.7: Measures of central tendency and dispersion on the compliance with the medication 
regimen 
 
Variable N Median Interquartile 
range 
Mean Range of 
scores 
Distribution SD 
CAMR 102 3.14 0.64 2.96 1.89-3.57 -1.01 0.43 
    CAMR = Compliance with antihypertension medication regimen; SD = Standard deviation 
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Figure 4.18 
Respondents’ mean scores on the Compliance with the Medication Regimen Scale 
 
The mean score for this scale was 2.96 (SD = 0.43) (refer to table 4.7). The 
mean scale score of individual respondents was used to categorise the 
respondents into compliant and non-compliant groups to facilitate correlational 
and inferential statistics (refer to section 4.12). Respondents with a mean 
score below 3 were considered as non-compliant and respondents with a 
mean score of 3 and above were considered as compliant. 
 
4.4 COMPLIANCE WITH THE LIFESTYLE MODIFICATIONS REGIMEN 
 
In this section the researcher intend to answer the following research 
question: 
How compliant are the respondents with their lifestyle 
modifications regimen? 
 
4.4.1 Number of cigarettes the respondents smoked per day 
(N=102) 
 
Item A16 on the interview schedule inquired about the number of cigarettes 
smoked per day (refer to figure 4.19). The majority of the respondents, 
namely 86 (84.31%) did not smoke at all, 7 (6.86%) smoked between one and 
four cigarettes, 5 (4.90%) smoked five to nine cigarettes and 4 (3.92%) 
smoked between ten and fourteen cigarettes per day. No respondents 
smoked fifteen and more cigarettes per day. 
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Figure 4.19 
Quantity of cigarettes smoked per day (N=102) 
 
The data is indicative of a general compliance with the smoking cessation 
requirement. 
 
4.4.2 Frequency of alcohol consumption (N=102) 
 
Item A17 on the interview schedule inquired about the frequency of alcohol 
consumption (refer to figure 4.20). The majority of the respondents, namely 33 
(32.35%) seldom ingested alcohol, 22 (21.57%) never ingested alcohol, 13 
(12.75%) ingested alcohol more than once per day, 11 (10.78%) ingested 
alcohol about once a week, 10 (9.80%) ingested alcohol less than once per 
week, 8 (7.84%) ingested alcohol a few times per week and 5 (4.90%) 
ingested alcohol daily.  
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Figure 4.20 
Respondents' frequency of alcohol consumption 
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The above data is indicative that the majority of the respondents tended to 
comply with the alcohol intake restriction requirement but that a substantial 
number failed to comply. 
 
4.4.3 Lifestyle modification compliance reported in the clinic records 
 
Item A4 on the checklist inquired about evidence of lifestyle modification 
compliance noted for past three appointments (refer to figure 4.21). In the 
clinic records of the majority of respondents, namely 65 (63.73%), there were 
no entries with regard to non-compliance with the lifestyle modifications 
regimen and in 37 (36.27%) respondents such entries were documented. It 
should however, be understood that absence of documentation does not 
necessarily imply those patients were compliant with required lifestyle 
modifications. Some omission may have been as a result of lack of 
documentation by clinicians. 
63.73%
36.27%
Compliant with lifestyle modifications Non-compliant with lifestyle modification
 
Figure 4.21 
Respondents' compliance with lifestyle modifications reported in the clinic records 
 
4.4.4 Compliance as measured on the Compliance with the 
Lifestyle Modifications Regimen Scale 
 
Section C of the interview schedule measured compliance with lifestyle 
modifications among respondents. The descriptive statistics of responses to 
this scale is discussed in this section while inferences and correlations with 
other variables are presented in sections 4.12. 
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The lifestyle modification behaviours assessed in this section were 
categorised into 6 recommended and 5 non-recommended behaviours. The 
recommended behaviours were eating vegetables, eating fruits, engaging in 
physical exercise, trying to lose some weight, relaxing and having enough 
sleep. The non-recommended behaviours were smoking, drinking alcohol, 
eating a meal high in animal fat, eating fast food and sprinkling salt on food.  
Table 4.8 indicates that the respondents tended to be compliant with the 
recommended behaviours of eating fruits and vegetables and relaxation. They 
tended to be less compliant with physical exercise and weight reduction. Most 
respondents indicated that they did not sleep enough. 
 
Table 4.8: Frequencies of responses on the Compliance with the Lifestyle Modifications 
Regimen Scale 
How often do you: Compliant Non-compliant 
Eat fruits? 96 (94.12%) 6 (5.88%) 
Eat vegetables? 94 (92.16%) 8 (7.84%) 
Relax? 70 (60.63%) 32 (31.37%) 
Engage in physical exercise? 51 (50.00%) 51 (50.00%) 
Try to lose some weight? 47 (46.08%) 55 (53.92%) 
Get enough sleep? 29 (28.43%) 73 (72.56%) 
 
Table 4.9 indicates that most respondents tended to be compliant with 
avoidance of the non-recommended behaviours namely smoking and the 
consumption of alcohol, salt, fast food and animal fat. However there are 
indications that interventions are required to motivate more respondents to 
refrain from consuming of alcohol, salt, fast food and animal fat. 
 
Table 4.9: Frequencies of responses on compliance with the avoidance of non-recommended 
behaviours on the Compliance with the Lifestyle Modifications Regimen Scale 
 
How often do you: Compliant Non-compliant 
Smoke? * 85 (84.16%) 16 (15.84%) 
Drink alcohol? 80 (78.43%) 22 (21.57%) 
Sprinkle salt on your food? 77 (75.49%) 25 (24.51%) 
Eat fast food? 74 (72.59) 28 (27.45%) 
Eat a meal high in animal fat? 73 (71.57%) 29 (28.35%) 
* 1 missing value 
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The distribution of the respondent’s scores for this scale as plotted in figure 
4.22 is negatively skewed (distribution = -0.46) indicating that most 
respondents scored high on the scale. This means that the majority of 
respondents tended to be compliant with lifestyle modifications. The median 
score was 3.09 and the interquartile range was 0.64 (refer to table 4.10).  
 
Table 4.10: Measures of central tendency and dispersion on the compliance with the lifestyle 
modifications regimen. 
 Variable N Mean SD Median Range of 
scores 
Distribution Interquartile 
range 
CLMR 102 3.04 0.46 3.09 1.82 – 3.91 -0.46 0.64 
Key: CLMR = compliance with lifestyle modification regimen. 
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Figure 4.22 
Respondents’ mean scores on the Compliance with the Lifestyle Modifications Regimen Scale 
 
The mean score for this scale was 3.04 (SD = 0.46) (refer to table 4.10). The 
mean scale score of individual respondents’ score was used to categorise the 
respondents into compliant and non-compliant groups to facilitate correlational 
and inferential statistics (refer to section 4.12). Respondents with a mean 
score below 3 were considered as non-compliant with recommended lifestyle 
modifications and respondents with a mean score of 3 and above were 
considered as compliant.  
 
 116 
4.5 RESPONDENTS' PERCEPTIONS OF THE SEVERITY OF 
HYPERTENSION (N=101) 
 
Section D of the interview schedule measured the respondents' perceptions of 
hypertension as a serious disease.  The descriptive statistics of responses to 
this scale are presented in this section while inferences and correlations with 
treatment compliance are presented in section 4.12. 
 
For discussion purposes, the responses were collapsed into two categories, 
namely high and low perception of severity. Table 4.11 shows that a 
significant number of the respondents rightly did not perceive themselves to 
be cured when they were symptom-free. The majority indicated that they 
perceived their hypertension as serious and that they were not relaxed about 
hypertension when they were symptom free. A problematic finding is that the 
majority of the respondents indicated that they did not consider their 
hypertension as serious. 
 
However the high number of respondents who had a low perception of 
severity is problematic. According to the WHO (2003a: 35), uncomplicated 
hypertension is usually asymptomatic and primary hypertension is not 
curable. The erroneous perception that hypertension is symptomatic is 
problematic because this could lead to non-compliance with treatment. 
Patients who believe hypertension is symptomatic, may not comply with their 
treatment when there are no symptoms present. Likewise patients who 
believe that an absence of symptoms means that they are cured may be likely 
to be non-compliant. 
 
Table 4.11: Perception of severity in order of importance 
To what extent do you agree with the following statements? High perceptions of 
severity 
Low 
perceptions 
of severity 
I think I am cured because I do not have symptoms # 76 (74.51%)  26 (25.49%) 
I am relaxed about my blood pressure condition because I don’t 
have any symptoms # 
64 (62.74%) 38 (37.62%) 
I am worried about my blood pressure condition because I have 
symptoms 
58 (56.86%) 44 (43.14%) 
My blood pressure condition is serious * 38 (37.62%) 63 (61.76%) 
* 1 missing value; # Item was reversed coded 
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Table 4.12 summarises the values of central tendency and dispersion on the 
Perceptions of Severity Scale. The data was positively skewed (distribution = 
0.37) (refer figure 4.23). The median score was 2.50 and the interquartile 
range was 0.75. A positively skewed distribution implies that the average 
score of most respondents was low on the scale. This implies that the 
respondents tended to have a low perception of severity. 
 
Table 4.12: Measures of central tendency and dispersion on perception of severity 
 
Variable N Mean SD Median Interquartile 
range 
Distribution Range of 
scores 
POS 102 2.65 0.47 2.50 0.75 0.37 1.50-3.75 
POS = Perception of severity. SD = Standard deviation. Missing values range from 0 to 1 
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Figure 4.23 
Respondents’ mean scores on the Perception of Severity Scale 
 
The mean score for this scale was 2.65 (SD = 0.47) (refer to table 4.12). The 
mean scale score of individual respondents was used to categorise the 
respondents into high and low perception of severity to facilitate correlational 
and inferential statistics (refer to section 4.12). The respondents with a mean 
score below 3 were considered as having a low perception of severity and 
respondents with a mean score of 3 and above were considered as having a 
high perception of severity. 
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4.6 RESPONDENTS' PERCEPTIONS OF THEIR RISK OF DEVELOPING 
HYPERTENSION COMPLICATIONS 
 
Section E of the interview schedule measured the respondents' perceptions of 
their risk of developing complications as a result of hypertension. The 
descriptive statistics of responses to this scale are presented in this section 
while inferences and correlations with treatment compliance are presented in 
section 4.12. 
 
For purposes of discussion, a choice of having a 0% to 49% chance of 
developing complications was taken as a low perception of risk while 50% to 
100% was taken as a high perception of risk. Table 4.13 indicates that the 
respondents perceived themselves to be most at risk of developing kidney 
problems, followed by becoming a burden for their families, having a disrupted 
family, social and career life and developing paralysis. The respondents 
indicated a lower risk for developing a stroke, heart problems and visual 
problems. 
 
Table 4.13: Perception of risks in order of importance 
 High risk Low risk 
Kidney problems 50 (49.02%) 52 (50.98%). 
Becoming a burden for the family 47 (46.53%) 54 (52.94%) 
Disrupted family life * 46 (45.54%) 58 (56.86%), 
Disrupted social life 46 (43.11% 58 (56.86%), 
Career being negatively affected 45 (44.12%) 57 (55.88%) 
Paralysis 45 (44.12%) 57 (55.88%) 
Stroke 42 (41.18%) 60 (58.82%) 
Heart problems 42 (41.18%) 60 (58.82%) 
Visual problems 38 (37.26%) 64 (62.75%) 
*1 missing value 
 
Table 4.14 summarises the values of central tendency and dispersion for the 
Perception of Risks Scale. The distribution of data was somewhat negatively 
skewed (-0.21) (see figure 4.24). The median was 2.94 while the interquartile 
range was 2.14. The distribution of respondents’ scores reveals that most 
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respondents scored low on this variable and a few scored high. Thus the 
respondents tended to underestimate their risk of developing the 
complications of hypertension. 
 
Table 4.14: Measures of central tendency and dispersion on perception of risk 
 
Variable N Mean SD Median Interquartile 
range 
Distribution Range of 
scores 
POR 102 2.77 1.11 2.94  2.14 -0.21 1.00-4.00 
POR = Perception of Risks; SD = Standard deviation. Missing values range from 0 to 1 
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Figure 4.24 
Respondents’ mean scores on the Perception of Risk Scale 
 
The mean score for this scale was 2.77 (SD = 1.11) (refer to table 4.14). The 
mean scale score of individual respondents was used to categorise the 
respondents into high and low perception of risk to facilitate correlational and 
inferential statistics (refer to section 4.12). Respondents with a mean score 
below 3 were considered as having a low perception of risk and respondents 
with a mean score of 3 and above were considered as having a high 
perception of risk. 
 
4.7 RESPONDENTS' PERCEPTIONS OF THE BENEFITS OF 
ANTIHYPERTENSION TREATMENT  
 
Section F of the interview schedule measured how beneficial the respondents 
perceived the hypertension treatment. The descriptive statistics of responses 
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to this scale are discussed in this section while inferences and correlations 
with treatment compliance are discussed in section 4.12. 
 
For discussion purposes the responses were collapsed into positive and 
negative perceptions of the benefits of treatment. Table 4.15 indicates the 
perceptions of benefits in order of importance. The most important benefit was 
indicated as protection from complications, followed by keeping blood 
pressure under control, increasing the quality of life, avoidance of added 
financial burden to treat complications, an increased sense of well-being, 
decreased chance of dying and giving peace of mind. 
 
Table 4.15: Perception of benefits in order of importance 
 
 Positive perception of 
benefits 
Negative perception of 
benefits  
Protection from complications * 88 (87.13%) 13 (12.87%) 
Keeping blood pressure under control * 84 (83.17%) 18 (17.82%) 
Increased quality of life * 79 (78.22%) 22 (21.78%) 
Avoidance of added financial burden to 
treat complications * 
78 (77.23%) 23 (22.77%) 
Increased sense of well-being * 76 (75.25%) 25 (24.75%), 
Decreased chance of dying * 76 (75.25%) 25 (24.75%) 
Giving peace of mind * 72 (71 .29%) 29 (28.71%) 
*1 missing value 
 
Table 4.16 summarises the values of central tendency and dispersion of this 
variable. The distribution was negatively skewed (distribution = -0.65). The 
median score was 3.29 while interquartile range was 1.86 (refer to table 4.16 
and figure 4.25). The high median score implies that the respondents scored 
high on the scale. Deductively, this means majority of respondents perceived 
the benefits of anti-hypertension treatment favourably.   
 
Table 4.16: Measures of central tendency and dispersion on perception of benefits 
Variable N Mean SD Median  Interquartile 
range 
Distribution Range of 
scores 
POBe 101 3.23 0.81 3.29 1.86 -0.65 1.00-4.00 
POBe = Perception of Benefits; SD = Standard deviation.  
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Figure 4.25 
Respondents’ mean scores on the Perception of Benefits Scale  
 
The mean scale score was 3.23 (SD = 0.81) (refer to table 4.16). The mean 
score was used to categorise the respondents into those who had a positive 
perception of benefits and those with a negative perception of benefits. 
Respondents with a mean score of 3 and above were categorised as having 
positive perceptions of benefits while those with a mean score of below 3 
were categorised as having negative perceptions of the benefits of 
antihypertension treatment. This distinction was necessary to facilitate 
correlational and inferential statistics (refer to section 4.12). 
 
4.8 RESPONDENTS' PERCEPTIONS OF BARRIERS TO 
ANTIHYPERTENSION TREATMENT 
 
Section G of the interview schedule measured the extent to which stated 
barriers hindered the respondents from complying with hypertension 
treatment. This section discusses the descriptive statistics of responses to this 
scale, while inferences and correlations are presented in section 4.12. 
 
The responses were collapsed into high perception of barriers and low 
perception of barriers for discussion purposes. The frequencies are presented 
in table 4.17. The most important barrier was lack of discipline to comply with 
the required dietary restrictions. Other important barriers were not having 
enough time to exercise, ineffectiveness of the medicine to stabilise their 
blood pressure, lack of motivation because they could not be cured, lack of 
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time to relax and sleeping problems. The least important barrier was a lack of 
discipline to stop smoking. 
 
Table 4.17: Perception of barriers in order of importance 
Barriers High perception 
of barriers 
Low perception 
of barriers 
lack of discipline to comply with the dietary restrictions * 57 (56.44%) 44 (43.56%) 
not having enough time to exercise 56 (54.90%) 46 (45.10%) 
Ineffectiveness of the medicine to stabilise my blood pressure ** 55 (55.00%) 45 (45.00%) 
lack of motivation because I cannot be cured 55 (53.92%) 47 (46.08%) 
lack of time to relax  54 (52.94%) 48 (47.06%) 
having sleeping problems 49 (48.04%) 53 (51.96%) 
lack of discipline to stop smoking 37(36.27%) 65 (63.73%) 
*1 missing value  ** 2 missing values 
 
Table 4.18 summarises the values of central tendency and dispersion for the 
Perception of Barriers Scale. The median was 2.29 and the interquartile range 
was 1.43. The distribution was positively skewed to the right (see figure 4.26), 
which means respondents generally scored low on this scale. By way of 
interpretation, this means that the respondents tended to have low 
perceptions of the stated barriers.  
 
Table 4.18: Measures of central tendency and dispersion on perception of barriers 
 
Variable N Mean SD Median  Interquartile 
range 
Distribution Range of 
scores 
POBa 102 2.34 0.77 2.29 1.43 0.01 1.00-4.00 
POBa = Perception of barriers; SD = Standard deviation. Missing values range from 0 to 2. 
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Figure 4.26 
Respondents’ mean scores on the Perception of Barriers Scale 
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The mean score for the scale was 2.34 (SD = 0.77) (refer to table 4.18). The 
mean scale score of individual respondents was used to categorise the 
respondents into high and low perception of barriers to facilitate correlational 
and inferential statistics (refer to section 4.12). Respondents with a mean 
score below 3 were considered as having a low perception of barriers and 
respondents with a mean score of 3 and above were considered as having a 
high perception of barriers.  
 
4.9 RESPONDENTS’ PERCEPTIONS OF INTERNAL FACTORS 
RELATED TO TREATMENT COMPLIANCE 
 
Section H of the interview schedule measured the extent to which internal 
factors influenced respondents’ compliance with antihypertension treatment. 
This section discusses the descriptive statistics of responses to this scale, 
while inferences and correlations with treatment compliance are presented in 
section 4.12. 
 
As in the previous sections, the responses were collapsed into high and low 
internal factors scores for discussion purposes. The collapsed frequencies in 
order of importance are presented in table 4.19.  
 
The respondents indicated that they understood their condition. An 
overwhelming majority understood why it was necessary to take medications 
as prescribed. They also understood what they should do to keep their blood 
pressure under control. It is noteworthy that the respondents understood how 
their medications worked to keep blood pressure under control, what caused 
their hypertension and the meaning of their blood pressure readings to a 
lesser extent. A point of concern is the fact that the majority of respondents 
indicated that they believed that hypertension could be cured with local herbs. 
 
The responses indicated that the respondents were highly self-aware. They 
were aware how healthy their body feels and would notice immediately if they 
didn’t feel healthy.  
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With regard to who is primarily responsible for managing their hypertension 
they indicated that they were in charge of their physical health, that their 
physical health was determined largely by what they did or did not do and that 
they were primarily responsible for managing their hypertension. Interestingly, 
they also considered their doctor as primarily responsible for managing their 
hypertension. This may be indicative that the respondents accepted 
responsibility for their health but that they regarded the management of 
hypertension as a shared responsibility. The majority indicated that they had 
the ability to manage their hypertension. However the number of respondents 
who were not convinced of their ability to manage their hypertension is 
noteworthy. 
 
Table 4.19: Perception of internal factors in order of importance (N=102) 
 High internal 
factors score 
Low internal 
factors score 
I understand why it is necessary to take my medicine as prescribed  98 (97.03%) 3(2.97%) 
I understand the nature of my condition 94 (92.16%) 8(7.84%) 
I am aware of how healthy my body feels 93 (91.18%) 9(8.82%) 
I notice immediately when my body is not healthy 92 (90.20%) 10(9.80%) 
I understand what I can do to keep my blood pressure under control  90 (88.24%) 12(11.88%) 
I am in charge of my physical health  89 (87.25%); 13(12.75%) 
My physical health is determined largely by what I do or don’t do  86 (85.15%; 15(14.85%) 
I am primarily responsible for managing  my hypertension 78 (76.47%) 24(23.52%) 
I have the ability to manage my hypertension  70 (69.31%). 31(30.69%) 
I understand how my medication works to keep my blood pressure under 
control   
65(64.36%) 36 (35.64%) 
I understand what caused my blood pressure condition 56 (54.90%) 46 (45.10%) 
I understand the meaning of the blood pressure readings 59 (57.84%) 43 (42.16%) 
I think that I can cure my hypertension with local herbs other than the 
prescribed medication# 
35 (34.31%) 67 (65.69%), 
My doctor is primarily responsible to manage managing my hypertension# 34 (33.33%) 68 (66.67%)  
# Item was reversed coded 
 
Table 4.20 summarises the values of central tendency and dispersion for the 
Internal Factors Scale. The median was 2.93 and the interquartile range was 
0.61. This indicates that the respondents scored low on this scale. The data 
followed a near normal distribution (distribution = 0.41) implying that the 
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respondents' scores were mainly clustered around the centre with few 
extreme scores (refer to figure 4.27).   
 
Table 4.20: Measures of central tendency and dispersion on internal factors 
Variable N Mean SD  Median Interquartile 
range 
Distribution Range of 
scores 
IF 102 2.96 0.52 2.93 0.61 0.41 1.79-4.00 
IF = Internal factors; SD = Standard deviation.  Missing values range from 0 to 1 
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Figure 4.27 
Respondents’ mean scores on the Internal Factors Scale 
 
The mean scale score was 2.96 (SD = 0.52) (refer to table 4.20). The mean 
scale score of individual respondents was used to categorise the respondents 
into high and low internal factors score groups to facilitate correlational and 
inferential statistics (refer to sections 4.12). Respondents with a mean score 
below 3 were considered as having a low internal factor score and 
respondents with a mean score of 3 and above were considered as having a 
high internal factors score. 
 
4.10 RESPONDENTS’ PERCEPTIONS ON HEALTH CARE PROVIDER 
FACTORS  
 
Section I of the interview schedule measured the respondents’ health care 
provider perceptions. This section discusses the descriptive statistics of 
responses to this scale, while inferences and correlations are presented in 
section 4.12.  
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For discussion purposes, the responses have been collapsed into two 
categories, positive and negative perceptions on the health care provider 
factors. As indicated in table 4.21, an overwhelming majority of the 
respondents indicated that they had confidence in their doctors. They had 
positive perceptions about their doctors’ attitudes. They indicated that the 
doctor was patient with them, treated them with respect and understood their 
concerns. The respondents indicated that they held positive perceptions about 
the knowledge and experience of their doctors. Likewise, the other health 
workers equally treated them with respect.   
 
With regard to the doctor’s interpersonal skills, an overwhelming majority of 
the respondents indicated that their doctor explained the nature of their 
condition and how to manage their blood pressure to them and listened to 
their concerns.  
 
Similarly an overwhelming majority held positive perceptions about the 
availability of medicines at the clinic and effectiveness of the medicines. The 
majority of the respondents regarded the waiting time at the clinic as 
acceptable. 
 
Table 4.21: Health care provider factors in order of importance 
 Positive 
perceptions 
Negative 
perceptions 
The doctors is patient with me 99 (97.06%) 3 (2.94%) 
I have confidence in the doctors 99 (97.06%) 3 (2.94%) 
The doctors treat me with respect 98 (96.08%) 4 (3.92%) 
The health care workers other than the doctors treat me with respect 98 (96.08%) 4 (3.92%) 
The doctor clearly explains to me how I should manage my blood 
pressure condition 
93 (91.18%) 9(8.82%) 
The doctor listens to my concerns 93 (91.18%) 9 (8.82%) 
The doctor understands my  concerns 92 (90.20%) 10 (9.80%) 
The availability of medicine when I need it is good * 89 (88.12%) 12 (11.88%) 
The medicine I receive at the clinic is effective * 89 (88.12%) 12 (11.88%) 
The doctor clearly explains my condition to me  * 85 (84.16%) 16 (15.54%) 
The doctor who attends to me at the clinic is knowledgeable * 84 (83.17%) 17 (16.67%) 
The doctor who attends to me at the clinic is experienced 82 (80.39%) 20 (19.61%) 
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 Positive 
perceptions 
Negative 
perceptions 
The waiting time at the clinic is acceptable 67 (65.69%) 35 (34.31%) 
* 1 missing value 
 
Table 4.22 summarises the values of central tendency and dispersion of the 
Health Care Provider Scale. This score indicates that the respondents had 
positive perceptions of the health care provider factors. The median was 3.00 
and the interquartile range was 0.25. The data followed a near normal 
distribution (distribution = -0.16) implying that the respondents' scores were 
mainly clustered around the centre with few extreme scores (refer to figure 
4.28).   
 
Table 4.22: Measures of central tendency and dispersion on health care providers factors 
 
Variable N Mean SD Median Interquartile 
range 
Distribution Range of 
scores 
HCPF 102 3.07 0.41 3.00 0.25 -0.16 1.58-4.00 
HCPF = Health care provider factors; SD = Standard deviation 
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Figure 4.28 
Respondents’ mean scores on the health care provider factors scale 
 
The mean score for this scale was 3.07 (SD = 0.41) (refer to table 4.22). The 
mean scale score of individual respondents was used to categorise the 
respondents into positive and negative perceptions of health care provider 
factors. This is done to facilitate correlational and inferential statistics (refer to 
section 4.12). Respondents with a mean score below 3 were considered as 
having a negative perception of health care provider factors and respondents 
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with a mean score of 3 and above were considered as having a positive 
perception of health care provider factors. 
 
4.11 RESPONDENTS’ PERCEPTIONS OF THE CUES TO ACTION 
FACTORS 
 
Section J of the interview schedule measured the extent to which stated cues 
to action could influence antihypertension treatment compliance. This section 
discusses the descriptive statistics of responses to this scale, while inferences 
and correlations with treatment compliance are presented in section 4.12. 
 
For discussion purposes these responses were collapsed into two categories, 
namely positive and negative perceptions of cues to actions. Table 4.23 
summarises these responses in order of importance. An overwhelming 
majority indicated that advice from their doctor and a health care worker other 
than the doctor motivated them to comply with their blood pressure treatment. 
Many respondents indicated that advice from family members and friends also 
motivated them to comply with their treatment. 
 
Television and radio programmes, health education leaflets and health 
posters displayed were also important motivators for treatment compliance. 
Reading newspaper articles and information on the Internet appeared to be 
weak motivators. 
 
The majority of the respondents indicated that they were motivated to comply 
with their treatment when they felt unwell and by the hypertension related 
death of a relation or friend.  
 
The findings of this current study differs from those of Oliviera, Chen, 
McCarthy, Davis and Hill  (2005:224).Their study, which was conducted in the 
USA, revealed that 74% of respondents indicated that doctors and other 
health care workers were major sources of information on hypertension, 55% 
indicated mass media (radio, television, newspaper and magazines) 
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motivated them to take treatment while only 30% indicated advice from friends 
or family members as motivators. 
 
Table: 4.23: Cues to actions in order of importance 
Which of the following motivates you to comply with 
your blood pressure treatment? 
Motivated Not motivated 
Advice from my doctor 92 (90.20%) 10 (9.80%) 
Advice from a health care worker other than my doctor 90 (88.24%) 12 (11.76%) 
TV programmes on high blood pressure 88 (86.27%) 14 (13.72%) 
Radio programmes on high blood pressure 84 (83.35%), 18 (17.65%) 
Advice from a family member 79 (77.45%), 23 (22.55%) 
Advice from my friends 73 (71.57%) 29 (28.43%) 
Health education leaflets given to me 71 (69.61%) 31 (30.39%) 
When I feel unwell 68 (66.67%) 34 (33.33%) 
Death of a relation or friend due to high blood pressure 66 (64.71%) 36 (35.29%) 
Health posters displayed  66 (64.71%) 36 (35.29%) 
Newspaper or journal article 47 (46.08%) 55 (53.92%) 
Information on the internet  34 (33.33%) 68 (66.67%) 
 
Table 4.24 summarises the values of central tendency and dispersion of the 
Cues to Action Scale. This indicates that the respondents scored low on this 
scale. The median was 2.75 and the interquartile range was 0.50. The data 
followed a near normal distribution (distribution = 0.74) implying that the 
respondents' scores were mainly clustered around the centre with few 
extreme scores (refer to figure 4.29). The respondents tended to have a low 
score on the Internal Factors Scale. 
 
Table 4.24: Measures of central tendency and dispersion on cues to action 
 
Variable N Mean SD Median Interquartile 
range 
Distribution Range of 
scores 
CA 102 2.81 0.52 2.75 0.50 0.74 1.58-4.00 
CA = Cues to action; SD = Standard deviation 
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Figure 4.29 
Respondents’ mean scores on the Cues to Action Scale 
 
The mean score for this scale was 2.81 (SD=0.52) (refer to table 4.24). The 
mean scale score of individual respondents was used to categorise the 
respondents into having high and low motivation scores to the cues to action. 
This was done to facilitate correlational and inferential statistics (refer to 
section 4.12). Respondents with a mean score below 3 were considered as 
having a low motivation score and respondents with a mean score of 3 and 
above were considered as having a high motivation score to the cues to 
action. 
 
4.12 RELATIONSHIPS BETWEEN THE RESEARCH VARIABLES 
 
This section discusses the results of correlational and inferential statistics that 
were conducted to investigate the relationships between the theoretical 
variables and treatment compliance. By combining sections B and C of the 
interview schedule, a single variable (treatment compliance) was created. 
Section B measured compliance with the antihypertension medication 
regimen and Section C measured compliance with lifestyle modifications 
regimen. Using the Health Belief Model as the theoretical framework, the 
researcher developed three research questions to examine the relationships 
of socio-demographic factors, perceptions of severity, perceptions of risks, 
perceptions of barriers, perceptions of benefits, internal factors, health care 
provider factors, and cues to actions with treatment compliance.  The 
specified variables encompassed the various aspects of compliance 
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behaviour. The results pertaining to each of the three research questions are 
discussed below:  
 
4.12.1 Relationships between the biographical variables and treatment 
compliance 
 
This section seeks to answer the following research question: 
What is the relationship between treatment compliance and the 
following variables among patients diagnosed with hypertension 
on the Island of Praslin: socio-demographic factors (age, gender, 
ethnic background; marital status, educational status, work 
status, household income); physiological factors (weight status); 
duration of illness; number of medications prescribed; doses of 
medication skipped; and alcohol intake per week?  
 
The Chi-square test was used to answer the above research question. Mosaic 
plots were developed to elucidate the associations between the research 
variables stated in the research question.  
 
At a 95% level of confidence set a priori, age, gender, employment status, 
duration of illness, doses of medication skipped  and alcohol intake per week 
demonstrated significant statistical associations with treatment compliance. 
The findings were as follows:  
• Respondents who were 44 years and older were more compliant with 
treatment than respondents who were younger than 44 years of age 
(Chi-square = 11.51 p-value = 0.0032).   
• A slightly significant relationship was found between gender and 
treatment compliance with females being more compliant than the 
males (Chi-square = 4.11, p-value=0.043). . 
• Respondents who had been employed during the past 12 months were 
statistically less compliant with treatment than unemployed 
respondents (Chi-square = 5.43 p-value =0.0198).  
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• Respondents who were diagnosed with hypertension five years and 
more ago were more compliant with treatment than those whose 
diagnosis was made less than five years ago (Chi-square =16.02 p-
value = 0.0001).  
• There was a strong relationship between doses of medication skipped 
in the last three days and compliance (Chi-square = 35.15 p-value = 
<0.0001). Respondents who admitted skipping one or more doses of 
medications in the previous three days were less compliant with 
treatment than those who reported not skipping any dose.  
• Respondents who admitted taking alcohol a few times per week were 
less likely to be compliant with treatment than those who seldom drink 
alcohol (Chi-square = 15.89 p-value = 0.0012).   
 
There were no significant associations between treatment compliance and the 
following factors:  
• Ethnic background (Chi-square =1.399 p-value = 0.7057)  
• Marital status (Chi-square = 0.102 p-value = 0.7495)  
• Household income  (Chi-Square = 2.02 p-value = 0.3639)  
• Number of pills taken daily (Chi-square = 0.838 p-value = 0.6577) 
• Number of cigarettes smoked per day (Chi-square 1.547 = p-value = 
0.2136).   
 
The Analysis of Variance (ANOVA) test was conducted to test for statistically 
significant differences between the means of compliant and non-compliant 
groups. A statistical significant difference was found between the means of 
medication compliance and the physiological measure of weight assessed 
with the body mass index. The respondents were classified into two groups of 
normal weight (BMI ≤ 24.9kg/m2) and overweight (BMI ≥ 25kg/ m2
 
). The result 
showed a statistically significant difference between the means of the two 
groups. Respondents who were overweight were more compliant with 
treatment than those who had a normal weight (F = 8.06 p-value = 0.0055).   
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4.12.2 Relationships between the theoretical variables and treatment 
compliance 
 
This section seeks to answer the following research question: 
What is the relationship between treatment compliance and the 
following variables among patients diagnosed with hypertension 
on the Island of Praslin: perception of severity; perception of risk; 
perception of benefits; perception of barriers; internal factors; 
health care provider factors; cues to action?  
 
Pearson’s correlation analysis was utilised to assess the relationships 
between the variables stated in the above question. In order to perform 
statistical analysis on the data, it was assumed that the respondents’ 
perceptions would relate in a linear fashion with treatment compliance. Thus 
zero-order (bivariate) correlation analysis was performed between the 
independent variables (perception of severity, perception of risk, perception of 
benefits, perception of barriers, internal factors, cues to action and health care 
provider factors) and the dependent variable (treatment compliance). 
Significant relationships were found between treatment compliance and 4 
variables namely; perception of benefits, perception of risks, internal factors 
and cues to action (Refer to table 4.25).  
 
The findings were as follows:    
• Perception of benefits demonstrated a significant relationship with 
treatment compliance (r = 0.46 P = < .0001) indicating that patients 
who perceived benefits of taking medications and effecting lifestyle 
modifications were likely to be compliant with their treatment.  
• Perception of risks demonstrated a significant relationship with 
treatment compliance (r = 0.30. P = 0.0020). This relationship implies 
that patients who perceived risks of developing complications of 
hypertension were likely to comply with their treatment.  
• A significant relationship was also noted between treatment 
compliance and internal factors (r = 0.37 P = 0 .0001). This indicates  
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that patients who measured high in self efficacy, knowledge and 
internal locus of control concerning taking antihypertension 
medications and adopting lifestyle modifications were likely to be 
compliant with their treatment. 
• A significant relationship was noted between cues to action and 
treatment compliance (r = 0.45 P = < .0001). This implies that cues to 
action are necessary to increase compliance with treatment in 
hypertension. 
 
Table 4.25: Zero-order correlational analysis showing theoretical variables that demonstrated 
significant relationships with treatment compliance (P ≤ 0.05).  
Variable r P -value 
Perceptions of benefits 0.46 <.0001 
Perceptions of risks 0.30 <0.0020 
Internal factors 0.37 <.0001 
Cues to actions 0.45 <0.0001 
 
4.12.3 Regression analysis between the theoretical variables and 
treatment compliance 
 
This section seeks to answer the following research question: 
 
Which of the following variables are predictor variables for 
treatment compliance: socio-demographic variables; perception 
of severity; perception of risk; perception of benefits; perception 
of barriers; internal factors; health care provider factors and cues 
to action? 
 
Stepwise multiple regression analysis was further performed on the seven 
theoretical variables (perception of severity, perception of risks, perception of 
benefits, perception of barriers cues to action, internal factors and health care 
provider factors). This was done to predict the relative contribution of each 
variable to treatment compliance. Multiple regression analysis was performed 
because   compliance was hypothesised as a complex multidimensional 
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phenomenon that cannot be easily predicted with only a single variable. 
According to Argyrous (2000:484), a stepwise multiple regression analysis 
involves creating a model and adding each independent variable sequentially 
to the model to test its relative contribution. Variables that do not contribute to 
the model are dropped and those that contribute are retested to ascertain 
veracity.  
 
Owing to a small sample size, subgroup analysis of the biographical variables 
could not be performed. However, a single model was created and each of 
the six theoretical variables was sequentially added to determine the relative 
contribution of each variable to treatment compliance. The best predictive 
model involved the combination of three predictor variables with an R2
 
 = 
0.313, thus contributing 31.32% of the variance in treatment compliance. The 
degree of significance was F= 14.742; P < 0.0001.  
The three independent variables that contributed significantly to predicting 
treatment compliance were (refer to table 4.26):  
• Perception of benefits  
• Perception of barriers and  
• Cues to action.  
 
Table 4.26: Regression analysis summaries of predictor variables for treatment compliance 
(medication and lifestyle modification) 
 
Variable Estimate (β) Std error of β t-Ratio P-value 
Intercept 2.024 0.198  10.21 <.0001 
Perception of benefits 0.181 0.050  3.64 0.0004 
Cues to action 0.239 0.077  3.10 0.0025 
Perception of barriers -0.118  0.046  -2.56 0.0120 
R2 = 0.31, R2  adjusted = 0.29, P < 0.0001 
 136 
 
 
4.13 CONCLUSION 
 
In this chapter, the researcher presented the results of the descriptive, 
correlational and inferential statistics. Various factors related to the 
respondents’ compliance with their hypertension medications and lifestyle 
modification regimens were covered. The information presented in this 
chapter form the basis for the recommendations and conclusions that are 
incorporated in the next chapter.  
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CHAPTER 5 
CONCLUSIONS AND RECOMMENDATIONS 
 
 
 
5.1 INTRODUCTION 
 
This chapter which concludes this study, summarises the research findings 
and proffers recommendations. The conduct of this study was motivated by 
the researcher’s observations that the prevalence of uncontrolled 
hypertension remained high on Praslin Island despite the availability of free 
health care. The literature confirmed that non-compliance with the medication 
and lifestyle modification regimens was by far the most significant cause of 
uncontrolled hypertension. The physical, psychological, social and financial 
implications of uncontrolled hypertension are grave, affecting not only the 
individual and his/her immediate family but also the society at large. In order 
to improve compliance with treatment (anti-hypertension medication and 
lifestyle modification regimens), factors that militate against compliance must 
be identified and addressed.  
 
Against this background, this study focused on identifying factors that affected 
compliance with medications and lifestyle modifications among patients 
diagnosed with hypertension on the Island of Praslin. It was assumed that if 
such factors were identified, then strategies could be developed to improve 
compliance. The Health Belief Model provided the theoretical background for 
which variables were developed for the study. The central question which the 
researcher sought to address was: 
What are the reasons for non-compliance with the drug treatment and 
lifestyle modification regimens among hypertensive patients on Praslin 
Island? 
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Specifically, the study sought to answer the following five questions: 
 
• How compliant are the respondents with their hypertension drug 
regimen? 
• How compliant are the respondents with their lifestyle modifications 
regimen? 
• What is the relationship between treatment compliance and socio-
demographic factors (age, gender, ethnic background; marital status, 
educational status, work status, household income); physiological 
factors (weight status); duration of illness; number of medications 
prescribed; doses of medication skipped; and alcohol intake per week? 
• What is the relationship between treatment compliance and perception 
of severity, perception of risks; perception of benefits; perception of 
barriers; internal factors; health care provider factors; cues to action? 
• Which of the following variables are predictor variables for treatment 
compliance: socio-demographic variables; perception of severity; 
perception of risks; perception of benefits; perception of barriers; 
internal factors; health care provider factors; and cues to action? 
 
5.2 SUMMARY OF THE RESEARCH FINDINGS 
 
5.2.1 Sample characteristics 
 
The multicultural sample (N=102) comprised of 58 women and 44 men. 
Altogether about 85.30% of respondents were aged between 35-74 years 
while only 14.70% were aged less than 35 years. This is not surprising as 
hypertension is largely seen in adult life. The respondents generally had some 
form of education, were economically productive and had a source of income. 
The majority (60.78%) had lived with hypertension for more than five years, 
42.14% were diagnosed 1-5 years ago and only 2.94% were diagnosed less 
than one year ago.  
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More respondents were placed on combined drug therapy (66.33%) than on 
monotherapy (29.70%), and 3.96% did not take any medication. Most 
respondents required two or more different kinds of medicine to control their 
high blood pressure. With regards to the specific drugs prescribed the majority 
of the respondents, namely (71.57%) took Amlodipine, followed by 
Bendrofluazide (39.22%) and Lisinopril (25.49%). Almost all the respondents 
(96.08%) were on a single dose regimen. This pattern of prescription probably 
arose because doctors adhered to the institutional requirements and standard 
treatment protocols which usually recommend these medications as first line. 
For many hypertension patients, combination therapy is required to achieve 
reasonable hypertension control. Combination therapy is believed to achieve 
a better control of blood pressure than mono-therapy as some drugs work 
synergistically. The fact that most antihypertension medications are now 
available in a single daily dosage, supports efforts to improve compliance 
among patients. Since antihypertension medications are taken daily for life, a 
simple dosage is expected to reduce frustration and a propensity for non-
compliance (Benson & Britten 2003:1314). 
 
The high number of respondents with high blood pressure values together 
with the evidence of uncontrolled hypertension as observed in this study, 
especially among the female respondents, is noteworthy. Altogether 65.69% 
respondents had high blood pressure recorded during the interview as against 
60.78% documented in the clinical notes. Similarly, 34.31% had a normal 
blood pressure at the time of data collection as against 39.22% documented 
in the clinical notes. The high percentage of obese and overweight 
respondents (87.25%) is of particular concern considering the fact that weight 
control is an important variable in blood pressure control. Another concern is 
the fact that 83.33% rarely or never had their blood pressure monitored. This 
is noteworthy as routine blood pressure monitoring is important and 
recommended for patients who are either on a drug therapy and/or a lifestyle 
modifications regimen (Chobanian et al 2003:1250). 
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Almost a half of the respondents (41.18%) had co-morbidities and a high 
prevalence of health complaints related to the cardiovascular and renal 
conditions, visual impairment and stroke were noted. 
 
5.2.2 Compliance with anti-hypertension medications 
 
The data obtained from the Compliance with the Medication Regimen Scale 
indicates that the respondents were generally compliant with their medications 
regimen (median 3.14, mean 2.96). The reasons for non-compliance were 
inherent in the respondents themselves (e.g. forgetfulness) rather than the 
medications (e.g. side-effects) or treatment factors (e.g. multiple dosage or 
frequent change of medications or dosage). 
 
Compliance with the medications regimen as reported by the respondents 
(71.57%) was almost similar to that observed in the clinic notes (70.59%). 
This similarity implies that the respondents were willing to reveal their level of 
compliance to their doctors. The majority of the respondents (63.73%) took 
their medications daily and 36.27% did not take it daily. The majority of the 
respondents (70.59%) did not skip doses of medications during the previous 
three days and 29.41% skipped doses. These non-compliance figures are 
unacceptable since hypertension medications should be taken as prescribed 
and not intermittently. The near similarity between the data obtained from the 
interviews and by means of document analysis may indicate that self-report is 
a reliable method of assessing medication compliance as suggested by Zen 
et al (2002:12). According to Vitolins, Rand, Rapp, Ribisl and Sevick 
(2000:193), medication adherence that requires recalling adherent behaviour 
over a short period is more reliable and valid than assessing compliance over 
a longer period of time. 
 
Medication side-effects are reported in the literature as a significant reason 
why most patients do not comply with their medications regimen (Benson & 
Britten 2003:1314; Jokisalo et al 2002:577). However, in this current study, 
there was no evidence of reported medication side-effects in the clinical 
records of 91.18% respondents. Only 9 (8.82%) respondents had such 
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records. This finding may indicate the relative tolerability of antihypertension 
medications. 
 
The interviews revealed that, although the majority of the respondents 
(72.55%) complied with follow-up visits, 27.45% did not comply. Similarly, the 
majority of the respondents (79.21%) were compliant with clinic appointments 
while 21.57% were non-compliant. A comparative analysis with clinic records 
of follow-up visits over three appointments (9 months duration), revealed that 
72.55% were compliant and 27.45% were non-compliant. The relatively high 
levels of non-compliance are problematic in light of the evidence of 
uncontrolled hypertension, co-morbidities and health complaints in the 
sample. Honouring clinic appointments is as important as complying with the 
medication regimen because it is an opportunity for the patient to interact with 
health provider, share problems associated with treatment and be examined 
to detect early onset of complications.   
 
5.2.3 Compliance with the lifestyle modifications regimen 
 
The respondents scored high on the Compliance with the Lifestyle 
Modifications Scale (median = 3.09, mean = 3.04). However, the respondents 
were insufficiently compliant with the following recommended behaviours: 
physical exercise (50.00%), weight reduction (53.92%), sleep (27.56%) and 
relaxation (31.37%). In addition to this, some respondents persisted with the 
following non-recommended behaviours: ingestion of animal fat (28.35%), fast 
foods (27.45%), salt (24.51%) and alcohol (21.57%), as well as smoking 
(15.84%). The respondents appeared to have internalised the importance of 
eating fruits (94.12%) and vegetables (92.16%).  
 
The comparative analysis of the clinical records of the respondents showed 
that there were no entries with regard to non-compliance with the lifestyle 
modifications regimen in 63.73% records, while in 36.27% records such 
entries were documented. The disparity between the data obtained from the 
clinical records and those obtained from the interview schedule may be 
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indicative that clinicians tended to focus on the drug regimen rather than the 
lifestyle modifications regimen during consultations. 
 
5.2.4 Relationships between treatment compliance and socio-
demographic factors 
 
The results indicate that employed persons younger than 44 years, who had a 
normal weight, smoked and skipped dosage were at risk of being 
inadequately compliant with their hypertension treatment (medication and 
lifestyle modification regimens). The relationship between normal weight and 
compliance with treatment is not entirely clear. It is possible that hypertensive 
patients with normal weights could perceive their condition as less serious 
compared to obese patients. Interestingly, this study showed that males and 
those persons who had been diagnosed less than five years ago might be 
particularly at risk of being inadequately compliant with their treatment.  
 
5.2.5 Relationships between treatment compliance and perceptions 
 
The WHO (2003a:35), and other authorities adjudge uncomplicated 
hypertension as an asymptomatic disorder, and primary hypertension as not 
curable. This current research revealed that the respondents underestimated 
the severity of their hypertension (median = 2.50, mean = 2.65) and their risk 
to develop physical, social and economic complications (median = 2.94, mean 
= 2.77). They perceived the benefits of anti-hypertension treatment favourably 
(median = 3.29, mean = 3.23) and had low perceptions of the stated barriers 
(median = 2.29, mean = 2.34). However, despite these favourable statistics, it 
is noteworthy that between 12.87% and 28.71% of the respondents were not 
convinced of the benefits of the hypertension treatment. In addition to this 
between 36.27% and 56.44% of the respondents indicated that they 
considered the stated barriers as problematic.  
 
The Health Belief Model hypothesises that, for health behaviour change to 
occur, perceived benefits must outweigh perceived barriers to performing that 
behaviour (Finfgeld et al 2003: 293; Von, Ebert, Ngamvitroj, Park & Kang 
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2004:472). However, this study found a weak statistical association between 
perceived barriers and treatment compliance. Perceived barriers therefore, 
did not influence the respondents’ compliance behaviour significantly. 
Pearson's correlation analysis indicated that the respondents who considered 
the treatment as beneficial (r = 0.46 P = < .0001) and considered themselves 
at risk for developing complications (r = 0.30. P = 0.0020) tended to comply 
with their treatment. According to the Health Belief Model, the risks of 
complications are supposed to provide the motivating force for individuals to 
comply with treatment (Finfgeld et al 2003: 293). This study corroborates the 
position of the model. It is therefore important to stress the benefits of 
hypertension treatment and the risks of developing complications if patients 
do not comply with their treatment when health care professionals give health 
education on the management of hypertension. 
 
The respondents bordered between high and low internal factors scores 
(median = 2.93, mean = 2.96) on the Internal Factors Scale. The respondents 
indicated that they understood their condition and the management thereof. 
They were self-aware with regard to their subjective state of health. There 
appeared to be insufficient understanding about how their medications worked 
to keep their blood pressure under control (35.64%), what caused their 
hypertension (45.10%) and the meaning of their blood pressure readings 
(42.16%). While the respondents indicated that they were primarily 
responsible for their hypertension, they simultaneously believed that the 
doctor was primarily responsible for this. This may be indicative that they 
regarded the management of hypertension as a shared responsibility. The 
respondents were generally confident about their ability to manage their 
hypertension. Of particular concern are the number of respondents (30.69%) 
who were not convinced of this latter ability and the high number of 
respondents (65.69%) who believed that their hypertension can be cured with 
local herbs. 
 
The study revealed that the respondents had positive perceptions as 
measured on the Health Care Provider Scale (median = 3.00, mean = 3.07). 
They indicated that they had confidence in their doctors. They perceived the 
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knowledge, experience, attitudes and interpersonal skills of their doctors 
positively. The availability of medicines at the clinic (88.12%), effectiveness of 
the medicines (88.12%) and the waiting time at the clinic (65.69%) were 
perceived positively by the majority of the respondents. However, it is 
unfortunate that some of the respondents did not have favourable perceptions 
of these aspects. Especially the waiting time at the clinic may be problematic 
because approximately a third of the respondents (34.31%) perceived this 
negatively. 
 
The respondents scored low on the Cues to Actions Scale (median = 2.75, 
mean = 2.81). However, they regarded advice from doctors, other health 
workers, friends and family members as significant motivators to comply with 
their hypertension treatment. Health education programmes on hypertension 
should therefore, focus on patients and the community alike. Suitable media 
are television and radio programmes, and health education leaflets and 
posters. 
 
Pearson’s correlational analysis indicated that Internal factors (knowledge, 
internal locus of control and self-efficacy) (r = 0.37 P = 0 .0001) and the 
presence of cues to action (advice, health education, being unwell and death 
of a friend/relative) (r = 0.45 P = < .0001) also significantly influenced 
treatment compliance behaviour. Cochrane (2008:543), states that high 
internal factors scores contribute towards treatment compliance. This stance 
was supported by this current study. According to Glanz et al (2002:48), cues 
to actions are either internal or external. External cues include media publicity, 
effective health education, reminder cards, telephone calls or email messages 
reminding patients to take their medications. Internal cues include 
experiencing the symptoms of the disease. In this current study, the 
respondents placed more emphasis on external than internal cues. 
 
5.2.6 Predictor variables of treatment compliance 
 
The simple regression analysis performed on all study variables demonstrated 
that the combination of perception of benefits, perception of barriers and cues 
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to action formed the best predictive model in this study and explained over 
31% of the variance in treatment compliance. The respondents who believed 
in the benefits of their treatment (medication and lifestyle modifications 
regimens) and held low perceptions of stated barriers would, in the presence 
of cues to action, comply with their treatment.  
 
5.3 CONCLUSION 
 
The findings in this current study have provided corroborative evidence to the 
usefulness of the Health Belief Model in the evaluation of compliance 
behaviour. This current study revealed high levels of uncontrolled 
hypertension, co-morbidities, overweight and obesity in the sample despite 
the favourable compliance scores on the Compliance to the Hypertension 
Medication Regimen and Compliance to the Lifestyle Modifications Regimen 
Scales and the corresponding favourable compliance evidence in the clinical 
records. This is not surprising since the respondents underestimated the 
severity of their disease and their risk of developing complications. They were 
not sufficiently convinced of the benefits of complying with their treatment 
despite their high perceptions of benefits scores and considered many of the 
stated barriers as problematic, despite the low perception of barriers score. 
Barriers against compliance were indicated as unacceptable waiting times at 
the clinics, unavailability of medications and attending doctors who lacked 
knowledge and experience. 
 
The respondents apparently failed to sufficiently translate their understanding 
of their condition and the importance of compliance into compliance 
behaviours. This may be due to their insufficient understanding of the cause 
of hypertension, how their medications worked and the meanings of their 
blood pressure readings. Many respondents might consequently ingest local 
herbs for their hypertension. Another reason may be that many were not 
convinced of their ability to manage their condition.  
 
The non-compliance behaviours which were revealed included failure to 
regularly monitor their blood pressure, comply with follow-up visit 
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requirements and honour their clinic appointments. An unacceptably high 
number of respondents also failed to ingest their medications as prescribed 
during the previous three days. 
 
The risk behaviours which were identified are insufficient relaxation, sleep and 
physical exercise and failure to keep their weight under control. An 
unacceptable number of the respondents insufficiently complied with the 
dietary requirements of limiting their consumption of animal fat, fast foods, salt 
and alcohol, and smoking cessation. 
 
5.4 RECOMMENDATIONS 
 
Based on the literature and outcome of this study, the following two-pronged 
recommendations are made:  
 
5.4.1 Recommendations for clinical practice 
 
The following recommendations for clinical practice are derived from the 
findings: 
• Doctors must educate hypertensive patients about their disease with 
specific emphasis on its causes, the severity of the disease, how their 
medications work and the consequences of non-compliance with 
treatment. Patients should be taught how to interpret their blood 
pressure readings. Doctors need to stress that the drug treatment is for 
life, dosage should not be skipped and that the medications should not 
be discontinued. Patients should be discouraged from relying on local 
herbs to treat their condition. Messages on the importance of keeping 
blood pressure under control should be especially targeted at females. 
• Doctors need to stress the importance of compliance with their 
hypertension treatment despite the absence of symptoms. This 
includes complying with follow-up visits and honouring clinic 
appointments. It is necessary to stress the benefits of their treatment 
and their risks of developing complications. The doctors should move 
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beyond these mere explanations by contributing towards the removal 
of the barriers which may compromise compliance. Special emphasis 
should be placed on reducing the waiting times at the clinics, ensuring 
that medicines are available at all times and regular in-service training 
sessions for doctors. Messages regarding treatment compliance should 
be targeted specifically at newly diagnosed patients who are males, 
young, smoke and consume alcohol. Contact mechanisms should be 
introduced at the health centres to trace and monitor patients who do 
not comply with follow-up visits and clinic appointments. 
• Health education campaigns concerning hypertension ought to be 
delivered through the mediums of radio and television, posters and 
pamphlets. It is necessary to target patients and the community at 
large, especially family and friends of hypertensive patients. The health 
education message could be conveyed by persons who developed 
complications as a result of non-compliance and those who lost a loved 
one as a result of hypertension.  
• This study has shown that most non-compliant patients are very likely 
to admit being so if interrogated by their doctors. Therefore, during 
consultation, doctors must inquire whether the patient is complying with 
prescribed medication and lifestyle modification regimens and if not 
steps must be taken to encourage compliance. 
• This study has highlighted essential lifestyle behaviours to which 
patients should be motivated to comply. These are physical exercise, 
weight control and adequate sleep. Thus, health professionals must 
encourage their patients to have adequate sleep (6-8hours per day) 
and engage in moderate physical exercise lasting between 30 minutes 
and one hour on at least 3 to 5 days per week. Exercise helps weight 
control and maintenance of normal blood pressure. 
• Doctors are required to motivate patients to reduce their consumption 
of animal fat, fast foods, salt and alcohol, and to quit smoking 
(15.84%). This study found unacceptably high level of obesity among 
the respondents. Therefore, policies should be formulated at the 
 148 
national level to address diet and physical activity concerns in the 
community as a step toward controlling obesity and hypertension. 
• Patient support groups should be established in all districts, as this 
would help compliant and non-compliant patients to meet, interact and 
share experiences. 
 
5.4.2 Recommendations for further research 
 
The following aspects require further research: 
• Surveys of population-based prevalence of hypertension and 
uncontrolled hypertension must be conducted in the country. The last 
conducted survey, which is over a decade old, is no longer relevant.  
Such survey would provide useful information for policy makers to 
evaluate trends over time. 
• A study aimed at comparing the medication and the lifestyle 
modifications compliance patterns in patients attending public and 
private health care centres should be conducted.  
• Qualitative research should be conducted to obtain much more detailed 
information about factors that could improve compliance. It is 
imaginable that not all factors that affect compliance with medications 
and lifestyle modifications requirement were studied. 
• Research should be conducted to demonstrate the effectiveness of the 
hypertension lifestyle modifications and medication regimens with 
regard to improved prognosis. No doubt, evidence from such studies 
would act to motivate not only patients to comply but also health care 
professionals to intensify strategies to improve compliance. 
 
5.4.3 Limitations of the study 
 
This study was conducted in government owned health facilities on the Island 
of Praslin and did not include patients who attended private clinics. It cannot 
be assumed that the responses expressed by respondents in this study would 
be similar to those attending private clinics. 
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The small sample size and the research settings, limits the generalisability of 
the study findings beyond the study population. Only diagnosed hypertensive 
patients who were registered at the clinics participated in the study. Thus 
patients who were not registered or are yet to be diagnosed were excluded in 
this study. However, the sample was representative of the clinic attendees 
with regards to the general characteristics assessed in this study. 
 
5.5 CONCLUSION 
 
This was a quantitative descriptive-corelational study aimed at determining 
the level of compliance of hypertensive patients to their treatment. The Health 
Belief Model was applied to investigate the interrelationships between various 
variables in the model and compliance.  
 
The study revealed unacceptably high levels of uncontrolled hypertension and 
obesity despite high reported levels of compliance. The relatively high level of 
medication compliance reported in this study supports the interplay of other 
contributory factors to uncontrolled hypertension in addition to non-
compliance.  
 
Specifically, findings of this study have wide ranging implications for health 
care professionals dealing directly with hypertension patients in the health 
centres and generally with the Ministry of Health and Social Development 
whose mandate involves development and implementation of appropriate 
policies geared towards effective hypertension management in the whole 
country. The findings could potentially contribute towards evidence-based 
practice in the interest of improved patient care. 
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       ANNEXURE E 
 
                                 DOCUMENT ANALYSIS CHECKLIST 
 
 
Respondent identification code: _______________________________ 
 
 
SECTION A: MEDICAL DATA  
          Office use 
1 Medical diagnosis of 
hypertension noted 
Yes    1  
 No    2  
     A1   
        
2 Evidence of co-morbidity noted Coronary artery disease    1  
  Myocardial infarction    2  
  Cardiac failure    3  
  Renal failure    4  
  Visual impairment    4  
  Paralysis from old CVA    6  
  Angina    7  
     A2   
        
3 Medications prescribed Bendrofluazide    1  
  Frusemide    2  
  Lisinopril    3  
  Amlodipine    4  
  Atenolol    5  
  Methyldopa    6  
  Losartan    7  
  Spironolactone     8  
     A3   
  
 
 
 
      
4 Prescribed dosage  Single dose regimen    1  
  Multiple dose regimen    2  
  Combination of single and 
multiple dose regimen 
   3 
 
 
  
 
   A4   
         
5 Complaints of medication side 
effects noted during past three 
appointments 
Yes    1  
  No    2  
     A5   
 
6 Evidence of follow-up visit non-compliance noted 
for past three appointments 
Yes    1  
  No    2  
     A6   
        
7 Evidence of medication non-compliance noted 
during past three appointments noted 
Yes    1  
  No    2  
     A7   
        
8 Evidence of lifestyle modification non-compliance 
noted during past three appointments 
Yes    1  
  No    2  
     A8   
        
9 Evidence of uncontrolled hypertension noted 
during past three appointments 
Yes    1  
  No    2  
   
 
  A9   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE F 
 
 
CONSENT FORM 
 
RESEARCH TITLE: Factors affecting compliance with antihypertensive drug treatment and lifestyle 
modification among diagnosed hypertension patients on the Island of Praslin. 
 
Researcher: Dr Thomas Akpan Edo 
Supervisor:  Prof. L. de Villiers 
 
It is my pleasure to invite you to participate in a study with the above-mentioned title. The purpose of this study is 
to determine why some patients find it difficult to comply with their treatment for hypertension. Once I understand 
the reasons, I may be able to make recommendations that would improve the medical care which patients receive 
for hypertension and ultimately their quality of life.  
 
The researcher would use an interview schedule to ask you questions about hypertension and its treatment. The 
interview would last not more than 25 minutes and would not cause you any physiological, financial or 
psychological harm. May I also stress that your participation in the study is entirely voluntary and you may decide 
not to participate. And should you withdraw from the study be assured that this would not affect the services you 
receive at the health centre. Code names rather than your real name would be assigned to the interviews to 
ensure your anonymity and all data collected would be for the research purposes. The information you share with 
the researcher would be treated as confidential. 
 
Although you may not obtain immediate direct benefit by participating in this study, it is anticipated the outcome of 
this study would influence policies concerning both the management of hypertension and overall drug utilization in 
the health centres. 
Please sign this form if you agree to participate. 
I ----------------------------------- fully understand the nature of the study for which I have been invited to participate. I 
fully understand that the researcher would maintain my rights of anonymity and confidentiality. Therefore I hereby 
voluntarily give my consent to participate in the study. 
Participant’s full name: ___________________________________________ 
 
Participant's signature: ________________________ Date: ______________ 
 
Researcher's signature----------------------------------------- Date------------------------ 
 
        ANNEXURE G 
INTERVIEW SCHEDULE 
 
 
Respondent identification code: _______________________________ 
 
 
SECTION A: BIOGRAPHICAL DATA 
For office use 
1 Blood pressure / mmHg A1   
       
2 Weight  kg A2   
       
3 Height  metre A3   
       
4 BMI  Kg/m A4 2   
       
5 How old are you?    
     
  Less than 25 years   1 
  25-34 years   2 
  35-44 years   3 
  45-54 years   4 
  55-64 years   5 
  65-74 years   6 
  75 years or older   7 
  A5   
     
6 What is your gender?  
   
  Male   1 
  Female   2 
  A6   
     
7 What is your ethnic background?  
  Black   1 
  Mixed   2 
  White   3 
  Indian/Chinese   4 
 A7   
    
8 What is your marital status?  
   
  Never married   1 
  Married   2 
  Divorced   3 
  Separated   4 
  Widowed   5 
  Cohabiting   6 
 A8   
    
9 What is the highest level of education you have completed?  
   
  No schooling   1 
  Primary school   2 
  Secondary school   3 
  Post secondary school (eg college)   4 
  University   5 
  Other (specify) ___________________________   6 
 A9   
    
10 What has your work status been in the last 3 months?    
     
  Government employee   1 
  Non -government employee   2 
  Self-employed   3 
  Student   4 
  Retired   5 
  Unemployed   6 
 A10   
   
11 Over the past one-year can you tell me what the average 
earnings of your household have been per month in rupees? 
   
     
  SR 0 -999   1 
  SR 1000-1999   2 
  SR 2000-2999   3 
  SR 3000-3999   4 
  SR 4000-4999   5 
  SR 5000 and more   6 
 A11   
   
12 When were you first told that you have high blood pressure? Would you say  
   
  Less  than one year ago   1 
  One year ago   2 
  Two years ago   3 
  Three years ago   4 
  Four years ago   5 
  Five years ago   6 
  More than five years ago    7 
  A12   
   
13 What health complaints other than high blood pressure do you have?  
   
  Heart problems   1 
  Paralysis of a limb   2 
  Swelling of the feet   3 
  Swelling of the legs   4 
  Visual impairment   5 
  Kidney problems   6 
  Heart cramps (angina)   7 
  Shortness of breath on exertion   8 
  Shortness of breath at rest   9 
  Irregular heart beats (palpitations)   10 
  None   11 
  A13-
23 
  
    
14 How many kinds of medicine are you taking for your high blood pressure?  
   
  None   1 
  One   2 
  Two   3 
  Three   4 
  Four   5 
  More than 4   6 
  A24   
     
   
15 How many doses of medication did you skip during the past 
three days? 
   
     
  None   1 
  1-3   2 
  4-5   3 
  More than 5   4 
  All   5 
 A25   
16 How many cigarettes do you smoke per day?    
     
  None   1 
  1-4   2 
  5-9   3 
  10-14   4 
  15-19   5 
  20 and more   6 
 A26   
17 How often do you consume alcohol per day?    
     
  More than once per day   1 
  Once daily   2 
  A few times per week   3 
  About once a week   4 
  Less than once per week   5 
  Seldom    6 
               Never   7 
 A27   
 
 
SECTION B:  COMPLIANCE TO THE MEDICATION REGIMEN 
 
 
How often 
Daily 
 
4 
Frequently 
 
3 
Rarely 
 
2 
Never 
 
1 
 Office use  
1 do you take your medicine as prescribed?      B1  
2 do you forget to take your medicine?      B2  
3 are you careless about taking your medicine?      B3  
4 do you stop taking your medicine because you feel 
better? 
      
B4 
 
5 do you stop taking your medicine because it makes 
you feel  worse? 
      
B5 
 
6 do you stop taking the medication because you 
believe that they are ineffective? 
      
B6 
 
7 do you stop taking your medicine because you try to 
avoid addiction? 
      
B7 
 
8 do you stop taking your medicine because you fear 
negative side-effects? 
      
B8 
 
9  do you stop taking your medicine because the doctor 
changes the type of medicine frequently? 
      
B9 
 
10 do you stop taking your medicine because the doctor 
changes the dosage frequently? 
      
B10 
 
11 do you stop taking your medicine because you want to 
try out alternative remedies? 
      
B11 
 
12 do you obtain a medication refill in before   you run out 
of medicine? 
     
B12 
 
13 do you turn up for your clinic appointments as 
scheduled? 
      
B13 
 
14 do you have your blood pressure checked?       
B14 
 
 
SECTION C: COMPLIANCE TO THE LIFESTYLE MODIFICATION REGIMEN 
 
 
How often do you 
Daily 
 
4 
Frequently 
 
3 
Rarely 
 
2 
Never 
 
1 
 Office use  
1 smoke?      C1  
2 drink alcohol?      C2  
3 eat a meal high in animal fat?      C3  
4 eat vegetables?      C4  
5 eat fruits?      C5  
6 eat fast food?      C6  
7 sprinkle salt on your food?      C7  
8 engage in physical exercise?      C8  
9 try to lose some weight?      C9  
10 relax?      C10  
11 get enough sleep?      C11  
 
 
SECTION D: PERCEPTIONS OF SEVERITY 
 
To what extent do you agree with the following 
statements? 
Strongly 
agree 
 
4 
Agree 
 
 
3 
Disagree 
 
 
2 
Strongly 
disagree 
 
1 
  Office use  
1 My blood pressure condition is serious      D1  
2 I am relaxed about my blood pressure condition 
because I don’t have any symptoms 
      
D2 
 
3 I am worried about my blood pressure condition 
because I have symptoms 
     D3  
4 I think I am cured because I do not have symptoms        
D4 
 
 
SECTION E: PERCEPTIONS OF RISK 
 
 How do you view your risk of the following 
happening to you as a result of your high blood 
pressure? 
75-100% 
chance 
 
4 
50-74% 
chance 
 
3 
25-49% 
chance 
 
2 
0-24% 
chance 
 
1 
   
1 to have a stroke      E1  
2 to develop visual impairment       E2  
3 to develop heart problems      E3  
4 to develop kidney problems       E4  
5 to develop paralysis       E5  
6 to become a burden for my family       E6  
7 career being negatively affected      E7  
8 disrupted family life       E8  
9 disrupted social life       E9  
 
 
SECTION F: PERCEPTIONS OF BENEFITS 
 
 How do you view the benefits of complying with 
the doctor’s treatment? 
Extremely 
beneficial 
 
 
4 
Bene-
ficial 
 
 
3 
Some-
what 
beneficial 
 
2 
Not at all 
beneficial 
 
1 
   
1 keeping my blood pressure under control      F1  
2 increasing my quality of life      F2  
3 increasing my sense of well-being      F3  
4 protecting me from complications       F4  
5 avoiding added financial burden to treat complications      F5  
6 decreasing my chance of dying        F6  
7 giving me peace of mind       F7  
 
SECTION G: PERCEPTIONS OF BARRIERS 
 
 Which aspects are problematic and hinder you 
from complying with your treatment 
Extremely 
problematic 
 
 
4 
Proble-
matic 
 
 
3 
Some-
what 
problemati
c 
2 
Not at all 
proble-
matic 
 
1 
   
1 ineffectiveness of the medicine to stabilise my blood 
pressure 
     G1  
2 lack of motivation because I cannot be cured      G2  
3 not having enough time to exercise      G3  
4 
 
lack of discipline to comply with the dietary 
restrictions 
     G4  
5 lack of discipline to stop smoking      G5 
 
 
6 lack of time to relax      G6  
7 having sleeping problems      G7  
 
 
SECTION H: INTERNAL FACTORS 
 To what extent do you agree with the following 
statements? 
Strongly 
agree 
4 
Agree 
 
3 
Disagree 
 
2 
Strongly 
disagree 
1 
   
1 I understand the nature of my condition      H1  
2 I understand what caused my blood pressure 
condition 
     H2  
3 I understand how my medication work to keep my 
blood pressure under control 
     H3  
4 I understand why it is necessary to take my medicine 
as prescribed 
     H4  
5 I understand what I can do to keep my blood pressure      H5  
under control 
6 I understand the meaning of the blood pressure 
readings 
     H6  
7 I think that I can cure my hypertension with local 
herbs other than the prescribed medication 
     H7  
8 I have the ability to manage my hypertension       H8  
9 I am primarily responsible for managing my 
hypertension 
     H9  
10 My doctor is primarily responsible to manage my 
hypertension 
     H10  
11 I am in charge of my physical health       H11 
 
 
12 My physical health is determined largely by what I do 
or what I don’t do 
     H12  
13 I am aware of how healthy my body feels.      H13  
14 I notice immediately when my body does not feel 
healthy 
     H14  
 
SECTION I: HEALTH CARE PROVIDER FACTORS 
 
To what extent do you agree with the following 
statements? 
Strongly 
agree 
4 
Agree 
 
3 
Disagree 
 
2 
Strongly 
disagree 
1 
 FOR OFFICE 
USE  
1 The waiting time at the clinic is acceptable      I1  
2 The doctor who attends to me at the clinic is 
experienced  
     I2 
 
 
3 The doctor who attends to me at the clinic is 
knowledgeable 
     I3  
4 I have confidence in the doctor       I4  
5 The doctor is patient with me      I5  
6 The doctor treats me with respect      I6  
7 The health care workers other than the doctors treat 
me with respect 
     I7  
8 The doctor listens to my concerns      I8  
9 The doctor understands my  concerns      I9 
 
 
10 The doctor clearly explains my condition to me       I10 
 
 
11 The doctor clearly explains to me how I should 
manage my blood pressure condition 
     I11 
 
 
12 The availability of medicine when I need it is good      I12  
13 The medicine I receive at the clinic is effective      I13 
 
 
 
SECTION J: CUES TO ACTION 
 
Which of the following motivates you to comply with 
your blood pressure treatment? 
Strongly 
agree 
4 
Agree 
 
3 
Disagree 
 
2 
Strongly 
disagree 
1 
 FOR OFFICE 
USE  
1 TV programmes on high blood pressure      J1  
2 radio programmes on high blood pressure      J2 
 
 
3 advice from my friends      J3 
 
 
4 advice from my doctor      J4  
5 advice from a health care worker other than my doctor      J5  
6 advice from a family member      J6  
7 death of a relation or friend due to high blood      J7  
pressure 
8 newspaper or journal article      J8  
9 information on the internet       J9  
10 health posters displayed       J10  
11 health education leaflets given to me      J11  
12 when I feel unwell      J12  
 
 
 
 
 
 
 
 
 
